data_5x39_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5x39 _Structure_validation_residue.Date_analyzed 2017-05-26 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.46 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 p -104.69 153.12 21.66 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.22 -173.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -69.67 123.19 20.72 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 78.06 6.96 2.61 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.589 1.156 . . . . 0.0 112.002 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -103.3 167.29 16.69 Favored Glycine 0 N--CA 1.423 -2.213 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 175.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.6 tt0 -70.39 127.63 33.4 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.634 ' O ' ' HA ' ' A' ' 17' ' ' THR . 20.1 p -103.52 -39.1 6.87 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.18 76.13 0.11 Allowed Glycine 0 CA--C 1.484 -1.844 0 C-N-CA 118.392 -1.861 . . . . 0.0 113.608 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.34 169.78 16.77 Favored Glycine 0 C--N 1.291 -1.926 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 176.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.0 mt -66.95 119.49 12.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.71 -17.17 42.9 Favored Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -85.1 106.25 16.43 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.0 p -94.37 4.9 53.26 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.298 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.26 -169.8 32.65 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 115.553 -0.748 . . . . 0.0 112.692 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -59.55 114.49 2.07 Favored 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 123.592 2.861 . . . . 0.0 111.797 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.7 p -93.98 -17.12 23.27 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.539 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.8 t -88.68 120.59 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.7 m -72.89 167.61 20.64 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.42 165.0 24.96 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.419 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.1 m -64.85 124.11 21.13 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 120.643 0.259 . . . . 0.0 110.367 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.92 -0.01 48.41 Favored Glycine 0 N--CA 1.432 -1.593 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.331 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.556 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 42.1 p -128.43 151.03 49.85 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.6 p -130.15 137.72 50.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.759 0.314 . . . . 0.0 111.679 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.1 t -74.16 114.78 12.89 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.506 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 50.0 mt-30 -121.76 117.7 27.24 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-O 121.379 0.609 . . . . 0.0 111.109 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.5 t -71.02 116.89 13.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.437 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.9 mt -97.44 -39.76 9.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.889 0.852 . . . . 0.0 108.95 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -137.7 164.32 42.07 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -62.61 -32.73 79.27 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 CA-C-N 120.865 1.344 . . . . 0.0 112.002 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.491 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 31.1 m-85 -97.77 -26.58 14.67 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 119.094 -1.042 . . . . 0.0 111.597 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.407 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 68.4 t80 -105.3 114.32 28.43 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 119.779 -0.769 . . . . 0.0 112.664 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.0 m -121.05 130.8 53.93 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 174.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.407 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 53.9 tt0 -115.06 140.78 48.78 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -173.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.556 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 13.3 t -87.12 112.96 22.44 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.593 178.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.506 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 81.3 mt . . . . . 0 C--N 1.278 -2.532 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.495 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.8 p -98.09 153.51 18.38 Favored 'General case' 0 C--N 1.272 -2.78 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.146 -172.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -65.35 122.51 17.31 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 79.34 12.26 1.26 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.815 1.246 . . . . 0.0 111.416 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -107.56 168.05 13.86 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.437 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.5 tt0 -77.31 122.4 25.05 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.578 ' O ' ' HA ' ' A' ' 17' ' ' THR . 7.2 p -104.97 -37.01 7.13 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.32 68.13 0.12 Allowed Glycine 0 CA--C 1.474 -2.53 0 C-N-CA 118.052 -2.023 . . . . 0.0 113.127 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.84 165.75 13.99 Favored Glycine 0 C--N 1.284 -2.316 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.0 mt -62.21 126.71 20.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.92 -11.52 57.49 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.88 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -100.9 126.6 47.53 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.8 p -119.26 14.48 12.99 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.491 0.663 . . . . 0.0 111.661 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.88 -155.86 16.12 Favored Glycine 0 C--O 1.258 1.644 0 CA-C-N 115.954 -0.566 . . . . 0.0 113.086 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -56.27 104.94 0.15 Allowed 'Trans proline' 0 C--O 1.222 -0.277 0 C-N-CA 123.854 3.036 . . . . 0.0 113.372 174.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.0 p -87.79 -15.76 36.0 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.55 0.691 . . . . 0.0 110.776 177.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.8 t -88.09 122.94 40.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.069 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.402 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 56.6 m -79.22 175.3 10.71 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.344 0.592 . . . . 0.0 112.274 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.74 163.4 24.52 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.2 m -64.64 122.95 18.04 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.77 5.76 54.97 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.433 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.58 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 40.0 p -128.28 149.21 50.59 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.3 p -130.61 138.7 50.24 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 117.793 0.269 . . . . 0.0 111.275 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.7 t -72.98 111.42 8.07 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -109.6 133.09 53.52 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-O 121.292 0.568 . . . . 0.0 110.515 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.6 t -83.83 105.93 13.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.646 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.1 mt -87.41 -38.36 16.22 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.981 0.896 . . . . 0.0 108.691 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -144.51 167.77 14.09 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -64.45 -41.71 19.39 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 CA-C-N 120.807 1.324 . . . . 0.0 112.101 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.511 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 17.7 m-85 -91.97 -26.44 18.4 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.628 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -104.76 113.24 26.7 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.875 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.4 m -121.89 130.01 53.01 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 174.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -119.94 139.01 53.1 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -173.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.58 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 9.7 t -81.03 117.08 21.32 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-O 121.502 0.668 . . . . 0.0 110.093 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 N--CA 1.405 -2.678 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.693 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.036 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 99.8 p -86.71 166.79 15.02 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.705 -175.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -70.89 123.87 23.02 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 78.53 11.69 1.66 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.059 0.944 . . . . 0.0 112.493 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.37 160.83 19.06 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 174.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.3 tt0 -73.79 121.63 21.15 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 17' ' ' THR . 6.8 p -103.53 -44.15 5.2 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -174.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.35 68.15 0.24 Allowed Glycine 0 CA--C 1.476 -2.377 0 C-N-CA 118.183 -1.96 . . . . 0.0 113.559 -171.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -104.73 160.15 15.61 Favored Glycine 0 C--N 1.279 -2.626 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.3 mt -62.51 122.83 14.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.33 -14.85 50.97 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.045 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -92.01 116.45 28.93 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 p -111.63 21.25 16.31 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.41 0.624 . . . . 0.0 111.675 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.76 -153.87 20.02 Favored Glycine 0 C--O 1.252 1.241 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.975 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.77 110.56 0.99 Allowed 'Trans proline' 0 C--N 1.328 -0.523 0 C-N-CA 123.889 3.059 . . . . 0.0 111.871 174.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 62.7 p -96.31 -20.94 18.13 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.745 0.783 . . . . 0.0 110.524 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.7 t -82.04 118.46 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.092 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.3 m -77.21 164.09 25.93 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 120.991 0.424 . . . . 0.0 111.72 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.46 153.85 37.36 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.7 m -60.88 121.03 11.34 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.41 0.624 . . . . 0.0 111.22 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.22 -20.84 23.07 Favored Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.554 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.526 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 35.3 p -105.65 146.55 29.56 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 122.278 -0.542 . . . . 0.0 110.101 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.1 p -124.85 134.16 52.83 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 122.352 0.261 . . . . 0.0 110.784 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.5 t -73.11 112.91 9.58 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -116.82 132.65 56.64 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-O 121.246 0.546 . . . . 0.0 111.116 -177.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.3 t -75.22 117.01 18.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.783 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 32.8 mt -93.87 -48.47 6.27 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.413 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 81.1 m-20 -131.18 167.67 20.66 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 29' ' ' ASN . 1.6 Cg_endo -60.9 -33.34 92.69 Favored 'Trans proline' 0 C--N 1.359 1.13 0 CA-C-N 121.335 1.513 . . . . 0.0 113.167 -176.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.582 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 82.4 m-85 -99.95 -25.21 14.4 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.239 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -103.57 113.83 27.63 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.583 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.7 m -120.93 132.04 54.71 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 175.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -119.98 139.76 51.98 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -174.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.526 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 9.9 t -84.87 121.38 27.65 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.201 -177.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 N--CA 1.422 -1.833 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 -176.923 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.572 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.6 p -85.37 163.73 18.37 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.996 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -65.95 124.41 22.46 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 81.26 9.62 0.96 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.146 1.378 . . . . 0.0 112.114 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.07 164.65 20.53 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 33' ' ' SER . 61.5 tt0 -75.6 125.25 28.66 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 17' ' ' THR . 24.5 p -112.75 1.72 15.75 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -172.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.18 73.98 0.01 OUTLIER Glycine 0 CA--C 1.487 -1.68 0 C-N-CA 116.695 -2.669 . . . . 0.0 114.895 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.602 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -94.96 165.04 25.28 Favored Glycine 0 N--CA 1.423 -2.218 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 176.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.5 mt -62.05 115.91 2.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 121.206 0.527 . . . . 0.0 110.805 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.96 1.19 70.51 Favored Glycine 0 C--N 1.312 -0.796 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.039 -178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -100.11 106.84 18.61 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.9 p -101.99 18.8 19.75 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.954 -176.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.97 -161.14 16.06 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.95 114.02 1.43 Allowed 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 123.526 2.817 . . . . 0.0 111.783 175.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 12.9 p -110.69 -30.3 7.65 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.501 0.667 . . . . 0.0 111.499 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.5 t -79.7 128.51 38.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.8 m -88.65 174.02 8.28 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.22 0.533 . . . . 0.0 112.348 -177.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.66 169.66 12.49 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.781 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.4 m -63.64 113.09 3.13 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.78 9.57 32.44 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.164 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.63 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 21.4 p -132.13 149.12 52.48 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-N 117.451 0.626 . . . . 0.0 110.595 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.8 p -128.34 139.04 52.61 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.466 0.175 . . . . 0.0 111.393 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.3 t -76.57 117.86 18.64 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -118.65 128.29 54.39 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-O 121.368 0.604 . . . . 0.0 110.936 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -79.23 114.25 19.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.272 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.6 mt -95.87 -44.49 7.37 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -136.71 167.61 20.54 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -63.91 -42.46 19.37 Favored 'Trans proline' 0 C--O 1.241 0.639 0 CA-C-N 120.99 1.389 . . . . 0.0 112.577 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.602 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 76.8 m-85 -92.06 -24.81 19.05 Favored 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.412 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -104.66 113.83 27.66 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.568 -0.853 . . . . 0.0 112.273 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 35.1 m -122.55 134.83 54.53 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 174.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -122.09 140.97 51.88 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -174.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.63 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 10.4 t -84.82 114.57 22.18 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.0 mt . . . . . 0 C--N 1.283 -2.298 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -176.528 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.381 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.9 p -83.87 153.93 23.73 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.558 -173.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -61.94 119.34 8.65 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 85.1 3.45 0.65 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.29 1.436 . . . . 0.0 112.743 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.81 165.16 22.02 Favored Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -73.35 128.76 36.39 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 17' ' ' THR . 14.5 p -107.2 -45.76 4.04 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -175.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.09 74.75 0.14 Allowed Glycine 0 CA--C 1.488 -1.62 0 C-N-CA 118.265 -1.921 . . . . 0.0 114.427 -173.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.76 164.57 13.89 Favored Glycine 0 C--N 1.295 -1.739 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 175.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.401 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 53.3 mt -61.74 120.37 7.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 117.29 0.545 . . . . 0.0 110.252 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.47 -7.85 51.26 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.5 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -100.79 106.65 18.07 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.3 p -104.33 28.27 7.03 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.583 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.44 -163.67 39.26 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -59.16 111.71 1.0 Allowed 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.399 2.733 . . . . 0.0 111.476 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 36.3 p -99.39 -11.0 21.55 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.172 0.51 . . . . 0.0 111.791 -178.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.6 t -85.23 120.52 35.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 57.0 m -84.52 158.65 20.91 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.35 0.595 . . . . 0.0 112.382 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.39 172.62 11.58 Favored 'General case' 0 C--O 1.251 1.136 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.884 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.5 m -64.86 112.55 3.32 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 123.196 0.598 . . . . 0.0 110.95 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.19 -4.14 38.14 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.44 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.641 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 37.5 p -117.65 147.39 42.94 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.041 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.0 p -129.77 140.62 51.02 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 123.1 0.25 . . . . 0.0 110.795 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -75.14 102.86 5.09 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 121.054 0.454 . . . . 0.0 110.34 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -101.02 124.01 46.09 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-O 121.96 0.886 . . . . 0.0 112.388 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.3 t -77.91 112.93 16.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 114.176 -1.375 . . . . 0.0 108.688 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.423 HD11 ' CE1' ' A' ' 32' ' ' TYR . 89.0 mt -94.14 -39.62 10.48 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -141.08 169.15 12.1 Favored Pre-proline 0 C--N 1.297 -1.701 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.9 -36.31 39.86 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 CA-C-N 121.24 1.479 . . . . 0.0 113.144 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.582 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 31.0 m-85 -98.94 -25.6 14.54 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.059 -176.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.423 ' CE1' HD11 ' A' ' 28' ' ' LEU . 67.7 t80 -104.04 114.12 28.15 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.116 0.484 . . . . 0.0 111.639 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 m -126.35 132.31 51.62 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 175.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -119.89 139.34 52.55 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.641 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.0 t -82.7 115.67 21.73 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.837 -178.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.4 mt . . . . . 0 N--CA 1.418 -2.075 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 -179.546 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -1.777 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.1 p -101.99 155.26 18.28 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.557 -171.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -66.92 125.19 25.17 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 81.07 -0.4 1.75 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.909 1.283 . . . . 0.0 111.612 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -96.17 172.14 28.99 Favored Glycine 0 N--CA 1.428 -1.853 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.557 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.1 tt0 -78.57 130.61 36.14 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 17' ' ' THR . 21.4 p -113.6 -25.83 8.54 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -175.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.2 65.96 0.09 OUTLIER Glycine 0 CA--C 1.489 -1.575 0 C-N-CA 118.273 -1.918 . . . . 0.0 113.431 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.79 165.33 13.92 Favored Glycine 0 C--N 1.298 -1.574 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 176.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.8 mt -60.17 117.77 2.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 117.341 0.57 . . . . 0.0 109.896 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.6 -2.96 57.47 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.349 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -92.52 108.42 19.96 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 p -104.81 26.43 9.18 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.426 -177.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.98 -169.44 33.59 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.327 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -58.14 126.39 21.41 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.901 3.067 . . . . 0.0 111.311 176.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 4.9 p -102.61 -21.14 14.2 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.064 -176.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.7 t -81.71 121.33 34.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.4 m -75.64 174.48 9.7 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.14 165.05 17.76 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.481 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.2 m -58.1 115.29 2.81 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 123.17 0.588 . . . . 0.0 111.271 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.84 -14.25 37.95 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.613 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.589 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 34.3 p -111.97 148.4 33.86 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 122.477 -0.425 . . . . 0.0 111.433 -177.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.4 p -126.63 139.35 53.24 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.1 t -74.08 110.62 8.51 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.435 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 76.3 mt-30 -111.07 119.42 38.96 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-O 121.468 0.652 . . . . 0.0 110.189 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.7 t -78.42 109.69 13.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.162 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.472 HD12 ' CE2' ' A' ' 32' ' ' TYR . 76.0 mt -88.79 -51.36 5.69 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -125.55 167.15 17.38 Favored Pre-proline 0 C--N 1.291 -1.964 0 N-CA-C 105.026 -2.212 . . . . 0.0 105.026 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -65.4 -33.59 46.84 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 CA-C-N 120.799 1.321 . . . . 0.0 111.188 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.468 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 6.7 m-85 -94.6 -27.45 15.9 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.27 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.529 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 52.9 t80 -105.27 114.01 27.94 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.264 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.5 m -126.39 127.69 45.86 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 175.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.529 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 31.8 tt0 -116.94 137.95 51.87 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 123.416 0.447 . . . . 0.0 110.209 -174.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.589 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 14.9 t -84.22 121.91 28.14 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 119.819 -0.753 . . . . 0.0 109.493 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.435 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 97.2 mt . . . . . 0 C--N 1.294 -1.818 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -1.746 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.3 p -78.34 164.02 25.19 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.118 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -65.21 123.19 18.9 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 82.78 5.65 0.92 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.866 1.266 . . . . 0.0 111.629 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.53 160.03 20.43 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 175.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.549 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.4 tt0 -70.92 137.76 49.52 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 17' ' ' THR . 23.5 p -126.54 -4.0 6.63 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -173.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.73 70.74 0.02 OUTLIER Glycine 0 CA--C 1.487 -1.686 0 C-N-CA 117.295 -2.383 . . . . 0.0 114.071 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.53 167.43 14.74 Favored Glycine 0 C--N 1.294 -1.773 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 176.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.2 mt -63.63 119.61 8.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 117.746 0.773 . . . . 0.0 110.282 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.62 14.52 59.68 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.105 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -101.21 113.38 26.37 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.114 0.483 . . . . 0.0 110.142 177.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.5 p -101.15 8.44 42.71 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.171 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.26 -165.98 41.13 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.544 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.27 118.53 5.41 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.879 3.053 . . . . 0.0 112.192 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.1 p -106.87 -5.46 18.3 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.85 0.833 . . . . 0.0 111.126 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.2 t -98.02 117.46 42.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.325 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.0 m -78.2 179.18 7.05 Favored 'General case' 0 C--O 1.254 1.321 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.07 -179.14 4.43 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.646 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.1 m -72.41 121.91 20.34 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.29 19.35 36.02 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.005 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.675 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 23.6 p -140.29 142.63 35.67 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.1 p -131.63 139.87 49.24 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 123.319 0.387 . . . . 0.0 111.477 -177.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.3 t -73.05 114.14 10.88 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 120.835 0.35 . . . . 0.0 110.41 -178.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.505 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 67.4 mt-30 -111.33 123.31 49.95 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 120.876 0.37 . . . . 0.0 110.163 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.2 t -81.43 108.75 14.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.3 mt -86.27 -42.49 13.71 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -140.79 165.49 29.29 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.64 -31.17 59.86 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 120.932 1.369 . . . . 0.0 112.9 -175.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.535 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 68.9 m-85 -100.35 -26.84 13.75 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 119.051 -1.059 . . . . 0.0 110.302 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -105.7 114.01 27.92 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.961 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.549 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.2 m -123.03 134.71 54.28 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -122.32 138.28 54.57 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -172.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.675 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 9.8 t -83.02 114.48 21.3 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.419 0.628 . . . . 0.0 110.293 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.505 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 52.9 mt . . . . . 0 N--CA 1.412 -2.349 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.172 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.3 p -96.86 159.96 14.63 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.369 0.604 . . . . 0.0 112.195 -173.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -68.51 123.07 19.82 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 81.67 5.86 1.21 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.793 1.237 . . . . 0.0 112.483 -175.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.75 164.39 18.69 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 175.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.2 tt0 -71.66 137.11 47.61 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 17' ' ' THR . 10.4 p -125.9 -16.92 5.51 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -174.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.16 64.62 0.07 OUTLIER Glycine 0 CA--C 1.489 -1.568 0 C-N-CA 117.687 -2.197 . . . . 0.0 113.759 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.588 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -106.01 162.29 14.08 Favored Glycine 0 C--N 1.295 -1.731 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.215 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.4 mt -64.14 119.09 7.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.058 0.456 . . . . 0.0 109.894 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.74 -22.79 23.25 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.224 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -87.66 132.14 34.2 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 123.666 0.786 . . . . 0.0 109.109 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.9 p -131.66 17.73 4.76 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.127 0.489 . . . . 0.0 111.012 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.55 -156.97 23.7 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.435 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.19 114.79 1.8 Allowed 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 124.11 3.206 . . . . 0.0 112.254 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.1 p -103.77 -25.61 13.04 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.663 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.0 t -81.91 111.24 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 47.2 m -68.59 156.76 37.47 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.28 158.91 19.04 Favored 'General case' 0 C--O 1.253 1.239 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.625 176.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -65.35 112.99 3.76 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.014 0.435 . . . . 0.0 110.825 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.7 -2.38 29.01 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.257 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.529 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 26.4 p -120.24 150.07 41.26 Favored 'General case' 0 C--N 1.319 -0.749 0 O-C-N 122.329 -0.512 . . . . 0.0 110.908 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.1 p -126.6 138.42 53.45 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 122.446 0.299 . . . . 0.0 111.714 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 34.4 t -75.37 117.87 17.64 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -120.12 124.6 46.19 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.72 0.771 . . . . 0.0 111.207 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.7 t -76.78 117.67 22.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.483 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.455 HD12 ' CE2' ' A' ' 32' ' ' TYR . 88.0 mt -100.05 -44.66 5.93 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -130.87 167.4 21.59 Favored Pre-proline 0 C--N 1.31 -1.132 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -64.32 -35.18 52.24 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 CA-C-N 120.998 1.392 . . . . 0.0 111.048 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.588 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 27.8 m-85 -94.05 -27.49 16.26 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 119.879 -0.728 . . . . 0.0 109.927 -178.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.561 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 54.5 t80 -103.99 113.95 27.84 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.654 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.1 m -129.18 123.67 32.66 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.561 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 32.8 tt0 -113.69 141.59 47.05 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 123.647 0.592 . . . . 0.0 109.974 -173.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.529 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 9.0 t -85.02 121.68 28.15 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.428 -1.555 0 C-N-CA 123.829 0.852 . . . . 0.0 109.522 -176.856 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.573 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.5 p -75.15 165.24 25.52 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.531 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -69.38 127.96 34.87 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 76.37 6.91 3.51 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.276 1.431 . . . . 0.0 112.171 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.82 165.06 28.04 Favored Glycine 0 C--O 1.256 1.494 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 176.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.2 tt0 -72.94 120.27 18.33 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.586 ' O ' ' HA ' ' A' ' 17' ' ' THR . 22.1 p -100.93 -39.12 7.91 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -174.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.59 75.34 0.09 OUTLIER Glycine 0 CA--C 1.484 -1.906 0 C-N-CA 117.873 -2.108 . . . . 0.0 113.881 -173.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.52 169.08 15.84 Favored Glycine 0 C--N 1.285 -2.278 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 176.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.4 mt -61.22 127.59 21.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 117.655 0.727 . . . . 0.0 109.901 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.89 -21.65 42.53 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.11 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -79.41 116.71 19.8 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 121.05 0.453 . . . . 0.0 109.813 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 p -107.11 17.55 22.84 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.202 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.36 -176.49 51.35 Favored Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.389 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -54.04 111.3 0.66 Allowed 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 124.076 3.184 . . . . 0.0 112.627 177.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.2 p -89.09 -23.34 22.53 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.074 0.464 . . . . 0.0 111.914 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -79.81 118.69 27.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.8 m -73.73 171.39 13.4 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.05 -179.34 6.62 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.779 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.0 m -70.65 119.97 15.58 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.08 20.19 33.95 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 119.863 -1.16 . . . . 0.0 112.897 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.765 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 21.9 p -136.72 148.37 47.27 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.8 p -127.17 134.83 50.1 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 122.838 0.455 . . . . 0.0 111.081 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.6 t -75.25 112.57 11.67 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -118.78 127.27 53.37 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-O 121.042 0.449 . . . . 0.0 110.575 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.3 t -74.23 121.92 26.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.526 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.6 mt -101.75 -37.52 8.28 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.595 0.712 . . . . 0.0 109.466 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.409 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 52.2 m-80 -142.15 167.44 16.59 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 29' ' ' ASN . 1.8 Cg_endo -61.83 -32.47 85.6 Favored 'Trans proline' 0 C--N 1.353 0.793 0 CA-C-N 121.187 1.459 . . . . 0.0 112.762 -176.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.617 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 63.8 m-85 -100.43 -25.97 14.03 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.797 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -103.69 114.11 28.13 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.814 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.8 m -123.42 133.73 54.04 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -120.01 142.65 48.61 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -173.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.765 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 13.4 t -86.88 118.78 26.49 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.159 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 C--N 1.295 -1.783 0 C-N-CA 123.687 0.795 . . . . 0.0 108.928 -179.644 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.008 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 p -83.99 159.19 21.28 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -64.52 126.31 27.46 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.89 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 78.48 1.29 2.61 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.94 1.296 . . . . 0.0 113.408 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.49 164.83 24.54 Favored Glycine 0 C--O 1.254 1.352 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.599 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.0 tt0 -68.24 120.18 13.99 Favored 'General case' 0 C--O 1.207 -1.154 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 17' ' ' THR . 15.0 p -102.51 -29.28 11.68 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -175.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.19 65.88 0.1 Allowed Glycine 0 CA--C 1.483 -1.918 0 C-N-CA 118.415 -1.85 . . . . 0.0 112.652 -175.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.76 162.68 14.09 Favored Glycine 0 N--CA 1.429 -1.818 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 178.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.2 mt -59.47 123.34 11.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.29 -13.29 58.56 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.323 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -87.79 113.96 23.95 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.1 p -101.27 9.36 41.84 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.677 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.6 -171.68 48.34 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.411 -177.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.94 122.34 11.56 Favored 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 124.211 3.274 . . . . 0.0 111.753 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 29.1 p -101.07 -18.58 16.18 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.103 0.478 . . . . 0.0 111.558 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.0 t -79.16 113.89 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.9 m -71.91 169.48 15.76 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.7 169.39 18.32 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.409 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.4 m -58.01 121.46 10.66 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.301 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.86 -18.45 54.86 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.692 176.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.598 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 43.8 p -103.37 146.84 27.88 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 122.5 -0.412 . . . . 0.0 111.045 -176.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.2 p -127.41 144.56 51.04 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 122.144 0.177 . . . . 0.0 110.831 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -80.62 113.36 18.76 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.076 0.465 . . . . 0.0 109.855 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.416 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 78.7 mt-30 -113.54 112.89 24.32 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-O 121.198 0.523 . . . . 0.0 109.825 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -75.4 104.02 3.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.1 mt -80.3 -48.19 13.38 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.464 0.649 . . . . 0.0 109.429 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.57 165.21 31.29 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.46 -37.29 72.23 Favored 'Trans proline' 0 C--O 1.246 0.894 0 CA-C-N 121.469 1.56 . . . . 0.0 112.56 -176.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.502 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 46.6 m-85 -93.06 -26.27 17.56 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.927 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.514 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 63.9 t80 -104.0 113.5 27.08 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 118.966 -1.093 . . . . 0.0 112.376 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.5 m -121.84 132.5 54.61 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 175.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.514 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 33.2 tt0 -120.98 136.53 54.96 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 123.154 0.284 . . . . 0.0 110.296 -174.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.598 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 14.4 t -83.56 122.04 28.03 Favored 'General case' 0 N--CA 1.429 -1.522 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.728 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.416 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 89.8 mt . . . . . 0 C--N 1.291 -1.942 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.019 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.3 p -100.8 165.47 11.35 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.286 -175.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.477 ' CD2' ' HA ' ' A' ' 36' ' ' LEU . 14.3 t-160 -69.02 123.8 22.02 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 82.48 9.69 0.71 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.221 1.409 . . . . 0.0 112.61 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.52 158.19 19.33 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.577 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.3 tt0 -68.88 127.06 31.76 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 17' ' ' THR . 13.3 p -116.58 5.76 13.34 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -173.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.93 75.42 0.01 OUTLIER Glycine 0 CA--C 1.482 -2.012 0 C-N-CA 116.934 -2.555 . . . . 0.0 114.791 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.87 165.39 13.89 Favored Glycine 0 C--N 1.289 -2.075 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 175.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 30' ' ' PRO . 60.1 mt -61.62 127.03 20.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.95 -13.71 66.84 Favored Glycine 0 C--N 1.312 -0.788 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.052 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -101.43 114.0 27.62 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 123.191 0.596 . . . . 0.0 109.7 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.8 p -111.06 21.81 15.98 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.035 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.25 -160.95 25.94 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.995 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.27 111.05 0.48 Allowed 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.989 3.126 . . . . 0.0 112.911 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 14.6 p -105.47 -23.99 12.71 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.631 0.729 . . . . 0.0 111.436 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.9 t -85.83 120.64 36.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.6 m -79.41 163.29 24.93 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 120.972 0.415 . . . . 0.0 111.905 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.8 163.52 25.64 Favored 'General case' 0 C--O 1.253 1.247 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -65.82 117.53 8.35 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 120.963 0.411 . . . . 0.0 110.178 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.8 -19.48 25.67 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.86 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.642 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 19.8 p -103.14 147.6 26.81 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 122.445 -0.444 . . . . 0.0 109.909 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.4 p -127.47 135.26 50.16 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 122.475 0.31 . . . . 0.0 111.311 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.3 t -73.87 111.3 8.9 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.423 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 76.5 mt-30 -109.15 121.74 45.8 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-O 121.517 0.675 . . . . 0.0 109.613 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.9 t -80.14 104.31 8.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.368 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.8 mt -80.7 -44.34 18.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.863 0.84 . . . . 0.0 108.908 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -136.15 164.4 43.26 Favored Pre-proline 0 C--N 1.298 -1.655 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.473 ' O ' HG13 ' A' ' 11' ' ' ILE . 4.3 Cg_exo -64.4 -30.59 62.68 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 CA-C-N 120.554 1.234 . . . . 0.0 111.664 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.582 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 78.6 m-85 -97.77 -27.86 14.13 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 118.919 -1.113 . . . . 0.0 111.314 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.418 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 61.6 t80 -105.9 114.31 28.38 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.469 -0.892 . . . . 0.0 112.316 175.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.577 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 36.6 m -121.49 131.36 54.1 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 175.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.418 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 36.1 tt0 -120.66 138.52 53.89 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -174.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.642 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 12.0 t -85.84 123.21 30.95 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 120.364 -0.535 . . . . 0.0 110.544 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.477 ' HA ' ' CD2' ' A' ' 4' ' ' HIS . 95.6 mt . . . . . 0 C--N 1.286 -2.169 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.854 0 CA-C-O 121.006 0.431 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.1 p -99.66 152.82 19.63 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.718 -172.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -71.77 122.73 21.18 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.422 ' HA ' ' CG ' ' A' ' 34' ' ' GLN . 55.7 m-85 77.8 2.19 2.92 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.546 1.138 . . . . 0.0 111.546 -175.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -97.28 174.16 29.51 Favored Glycine 0 N--CA 1.418 -2.522 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.59 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.2 tt0 -79.3 130.81 35.83 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 17' ' ' THR . 10.7 p -114.86 -31.8 5.99 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 113.107 0.781 . . . . 0.0 113.107 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.0 62.75 0.22 Allowed Glycine 0 CA--C 1.48 -2.117 0 C-N-CA 118.459 -1.829 . . . . 0.0 112.729 -175.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.82 162.67 14.06 Favored Glycine 0 C--N 1.29 -1.974 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.506 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 61.7 mt -65.36 119.37 9.81 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.34 -7.61 32.48 Favored Glycine 0 C--N 1.306 -1.101 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.599 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -94.86 115.59 27.66 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.1 p -104.2 6.74 35.81 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.037 0.446 . . . . 0.0 111.037 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.02 -173.29 43.6 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.199 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.48 114.47 1.96 Allowed 'Trans proline' 0 C--N 1.328 -0.535 0 C-N-CA 123.798 2.999 . . . . 0.0 111.625 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.595 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 31.7 p -87.94 -22.85 24.1 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.318 0.58 . . . . 0.0 110.945 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.5 t -72.0 117.07 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.2 m -71.72 161.35 31.11 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.7 162.88 28.93 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.072 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.5 m -62.07 113.07 2.63 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.147 0.499 . . . . 0.0 111.775 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.55 -10.18 32.85 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.107 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.54 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 23.2 p -115.07 152.13 33.05 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 122.695 -0.297 . . . . 0.0 111.102 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.4 p -128.14 139.99 52.18 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 123.118 0.261 . . . . 0.0 110.445 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.6 t -73.66 111.69 9.05 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.845 0.355 . . . . 0.0 110.177 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.488 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 69.4 mt-30 -111.28 115.62 29.64 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-O 120.948 0.404 . . . . 0.0 110.471 -178.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.4 t -71.16 110.87 4.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.2 mt -89.72 -46.6 8.5 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -131.07 168.89 15.32 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -63.91 -34.82 58.62 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 CA-C-N 120.987 1.388 . . . . 0.0 113.019 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.511 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 12.4 m-85 -102.72 -24.76 13.71 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 119.306 -0.958 . . . . 0.0 110.892 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -103.54 114.86 29.45 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.946 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.59 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 13.7 m -120.89 127.63 52.05 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 36.3 tt0 -111.94 135.88 51.99 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 123.509 0.506 . . . . 0.0 109.721 -173.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.54 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 12.3 t -85.95 115.78 23.77 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.253 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.488 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 89.3 mt . . . . . 0 N--CA 1.414 -2.237 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.305 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 p -106.32 155.75 19.2 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.311 -0.859 . . . . 0.0 113.139 -172.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -59.44 124.51 20.27 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.75 1.22 . . . . 0.0 109.836 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 71.75 10.25 6.31 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.726 1.21 . . . . 0.0 112.702 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -104.8 165.88 14.69 Favored Glycine 0 N--CA 1.42 -2.401 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 174.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.6 tt0 -70.57 128.81 37.39 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.661 ' O ' ' HA ' ' A' ' 17' ' ' THR . 16.7 p -109.72 -36.64 5.87 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.6 63.81 0.18 Allowed Glycine 0 CA--C 1.483 -1.953 0 C-N-CA 118.359 -1.877 . . . . 0.0 113.015 -174.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.77 159.92 15.09 Favored Glycine 0 C--N 1.291 -1.97 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 175.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.418 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 58.3 mt -61.4 116.23 2.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 117.774 0.787 . . . . 0.0 109.696 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.61 -11.76 21.14 Favored Glycine 0 N--CA 1.436 -1.337 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.111 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -90.99 109.19 20.42 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.7 p -92.64 5.25 51.68 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.492 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.26 -179.09 50.75 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.287 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -55.02 122.81 12.37 Favored 'Trans proline' 0 N--CA 1.479 0.647 0 C-N-CA 124.594 3.529 . . . . 0.0 112.501 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.661 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.5 p -90.98 -20.22 22.38 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.4 t -83.95 126.46 40.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.8 m -76.35 171.13 15.08 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.57 176.17 9.6 Favored 'General case' 0 C--O 1.252 1.225 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.115 177.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -62.64 119.39 9.16 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.483 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.87 6.3 58.15 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.998 -0.62 . . . . 0.0 113.471 176.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.713 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 3.0 p -131.23 150.95 51.93 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 117.196 0.498 . . . . 0.0 111.245 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.9 p -129.95 144.14 51.17 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.636 0.236 . . . . 0.0 111.636 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.8 t -79.43 107.9 12.54 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -107.91 116.31 31.72 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-O 121.522 0.677 . . . . 0.0 110.353 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.4 t -74.92 108.77 6.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.115 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.2 mt -85.22 -50.49 7.33 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -129.87 166.58 25.21 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.16 -33.69 71.46 Favored 'Trans proline' 0 C--N 1.348 0.53 0 CA-C-N 120.669 1.274 . . . . 0.0 112.804 -177.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.498 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 53.0 m-85 -98.39 -26.49 14.46 Favored 'General case' 0 N--CA 1.434 -1.268 0 C-N-CA 118.914 -1.115 . . . . 0.0 110.827 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 57.4 t80 -105.11 114.25 28.34 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 119.188 -1.005 . . . . 0.0 112.978 175.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.8 m -122.72 131.4 53.77 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 174.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.431 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 35.5 tt0 -117.82 138.83 51.82 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 123.407 0.442 . . . . 0.0 110.094 -173.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.713 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 14.4 t -84.35 115.67 22.62 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.035 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.9 mt . . . . . 0 C--N 1.286 -2.193 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.601 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.91 0 CA-C-O 120.864 0.364 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.3 p -92.77 162.86 13.96 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.66 -177.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -67.77 126.74 30.37 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 81.16 6.47 1.29 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.485 1.114 . . . . 0.0 112.699 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.78 159.7 21.61 Favored Glycine 0 N--CA 1.436 -1.309 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -70.86 126.38 29.43 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 17' ' ' THR . 6.2 p -104.23 -42.67 5.44 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -176.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.4 64.83 0.29 Allowed Glycine 0 CA--C 1.476 -2.353 0 C-N-CA 118.31 -1.9 . . . . 0.0 112.852 -172.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.34 156.2 16.77 Favored Glycine 0 N--CA 1.42 -2.415 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 177.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.571 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 62.4 mt -61.62 121.25 9.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.18 -11.79 40.36 Favored Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -100.92 116.5 32.93 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.9 p -114.49 17.07 17.56 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.08 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.56 -162.38 31.4 Favored Glycine 0 C--O 1.24 0.494 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.76 109.05 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.406 2.738 . . . . 0.0 111.579 175.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 11.1 p -95.25 -22.24 17.92 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.782 -177.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.52 119.57 35.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.7 m -73.21 170.09 15.7 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.79 162.97 25.74 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.375 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.1 m -65.03 113.17 3.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.05 0.452 . . . . 0.0 110.11 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.16 7.65 26.5 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.977 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.679 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 19.2 p -131.9 146.72 52.27 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.4 p -127.25 138.87 53.19 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 121.208 -0.197 . . . . 0.0 110.881 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.7 t -75.97 109.95 10.03 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -105.2 133.15 50.44 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-O 121.445 0.641 . . . . 0.0 111.351 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.4 t -81.48 99.59 4.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.9 mt -82.18 -40.63 21.49 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -145.01 168.46 12.05 Favored Pre-proline 0 N--CA 1.431 -1.399 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -65.16 -38.95 25.35 Favored 'Trans proline' 0 C--O 1.25 1.084 0 CA-C-N 120.403 1.18 . . . . 0.0 112.659 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.571 ' CD1' ' HB ' ' A' ' 11' ' ' ILE . 53.0 m-85 -96.1 -27.01 15.28 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.643 -176.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -104.2 114.08 28.07 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.589 -0.845 . . . . 0.0 111.418 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.5 m -125.68 130.04 50.76 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 174.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -118.56 144.63 45.95 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -172.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.679 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 10.2 t -87.54 114.46 24.17 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.086 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.5 mt . . . . . 0 N--CA 1.418 -2.058 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -177.72 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -1.68 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.5 p -93.92 166.1 12.34 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.361 0.601 . . . . 0.0 111.8 -175.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -61.89 124.07 19.77 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.067 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 80.14 6.31 1.71 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.288 1.435 . . . . 0.0 112.866 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.31 159.17 20.56 Favored Glycine 0 N--CA 1.435 -1.393 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.524 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.5 tt0 -70.66 128.94 37.8 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.2 p -120.27 8.14 10.83 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 153.38 76.21 0.02 OUTLIER Glycine 0 CA--C 1.483 -1.93 0 C-N-CA 117.292 -2.385 . . . . 0.0 114.511 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.54 166.63 14.38 Favored Glycine 0 N--CA 1.419 -2.459 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 176.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.3 mt -64.93 118.54 7.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.54 -13.92 66.3 Favored Glycine 0 C--N 1.315 -0.637 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.362 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -79.49 108.4 12.99 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.22 0.533 . . . . 0.0 110.548 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.2 p -92.24 6.94 44.88 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.222 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.44 -171.23 41.08 Favored Glycine 0 C--N 1.316 -0.569 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.647 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -49.22 131.47 26.67 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 124.556 3.504 . . . . 0.0 112.299 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.4 p -125.52 -22.32 4.31 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 51.7 t -91.1 119.53 38.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.7 m -76.45 166.01 24.01 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.397 0.618 . . . . 0.0 112.479 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.91 167.82 20.03 Favored 'General case' 0 C--O 1.255 1.374 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.004 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.2 m -70.15 119.83 14.93 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 120.964 0.412 . . . . 0.0 110.268 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.46 -16.74 29.04 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.658 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 27.1 p -109.18 146.5 34.05 Favored 'General case' 0 C--O 1.251 1.163 0 O-C-N 122.426 -0.455 . . . . 0.0 111.329 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.0 p -124.9 133.73 52.95 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.799 -177.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.0 t -76.08 111.99 12.06 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -113.71 119.01 35.93 Favored 'General case' 0 N--CA 1.406 -2.648 0 CA-C-O 121.206 0.526 . . . . 0.0 110.866 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 82.4 t -70.78 108.48 2.59 Favored 'Isoleucine or valine' 0 C--O 1.253 1.248 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.816 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.418 HD11 ' CE2' ' A' ' 32' ' ' TYR . 71.2 mt -85.61 -46.41 10.81 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -133.49 166.76 26.9 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.63 -31.17 79.51 Favored 'Trans proline' 0 C--N 1.35 0.62 0 CA-C-N 120.906 1.359 . . . . 0.0 112.347 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.539 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 92.5 m-85 -99.89 -26.28 14.06 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.757 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.418 ' CE2' HD11 ' A' ' 28' ' ' LEU . 54.2 t80 -104.85 114.12 28.14 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 119.463 -0.895 . . . . 0.0 111.819 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 26.8 m -122.32 128.94 51.66 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 176.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -121.99 138.72 54.32 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -175.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.658 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 8.6 t -82.04 118.71 23.22 Favored 'General case' 0 N--CA 1.422 -1.854 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.937 -178.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.0 mt . . . . . 0 C--N 1.286 -2.194 0 C-N-CA 123.78 0.832 . . . . 0.0 109.364 -176.517 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.721 0 CA-C-O 121.47 0.652 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.5 p -104.86 158.38 16.57 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.767 -175.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -71.87 128.75 36.74 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 77.56 -0.78 2.76 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.084 1.354 . . . . 0.0 111.551 -176.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.14 165.83 36.3 Favored Glycine 0 N--CA 1.416 -2.638 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.597 ' HA ' ' O ' ' A' ' 33' ' ' SER . 60.7 tt0 -74.65 123.39 24.79 Favored 'General case' 0 C--O 1.199 -1.599 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 23.9 p -108.88 -5.62 16.11 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 163.41 57.53 0.02 OUTLIER Glycine 0 CA--C 1.474 -2.477 0 C-N-CA 117.717 -2.182 . . . . 0.0 112.858 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -106.3 164.13 13.62 Favored Glycine 0 N--CA 1.421 -2.358 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 176.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.0 116.87 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 117.401 0.6 . . . . 0.0 109.728 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.68 -25.5 8.5 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.422 -178.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -83.78 121.9 27.94 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.0 p -116.58 13.73 15.34 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.253 0.549 . . . . 0.0 111.194 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.04 -170.29 47.01 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.075 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -57.23 117.13 3.77 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 123.933 3.089 . . . . 0.0 110.9 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 39.5 p -93.75 -4.9 49.53 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.1 t -93.15 134.48 30.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 175.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.5 m -81.29 169.45 17.28 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -177.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.93 165.71 23.77 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.901 177.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 p -60.07 116.9 4.51 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.4 -17.26 37.15 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.031 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.63 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 41.4 p -108.87 148.94 29.86 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.61 -177.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.7 p -127.47 141.68 51.6 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 122.492 -0.13 . . . . 0.0 110.725 -178.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.1 t -79.05 113.04 16.85 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -116.58 113.41 22.69 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-O 121.305 0.574 . . . . 0.0 110.188 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.4 t -70.91 106.01 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.779 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.8 mt -87.04 -39.29 15.76 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.596 0.712 . . . . 0.0 109.397 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -141.24 167.75 16.25 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.19 -33.81 29.85 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 CA-C-N 120.917 1.363 . . . . 0.0 112.559 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.536 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 48.0 m-85 -97.32 -27.47 14.48 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 118.351 -1.34 . . . . 0.0 109.829 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.552 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 57.9 t80 -104.57 113.68 27.41 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 118.703 -1.199 . . . . 0.0 112.548 177.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.9 m -118.13 130.72 56.28 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 173.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.552 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 36.3 tt0 -116.94 140.55 49.33 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 118.057 0.39 . . . . 0.0 110.311 -173.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.63 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 18.5 t -89.09 121.91 31.89 Favored 'General case' 0 N--CA 1.416 -2.137 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.715 177.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 N--CA 1.421 -1.92 0 C-N-CA 123.975 0.91 . . . . 0.0 108.941 -179.565 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.832 0 CA-C-O 121.321 0.582 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 13.9 p -99.83 153.26 19.29 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.919 -171.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -70.51 116.96 11.45 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.862 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 77.63 19.47 1.18 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.287 1.035 . . . . 0.0 110.864 -176.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.45 159.28 13.78 Favored Glycine 0 N--CA 1.416 -2.64 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 172.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.5 tt0 -68.44 136.15 52.8 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 177.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 17' ' ' THR . 9.5 p -122.36 -37.39 2.81 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -175.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.85 58.38 0.31 Allowed Glycine 0 CA--C 1.484 -1.88 0 C-N-CA 118.815 -1.66 . . . . 0.0 112.37 -173.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.48 155.01 17.06 Favored Glycine 0 N--CA 1.421 -2.343 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 59.6 mt -65.0 115.67 3.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.34 -12.02 14.18 Favored Glycine 0 C--N 1.297 -1.599 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.75 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -93.9 122.79 36.75 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.143 0.497 . . . . 0.0 110.076 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 p -109.28 15.38 23.19 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.551 -177.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.49 -168.93 32.78 Favored Glycine 0 C--N 1.315 -0.6 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.892 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -53.64 117.3 3.69 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.955 3.103 . . . . 0.0 112.655 177.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 19.8 p -90.04 -25.75 20.65 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 123.295 0.638 . . . . 0.0 111.648 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -83.07 118.89 31.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.6 m -72.05 170.69 13.34 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.48 169.31 17.86 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.622 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.7 m -64.96 114.46 4.57 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.745 0.307 . . . . 0.0 110.867 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.3 6.17 45.2 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.268 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.668 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 27.4 p -128.26 147.17 50.58 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.8 p -129.38 137.71 51.09 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.728 0.299 . . . . 0.0 110.778 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.4 t -75.58 107.5 7.77 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.445 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 78.5 mt-30 -107.38 126.01 51.93 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-O 121.391 0.615 . . . . 0.0 110.949 -176.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.5 t -77.45 110.64 13.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.934 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.1 mt -89.3 -48.51 7.31 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -132.81 168.32 18.45 Favored Pre-proline 0 C--N 1.299 -1.597 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -63.39 -40.89 29.08 Favored 'Trans proline' 0 C--O 1.253 1.258 0 CA-C-N 120.994 1.391 . . . . 0.0 113.074 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.499 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 24.3 m-85 -94.72 -26.17 16.4 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.866 -177.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -104.63 113.49 27.1 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.982 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.0 m -127.03 133.88 50.42 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -124.1 143.03 50.7 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -172.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.668 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.2 t -85.84 121.74 28.91 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.28 0.562 . . . . 0.0 110.724 -177.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.445 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 94.5 mt . . . . . 0 C--N 1.289 -2.032 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -178.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.647 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p -88.02 143.51 27.05 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.606 -173.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -64.79 126.44 27.95 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 76.41 6.51 3.51 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.833 1.253 . . . . 0.0 111.375 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.09 164.39 18.31 Favored Glycine 0 N--CA 1.423 -2.194 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 177.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.8 tt0 -69.35 128.98 38.49 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 17' ' ' THR . 24.7 p -122.96 -8.98 8.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -173.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.34 64.47 0.04 OUTLIER Glycine 0 CA--C 1.482 -1.986 0 C-N-CA 116.855 -2.593 . . . . 0.0 114.072 -177.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.68 171.0 17.76 Favored Glycine 0 C--N 1.293 -1.841 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 175.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.8 mt -69.03 124.23 24.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.63 -1.68 60.14 Favored Glycine 0 C--N 1.305 -1.165 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.341 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -101.01 106.67 17.99 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.5 p -101.59 1.9 38.33 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.844 -176.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.77 -168.36 12.16 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.468 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -52.58 113.45 1.24 Allowed 'Trans proline' 0 N--CA 1.484 0.915 0 C-N-CA 124.183 3.255 . . . . 0.0 112.145 177.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.4 p -101.52 -30.28 11.49 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.889 0.376 . . . . 0.0 111.981 -178.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -73.79 112.29 10.22 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.249 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 54.1 m -66.93 165.2 15.96 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.17 175.62 9.49 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.006 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -66.7 115.36 6.43 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.792 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.35 9.14 58.17 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 121.251 -0.499 . . . . 0.0 112.733 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.593 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 41.2 p -122.88 148.03 45.89 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.839 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.5 p -128.66 135.12 48.85 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 123.125 0.266 . . . . 0.0 111.615 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.4 t -79.33 116.62 19.68 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.851 0.358 . . . . 0.0 110.05 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.44 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 60.0 mt-30 -114.89 114.8 25.97 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 120.778 0.323 . . . . 0.0 110.418 -177.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.4 t -70.99 118.21 15.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.43 HD12 ' CE2' ' A' ' 32' ' ' TYR . 93.7 mt -98.08 -49.28 4.8 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.282 0.563 . . . . 0.0 109.775 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.435 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 80.9 m-20 -124.25 169.11 11.25 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 178.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 29' ' ' ASN . 6.0 Cg_endo -64.14 -31.87 64.24 Favored 'Trans proline' 0 C--N 1.353 0.768 0 CA-C-N 121.404 1.537 . . . . 0.0 112.563 -177.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.485 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 51.8 m-85 -103.34 -24.51 13.5 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.159 0.504 . . . . 0.0 110.61 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.43 ' CE2' HD12 ' A' ' 28' ' ' LEU . 71.7 t80 -103.39 115.16 30.02 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 121.885 -0.509 . . . . 0.0 112.119 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.566 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.6 m -127.82 131.95 49.48 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 176.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -117.51 139.16 51.3 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -173.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.593 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.9 t -86.14 112.57 21.43 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.511 0.672 . . . . 0.0 110.566 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.44 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 43.0 mt . . . . . 0 N--CA 1.408 -2.531 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.022 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.461 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 31.4 p -89.04 172.1 9.36 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.509 -175.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -71.6 124.28 24.36 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 174.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 78.36 16.82 1.2 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.807 0.843 . . . . 0.0 111.664 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.48 153.86 17.17 Favored Glycine 0 N--CA 1.426 -1.989 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 174.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.582 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.5 tt0 -68.47 124.11 22.65 Favored 'General case' 0 C--O 1.21 -1.021 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.3 p -115.72 2.41 13.68 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.05 62.0 0.01 OUTLIER Glycine 0 CA--C 1.49 -1.53 0 C-N-CA 117.645 -2.217 . . . . 0.0 113.868 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.69 163.47 14.0 Favored Glycine 0 C--N 1.291 -1.922 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 59.8 mt -58.82 118.94 2.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 117.48 0.64 . . . . 0.0 110.492 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.4 -17.13 47.75 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.119 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -81.57 112.0 18.38 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 p -107.66 22.62 15.7 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.897 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.11 -169.22 39.37 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.367 177.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.74 122.99 12.77 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.95 3.1 . . . . 0.0 112.29 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 p -99.49 -10.06 22.59 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.437 0.637 . . . . 0.0 111.968 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.3 t -87.46 130.78 36.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.9 m -90.34 165.71 13.72 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.463 0.649 . . . . 0.0 112.106 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.71 163.99 26.72 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.459 176.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.6 m -74.34 124.29 26.2 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.62 -2.64 29.14 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -174.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.598 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 32.9 p -132.84 150.07 52.2 Favored 'General case' 0 C--O 1.248 1.017 0 O-C-N 122.763 -0.257 . . . . 0.0 111.018 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.3 p -128.64 139.51 52.22 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.6 t -77.44 116.56 18.12 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -117.74 122.63 43.97 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-O 121.259 0.552 . . . . 0.0 110.947 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.4 t -74.12 109.69 7.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.2 mt -87.3 -41.07 13.93 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -141.91 166.49 21.28 Favored Pre-proline 0 C--N 1.301 -1.535 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -62.6 -37.01 60.94 Favored 'Trans proline' 0 C--N 1.351 0.68 0 CA-C-N 121.206 1.467 . . . . 0.0 113.081 -177.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.514 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 84.6 m-85 -94.63 -27.25 15.98 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 118.501 -1.279 . . . . 0.0 110.813 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.485 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 48.1 t80 -105.52 113.93 27.79 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.416 -0.914 . . . . 0.0 112.782 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.582 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.0 m -120.24 129.13 53.92 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 174.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.485 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.9 tt0 -120.07 138.37 53.58 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -174.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.598 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.1 t -83.4 122.35 28.37 Favored 'General case' 0 N--CA 1.426 -1.661 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.839 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 N--CA 1.421 -1.881 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.024 -177.457 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.749 0 CA-C-O 120.934 0.397 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.9 p -83.94 153.64 23.81 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 114.844 -1.071 . . . . 0.0 113.069 -173.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -73.56 127.63 33.27 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 76.22 2.84 3.6 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.243 1.017 . . . . 0.0 111.471 -176.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.99 169.68 29.78 Favored Glycine 0 N--CA 1.415 -2.726 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 176.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.2 tt0 -77.36 127.34 32.4 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 18.7 p -116.09 4.47 13.67 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -174.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.51 62.85 0.01 OUTLIER Glycine 0 CA--C 1.481 -2.093 0 C-N-CA 118.085 -2.007 . . . . 0.0 113.417 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.38 161.25 14.75 Favored Glycine 0 N--CA 1.425 -2.059 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 177.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.49 119.79 5.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 117.724 0.762 . . . . 0.0 109.256 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.26 -22.13 25.46 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -81.05 117.15 21.39 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.038 0.447 . . . . 0.0 110.288 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.0 p -101.67 -0.23 34.98 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.751 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.33 -173.61 44.65 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.591 -177.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -53.33 124.34 15.45 Favored 'Trans proline' 0 N--CA 1.477 0.509 0 C-N-CA 124.435 3.423 . . . . 0.0 112.362 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.4 p -104.03 -18.97 14.36 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.17 0.509 . . . . 0.0 111.589 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.8 t -78.75 112.71 17.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 52.4 m -65.41 162.96 16.66 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.98 172.59 12.04 Favored 'General case' 0 C--O 1.254 1.334 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.086 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.5 m -67.13 119.95 12.91 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.714 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.85 19.93 35.44 Favored Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.905 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.582 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 44.4 p -138.09 148.49 45.06 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 117.038 0.419 . . . . 0.0 110.061 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.4 p -126.17 133.33 51.6 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 122.103 0.161 . . . . 0.0 110.943 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.1 t -74.25 119.82 18.99 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -119.0 120.17 36.46 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-O 121.558 0.694 . . . . 0.0 110.818 -178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.2 t -75.24 101.21 2.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.982 177.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.426 HD12 ' CE1' ' A' ' 32' ' ' TYR . 77.3 mt -79.51 -46.23 17.79 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.42 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 93.5 m-20 -140.31 170.5 9.52 Favored Pre-proline 0 C--N 1.31 -1.138 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 29' ' ' ASN . 4.3 Cg_exo -62.88 -43.15 21.23 Favored 'Trans proline' 0 C--N 1.358 1.056 0 CA-C-N 120.763 1.308 . . . . 0.0 112.979 -178.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.527 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 89.8 m-85 -89.77 -27.18 20.19 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 118.299 -1.36 . . . . 0.0 110.021 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.555 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 40.0 t80 -104.05 113.91 27.78 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 118.789 -1.164 . . . . 0.0 112.503 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.3 m -127.31 123.78 37.16 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 174.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.555 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 31.8 tt0 -116.64 140.59 49.23 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 123.504 0.502 . . . . 0.0 110.391 -173.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.582 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.4 t -88.81 123.25 33.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.5 mt . . . . . 0 C--N 1.296 -1.738 0 C-N-CA 123.794 0.838 . . . . 0.0 109.362 -176.556 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.444 -0.734 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.8 154.11 34.27 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 p -104.69 153.12 21.66 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.22 -173.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -69.67 123.19 20.72 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 78.06 6.96 2.61 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.589 1.156 . . . . 0.0 112.002 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -103.3 167.29 16.69 Favored Glycine 0 N--CA 1.423 -2.213 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 175.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.6 tt0 -70.39 127.63 33.4 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.634 ' O ' ' HA ' ' A' ' 17' ' ' THR . 20.1 p -103.52 -39.1 6.87 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.18 76.13 0.11 Allowed Glycine 0 CA--C 1.484 -1.844 0 C-N-CA 118.392 -1.861 . . . . 0.0 113.608 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.34 169.78 16.77 Favored Glycine 0 C--N 1.291 -1.926 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 176.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.0 mt -66.95 119.49 12.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.71 -17.17 42.9 Favored Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -85.1 106.25 16.43 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.0 p -94.37 4.9 53.26 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.298 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.26 -169.8 32.65 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 115.553 -0.748 . . . . 0.0 112.692 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -59.55 114.49 2.07 Favored 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 123.592 2.861 . . . . 0.0 111.797 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.7 p -93.98 -17.12 23.27 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.539 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.8 t -88.68 120.59 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.7 m -72.89 167.61 20.64 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.42 165.0 24.96 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.419 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.1 m -64.85 124.11 21.13 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 120.643 0.259 . . . . 0.0 110.367 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.92 -0.01 48.41 Favored Glycine 0 N--CA 1.432 -1.593 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.331 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.556 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 42.1 p -128.43 151.03 49.85 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.6 p -130.15 137.72 50.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.759 0.314 . . . . 0.0 111.679 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.1 t -74.16 114.78 12.89 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.506 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 50.0 mt-30 -121.76 117.7 27.24 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-O 121.379 0.609 . . . . 0.0 111.109 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.5 t -71.02 116.89 13.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.437 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.9 mt -97.44 -39.76 9.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.889 0.852 . . . . 0.0 108.95 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -137.7 164.32 42.07 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -62.61 -32.73 79.27 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 CA-C-N 120.865 1.344 . . . . 0.0 112.002 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.491 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 31.1 m-85 -97.77 -26.58 14.67 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 119.094 -1.042 . . . . 0.0 111.597 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.407 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 68.4 t80 -105.3 114.32 28.43 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 119.779 -0.769 . . . . 0.0 112.664 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.0 m -121.05 130.8 53.93 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 174.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.407 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 53.9 tt0 -115.06 140.78 48.78 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -173.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.556 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 13.3 t -87.12 112.96 22.44 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.593 178.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.506 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 81.3 mt . . . . . 0 C--N 1.278 -2.532 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.8 p . . . . . 0 C--O 1.25 1.079 0 CA-C-O 120.657 0.265 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.33 143.69 44.8 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 176.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.8 p -98.09 153.51 18.38 Favored 'General case' 0 C--N 1.272 -2.78 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.146 -172.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -65.35 122.51 17.31 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 79.34 12.26 1.26 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.815 1.246 . . . . 0.0 111.416 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -107.56 168.05 13.86 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.437 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.5 tt0 -77.31 122.4 25.05 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.578 ' O ' ' HA ' ' A' ' 17' ' ' THR . 7.2 p -104.97 -37.01 7.13 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.32 68.13 0.12 Allowed Glycine 0 CA--C 1.474 -2.53 0 C-N-CA 118.052 -2.023 . . . . 0.0 113.127 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.84 165.75 13.99 Favored Glycine 0 C--N 1.284 -2.316 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.0 mt -62.21 126.71 20.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.92 -11.52 57.49 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.88 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -100.9 126.6 47.53 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.8 p -119.26 14.48 12.99 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.491 0.663 . . . . 0.0 111.661 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.88 -155.86 16.12 Favored Glycine 0 C--O 1.258 1.644 0 CA-C-N 115.954 -0.566 . . . . 0.0 113.086 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -56.27 104.94 0.15 Allowed 'Trans proline' 0 C--O 1.222 -0.277 0 C-N-CA 123.854 3.036 . . . . 0.0 113.372 174.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.0 p -87.79 -15.76 36.0 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.55 0.691 . . . . 0.0 110.776 177.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.8 t -88.09 122.94 40.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.069 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.402 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 56.6 m -79.22 175.3 10.71 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.344 0.592 . . . . 0.0 112.274 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.74 163.4 24.52 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.2 m -64.64 122.95 18.04 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.77 5.76 54.97 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.433 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.58 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 40.0 p -128.28 149.21 50.59 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.3 p -130.61 138.7 50.24 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 117.793 0.269 . . . . 0.0 111.275 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.7 t -72.98 111.42 8.07 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -109.6 133.09 53.52 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-O 121.292 0.568 . . . . 0.0 110.515 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.6 t -83.83 105.93 13.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.646 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.1 mt -87.41 -38.36 16.22 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.981 0.896 . . . . 0.0 108.691 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -144.51 167.77 14.09 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -64.45 -41.71 19.39 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 CA-C-N 120.807 1.324 . . . . 0.0 112.101 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.511 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 17.7 m-85 -91.97 -26.44 18.4 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.628 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -104.76 113.24 26.7 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.875 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.4 m -121.89 130.01 53.01 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 174.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -119.94 139.01 53.1 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -173.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.58 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 9.7 t -81.03 117.08 21.32 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-O 121.502 0.668 . . . . 0.0 110.093 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 N--CA 1.405 -2.678 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.693 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.28 125.23 29.21 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 99.8 p -86.71 166.79 15.02 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.705 -175.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -70.89 123.87 23.02 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 78.53 11.69 1.66 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.059 0.944 . . . . 0.0 112.493 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.37 160.83 19.06 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 174.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.3 tt0 -73.79 121.63 21.15 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 17' ' ' THR . 6.8 p -103.53 -44.15 5.2 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -174.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.35 68.15 0.24 Allowed Glycine 0 CA--C 1.476 -2.377 0 C-N-CA 118.183 -1.96 . . . . 0.0 113.559 -171.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -104.73 160.15 15.61 Favored Glycine 0 C--N 1.279 -2.626 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.3 mt -62.51 122.83 14.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.33 -14.85 50.97 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.045 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -92.01 116.45 28.93 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 p -111.63 21.25 16.31 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.41 0.624 . . . . 0.0 111.675 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.76 -153.87 20.02 Favored Glycine 0 C--O 1.252 1.241 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.975 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.77 110.56 0.99 Allowed 'Trans proline' 0 C--N 1.328 -0.523 0 C-N-CA 123.889 3.059 . . . . 0.0 111.871 174.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 62.7 p -96.31 -20.94 18.13 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.745 0.783 . . . . 0.0 110.524 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.7 t -82.04 118.46 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.092 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.3 m -77.21 164.09 25.93 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 120.991 0.424 . . . . 0.0 111.72 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.46 153.85 37.36 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.7 m -60.88 121.03 11.34 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.41 0.624 . . . . 0.0 111.22 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.22 -20.84 23.07 Favored Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.554 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.526 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 35.3 p -105.65 146.55 29.56 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 122.278 -0.542 . . . . 0.0 110.101 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.1 p -124.85 134.16 52.83 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 122.352 0.261 . . . . 0.0 110.784 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.5 t -73.11 112.91 9.58 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -116.82 132.65 56.64 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-O 121.246 0.546 . . . . 0.0 111.116 -177.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.3 t -75.22 117.01 18.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.783 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 32.8 mt -93.87 -48.47 6.27 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.413 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 81.1 m-20 -131.18 167.67 20.66 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 29' ' ' ASN . 1.6 Cg_endo -60.9 -33.34 92.69 Favored 'Trans proline' 0 C--N 1.359 1.13 0 CA-C-N 121.335 1.513 . . . . 0.0 113.167 -176.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.582 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 82.4 m-85 -99.95 -25.21 14.4 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.239 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -103.57 113.83 27.63 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.583 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.7 m -120.93 132.04 54.71 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 175.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -119.98 139.76 51.98 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -174.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.526 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 9.9 t -84.87 121.38 27.65 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.201 -177.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 N--CA 1.422 -1.833 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 -176.923 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.547 ' H61' ' O3 ' ' A' ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.5 p . . . . . 0 N--CA 1.443 -0.81 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.46 130.89 34.48 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.6 p -85.37 163.73 18.37 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.996 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -65.95 124.41 22.46 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 81.26 9.62 0.96 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.146 1.378 . . . . 0.0 112.114 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.07 164.65 20.53 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 33' ' ' SER . 61.5 tt0 -75.6 125.25 28.66 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 17' ' ' THR . 24.5 p -112.75 1.72 15.75 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -172.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.18 73.98 0.01 OUTLIER Glycine 0 CA--C 1.487 -1.68 0 C-N-CA 116.695 -2.669 . . . . 0.0 114.895 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.602 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -94.96 165.04 25.28 Favored Glycine 0 N--CA 1.423 -2.218 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 176.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.5 mt -62.05 115.91 2.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 121.206 0.527 . . . . 0.0 110.805 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.96 1.19 70.51 Favored Glycine 0 C--N 1.312 -0.796 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.039 -178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -100.11 106.84 18.61 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.9 p -101.99 18.8 19.75 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.954 -176.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.97 -161.14 16.06 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.95 114.02 1.43 Allowed 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 123.526 2.817 . . . . 0.0 111.783 175.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 12.9 p -110.69 -30.3 7.65 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.501 0.667 . . . . 0.0 111.499 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.5 t -79.7 128.51 38.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.8 m -88.65 174.02 8.28 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.22 0.533 . . . . 0.0 112.348 -177.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.66 169.66 12.49 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.781 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.4 m -63.64 113.09 3.13 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.78 9.57 32.44 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.164 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.63 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 21.4 p -132.13 149.12 52.48 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-N 117.451 0.626 . . . . 0.0 110.595 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.8 p -128.34 139.04 52.61 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.466 0.175 . . . . 0.0 111.393 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.3 t -76.57 117.86 18.64 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -118.65 128.29 54.39 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-O 121.368 0.604 . . . . 0.0 110.936 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -79.23 114.25 19.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.272 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.6 mt -95.87 -44.49 7.37 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -136.71 167.61 20.54 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -63.91 -42.46 19.37 Favored 'Trans proline' 0 C--O 1.241 0.639 0 CA-C-N 120.99 1.389 . . . . 0.0 112.577 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.602 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 76.8 m-85 -92.06 -24.81 19.05 Favored 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.412 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -104.66 113.83 27.66 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.568 -0.853 . . . . 0.0 112.273 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 35.1 m -122.55 134.83 54.53 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 174.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -122.09 140.97 51.88 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -174.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.63 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 10.4 t -84.82 114.57 22.18 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.0 mt . . . . . 0 C--N 1.283 -2.298 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -176.528 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.507 ' H61' ' O3 ' ' A' ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.41 ' O ' ' H5 ' ' A' ' 101' ' ' MAN . 4.0 m . . . . . 0 N--CA 1.447 -0.616 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.46 112.46 15.52 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.9 p -83.87 153.93 23.73 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.558 -173.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -61.94 119.34 8.65 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 85.1 3.45 0.65 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.29 1.436 . . . . 0.0 112.743 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.81 165.16 22.02 Favored Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -73.35 128.76 36.39 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 17' ' ' THR . 14.5 p -107.2 -45.76 4.04 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -175.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.09 74.75 0.14 Allowed Glycine 0 CA--C 1.488 -1.62 0 C-N-CA 118.265 -1.921 . . . . 0.0 114.427 -173.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.76 164.57 13.89 Favored Glycine 0 C--N 1.295 -1.739 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 175.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.401 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 53.3 mt -61.74 120.37 7.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 117.29 0.545 . . . . 0.0 110.252 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.47 -7.85 51.26 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.5 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -100.79 106.65 18.07 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.3 p -104.33 28.27 7.03 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.583 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.44 -163.67 39.26 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -59.16 111.71 1.0 Allowed 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.399 2.733 . . . . 0.0 111.476 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 36.3 p -99.39 -11.0 21.55 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.172 0.51 . . . . 0.0 111.791 -178.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.6 t -85.23 120.52 35.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 57.0 m -84.52 158.65 20.91 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.35 0.595 . . . . 0.0 112.382 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.39 172.62 11.58 Favored 'General case' 0 C--O 1.251 1.136 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.884 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.5 m -64.86 112.55 3.32 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 123.196 0.598 . . . . 0.0 110.95 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.19 -4.14 38.14 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.44 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.641 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 37.5 p -117.65 147.39 42.94 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.041 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.0 p -129.77 140.62 51.02 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 123.1 0.25 . . . . 0.0 110.795 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -75.14 102.86 5.09 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 121.054 0.454 . . . . 0.0 110.34 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -101.02 124.01 46.09 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-O 121.96 0.886 . . . . 0.0 112.388 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.3 t -77.91 112.93 16.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 114.176 -1.375 . . . . 0.0 108.688 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.423 HD11 ' CE1' ' A' ' 32' ' ' TYR . 89.0 mt -94.14 -39.62 10.48 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -141.08 169.15 12.1 Favored Pre-proline 0 C--N 1.297 -1.701 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.9 -36.31 39.86 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 CA-C-N 121.24 1.479 . . . . 0.0 113.144 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.582 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 31.0 m-85 -98.94 -25.6 14.54 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.059 -176.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.423 ' CE1' HD11 ' A' ' 28' ' ' LEU . 67.7 t80 -104.04 114.12 28.15 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.116 0.484 . . . . 0.0 111.639 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 m -126.35 132.31 51.62 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 175.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -119.89 139.34 52.55 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.641 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.0 t -82.7 115.67 21.73 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.837 -178.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.4 mt . . . . . 0 N--CA 1.418 -2.075 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 -179.546 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.41 ' H5 ' ' O ' ' A' ' 1' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.441 -0.897 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.77 145.19 34.53 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.1 p -101.99 155.26 18.28 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.557 -171.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -66.92 125.19 25.17 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 81.07 -0.4 1.75 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.909 1.283 . . . . 0.0 111.612 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -96.17 172.14 28.99 Favored Glycine 0 N--CA 1.428 -1.853 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.557 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.1 tt0 -78.57 130.61 36.14 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 17' ' ' THR . 21.4 p -113.6 -25.83 8.54 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -175.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.2 65.96 0.09 OUTLIER Glycine 0 CA--C 1.489 -1.575 0 C-N-CA 118.273 -1.918 . . . . 0.0 113.431 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.79 165.33 13.92 Favored Glycine 0 C--N 1.298 -1.574 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 176.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.8 mt -60.17 117.77 2.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 117.341 0.57 . . . . 0.0 109.896 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.6 -2.96 57.47 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.349 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -92.52 108.42 19.96 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 p -104.81 26.43 9.18 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.426 -177.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.98 -169.44 33.59 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.327 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -58.14 126.39 21.41 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.901 3.067 . . . . 0.0 111.311 176.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 4.9 p -102.61 -21.14 14.2 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.064 -176.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.7 t -81.71 121.33 34.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.4 m -75.64 174.48 9.7 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.14 165.05 17.76 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.481 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.2 m -58.1 115.29 2.81 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 123.17 0.588 . . . . 0.0 111.271 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.84 -14.25 37.95 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.613 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.589 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 34.3 p -111.97 148.4 33.86 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 122.477 -0.425 . . . . 0.0 111.433 -177.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.4 p -126.63 139.35 53.24 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.1 t -74.08 110.62 8.51 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.435 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 76.3 mt-30 -111.07 119.42 38.96 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-O 121.468 0.652 . . . . 0.0 110.189 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.7 t -78.42 109.69 13.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.162 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.472 HD12 ' CE2' ' A' ' 32' ' ' TYR . 76.0 mt -88.79 -51.36 5.69 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -125.55 167.15 17.38 Favored Pre-proline 0 C--N 1.291 -1.964 0 N-CA-C 105.026 -2.212 . . . . 0.0 105.026 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -65.4 -33.59 46.84 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 CA-C-N 120.799 1.321 . . . . 0.0 111.188 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.468 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 6.7 m-85 -94.6 -27.45 15.9 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.27 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.529 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 52.9 t80 -105.27 114.01 27.94 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.264 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.5 m -126.39 127.69 45.86 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 175.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.529 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 31.8 tt0 -116.94 137.95 51.87 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 123.416 0.447 . . . . 0.0 110.209 -174.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.589 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 14.9 t -84.22 121.91 28.14 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 119.819 -0.753 . . . . 0.0 109.493 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.435 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 97.2 mt . . . . . 0 C--N 1.294 -1.818 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.3 p . . . . . 0 N--CA 1.443 -0.784 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.04 111.37 18.14 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.3 p -78.34 164.02 25.19 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.118 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -65.21 123.19 18.9 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 82.78 5.65 0.92 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.866 1.266 . . . . 0.0 111.629 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.53 160.03 20.43 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 175.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.549 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.4 tt0 -70.92 137.76 49.52 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 17' ' ' THR . 23.5 p -126.54 -4.0 6.63 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -173.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.73 70.74 0.02 OUTLIER Glycine 0 CA--C 1.487 -1.686 0 C-N-CA 117.295 -2.383 . . . . 0.0 114.071 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.53 167.43 14.74 Favored Glycine 0 C--N 1.294 -1.773 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 176.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.2 mt -63.63 119.61 8.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 117.746 0.773 . . . . 0.0 110.282 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.62 14.52 59.68 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.105 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -101.21 113.38 26.37 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.114 0.483 . . . . 0.0 110.142 177.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.5 p -101.15 8.44 42.71 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.171 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.26 -165.98 41.13 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.544 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.27 118.53 5.41 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.879 3.053 . . . . 0.0 112.192 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.1 p -106.87 -5.46 18.3 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.85 0.833 . . . . 0.0 111.126 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.2 t -98.02 117.46 42.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.325 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.0 m -78.2 179.18 7.05 Favored 'General case' 0 C--O 1.254 1.321 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.07 -179.14 4.43 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.646 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.1 m -72.41 121.91 20.34 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.29 19.35 36.02 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.005 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.675 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 23.6 p -140.29 142.63 35.67 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.1 p -131.63 139.87 49.24 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 123.319 0.387 . . . . 0.0 111.477 -177.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.3 t -73.05 114.14 10.88 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 120.835 0.35 . . . . 0.0 110.41 -178.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.505 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 67.4 mt-30 -111.33 123.31 49.95 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 120.876 0.37 . . . . 0.0 110.163 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.2 t -81.43 108.75 14.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.3 mt -86.27 -42.49 13.71 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -140.79 165.49 29.29 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.64 -31.17 59.86 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 120.932 1.369 . . . . 0.0 112.9 -175.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.535 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 68.9 m-85 -100.35 -26.84 13.75 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 119.051 -1.059 . . . . 0.0 110.302 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -105.7 114.01 27.92 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.961 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.549 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.2 m -123.03 134.71 54.28 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -122.32 138.28 54.57 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -172.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.675 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 9.8 t -83.02 114.48 21.3 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.419 0.628 . . . . 0.0 110.293 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.505 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 52.9 mt . . . . . 0 N--CA 1.412 -2.349 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.449 -0.48 0 CA-C-O 120.477 0.179 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.03 140.15 36.65 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.3 p -96.86 159.96 14.63 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.369 0.604 . . . . 0.0 112.195 -173.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -68.51 123.07 19.82 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 81.67 5.86 1.21 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.793 1.237 . . . . 0.0 112.483 -175.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.75 164.39 18.69 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 175.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.2 tt0 -71.66 137.11 47.61 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 17' ' ' THR . 10.4 p -125.9 -16.92 5.51 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -174.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.16 64.62 0.07 OUTLIER Glycine 0 CA--C 1.489 -1.568 0 C-N-CA 117.687 -2.197 . . . . 0.0 113.759 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.588 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -106.01 162.29 14.08 Favored Glycine 0 C--N 1.295 -1.731 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.215 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.4 mt -64.14 119.09 7.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.058 0.456 . . . . 0.0 109.894 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.74 -22.79 23.25 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.224 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -87.66 132.14 34.2 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 123.666 0.786 . . . . 0.0 109.109 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.9 p -131.66 17.73 4.76 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.127 0.489 . . . . 0.0 111.012 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.55 -156.97 23.7 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.435 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.19 114.79 1.8 Allowed 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 124.11 3.206 . . . . 0.0 112.254 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.1 p -103.77 -25.61 13.04 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.663 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.0 t -81.91 111.24 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 47.2 m -68.59 156.76 37.47 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.28 158.91 19.04 Favored 'General case' 0 C--O 1.253 1.239 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.625 176.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -65.35 112.99 3.76 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.014 0.435 . . . . 0.0 110.825 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.7 -2.38 29.01 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.257 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.529 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 26.4 p -120.24 150.07 41.26 Favored 'General case' 0 C--N 1.319 -0.749 0 O-C-N 122.329 -0.512 . . . . 0.0 110.908 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.1 p -126.6 138.42 53.45 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 122.446 0.299 . . . . 0.0 111.714 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 34.4 t -75.37 117.87 17.64 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -120.12 124.6 46.19 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.72 0.771 . . . . 0.0 111.207 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.7 t -76.78 117.67 22.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.483 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.455 HD12 ' CE2' ' A' ' 32' ' ' TYR . 88.0 mt -100.05 -44.66 5.93 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -130.87 167.4 21.59 Favored Pre-proline 0 C--N 1.31 -1.132 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -64.32 -35.18 52.24 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 CA-C-N 120.998 1.392 . . . . 0.0 111.048 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.588 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 27.8 m-85 -94.05 -27.49 16.26 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 119.879 -0.728 . . . . 0.0 109.927 -178.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.561 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 54.5 t80 -103.99 113.95 27.84 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.654 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.1 m -129.18 123.67 32.66 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.561 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 32.8 tt0 -113.69 141.59 47.05 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 123.647 0.592 . . . . 0.0 109.974 -173.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.529 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 9.0 t -85.02 121.68 28.15 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.428 -1.555 0 C-N-CA 123.829 0.852 . . . . 0.0 109.522 -176.856 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 26.6 p . . . . . 0 N--CA 1.441 -0.878 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.31 120.15 23.99 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.5 p -75.15 165.24 25.52 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.531 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -69.38 127.96 34.87 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 76.37 6.91 3.51 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.276 1.431 . . . . 0.0 112.171 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.82 165.06 28.04 Favored Glycine 0 C--O 1.256 1.494 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 176.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.2 tt0 -72.94 120.27 18.33 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.586 ' O ' ' HA ' ' A' ' 17' ' ' THR . 22.1 p -100.93 -39.12 7.91 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -174.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.59 75.34 0.09 OUTLIER Glycine 0 CA--C 1.484 -1.906 0 C-N-CA 117.873 -2.108 . . . . 0.0 113.881 -173.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.52 169.08 15.84 Favored Glycine 0 C--N 1.285 -2.278 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 176.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.4 mt -61.22 127.59 21.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 117.655 0.727 . . . . 0.0 109.901 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.89 -21.65 42.53 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.11 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -79.41 116.71 19.8 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 121.05 0.453 . . . . 0.0 109.813 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 p -107.11 17.55 22.84 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.202 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.36 -176.49 51.35 Favored Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.389 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -54.04 111.3 0.66 Allowed 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 124.076 3.184 . . . . 0.0 112.627 177.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.2 p -89.09 -23.34 22.53 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.074 0.464 . . . . 0.0 111.914 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -79.81 118.69 27.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.8 m -73.73 171.39 13.4 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.05 -179.34 6.62 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.779 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.0 m -70.65 119.97 15.58 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.08 20.19 33.95 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 119.863 -1.16 . . . . 0.0 112.897 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.765 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 21.9 p -136.72 148.37 47.27 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.8 p -127.17 134.83 50.1 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 122.838 0.455 . . . . 0.0 111.081 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.6 t -75.25 112.57 11.67 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -118.78 127.27 53.37 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-O 121.042 0.449 . . . . 0.0 110.575 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.3 t -74.23 121.92 26.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.526 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.6 mt -101.75 -37.52 8.28 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.595 0.712 . . . . 0.0 109.466 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.409 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 52.2 m-80 -142.15 167.44 16.59 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 29' ' ' ASN . 1.8 Cg_endo -61.83 -32.47 85.6 Favored 'Trans proline' 0 C--N 1.353 0.793 0 CA-C-N 121.187 1.459 . . . . 0.0 112.762 -176.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.617 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 63.8 m-85 -100.43 -25.97 14.03 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.797 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -103.69 114.11 28.13 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.814 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.8 m -123.42 133.73 54.04 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -120.01 142.65 48.61 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -173.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.765 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 13.4 t -86.88 118.78 26.49 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.159 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 C--N 1.295 -1.783 0 C-N-CA 123.687 0.795 . . . . 0.0 108.928 -179.644 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.732 ' O ' ' H5 ' ' A' ' 101' ' ' MAN . 18.3 p . . . . . 0 N--CA 1.441 -0.882 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.9 129.55 40.29 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 p -83.99 159.19 21.28 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -64.52 126.31 27.46 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.89 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 78.48 1.29 2.61 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.94 1.296 . . . . 0.0 113.408 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.49 164.83 24.54 Favored Glycine 0 C--O 1.254 1.352 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.599 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.0 tt0 -68.24 120.18 13.99 Favored 'General case' 0 C--O 1.207 -1.154 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 17' ' ' THR . 15.0 p -102.51 -29.28 11.68 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -175.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.19 65.88 0.1 Allowed Glycine 0 CA--C 1.483 -1.918 0 C-N-CA 118.415 -1.85 . . . . 0.0 112.652 -175.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.76 162.68 14.09 Favored Glycine 0 N--CA 1.429 -1.818 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 178.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.2 mt -59.47 123.34 11.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.29 -13.29 58.56 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.323 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -87.79 113.96 23.95 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.1 p -101.27 9.36 41.84 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.677 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.6 -171.68 48.34 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.411 -177.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.94 122.34 11.56 Favored 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 124.211 3.274 . . . . 0.0 111.753 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 29.1 p -101.07 -18.58 16.18 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.103 0.478 . . . . 0.0 111.558 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.0 t -79.16 113.89 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.9 m -71.91 169.48 15.76 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.7 169.39 18.32 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.409 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.4 m -58.01 121.46 10.66 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.301 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.86 -18.45 54.86 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.692 176.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.598 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 43.8 p -103.37 146.84 27.88 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 122.5 -0.412 . . . . 0.0 111.045 -176.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.2 p -127.41 144.56 51.04 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 122.144 0.177 . . . . 0.0 110.831 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -80.62 113.36 18.76 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.076 0.465 . . . . 0.0 109.855 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.416 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 78.7 mt-30 -113.54 112.89 24.32 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-O 121.198 0.523 . . . . 0.0 109.825 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -75.4 104.02 3.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.1 mt -80.3 -48.19 13.38 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.464 0.649 . . . . 0.0 109.429 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.57 165.21 31.29 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.46 -37.29 72.23 Favored 'Trans proline' 0 C--O 1.246 0.894 0 CA-C-N 121.469 1.56 . . . . 0.0 112.56 -176.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.502 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 46.6 m-85 -93.06 -26.27 17.56 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.927 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.514 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 63.9 t80 -104.0 113.5 27.08 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 118.966 -1.093 . . . . 0.0 112.376 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.5 m -121.84 132.5 54.61 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 175.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.514 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 33.2 tt0 -120.98 136.53 54.96 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 123.154 0.284 . . . . 0.0 110.296 -174.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.598 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 14.4 t -83.56 122.04 28.03 Favored 'General case' 0 N--CA 1.429 -1.522 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.728 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.416 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 89.8 mt . . . . . 0 C--N 1.291 -1.942 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.732 ' H5 ' ' O ' ' A' ' 1' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.244 0.766 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.57 139.28 32.22 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.3 p -100.8 165.47 11.35 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.286 -175.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.477 ' CD2' ' HA ' ' A' ' 36' ' ' LEU . 14.3 t-160 -69.02 123.8 22.02 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 82.48 9.69 0.71 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.221 1.409 . . . . 0.0 112.61 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.435 ' HA3' ' H3 ' ' A' ' 101' ' ' MAN . . . -100.52 158.19 19.33 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 175.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.577 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.3 tt0 -68.88 127.06 31.76 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 17' ' ' THR . 13.3 p -116.58 5.76 13.34 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -173.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.93 75.42 0.01 OUTLIER Glycine 0 CA--C 1.482 -2.012 0 C-N-CA 116.934 -2.555 . . . . 0.0 114.791 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.87 165.39 13.89 Favored Glycine 0 C--N 1.289 -2.075 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 175.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 30' ' ' PRO . 60.1 mt -61.62 127.03 20.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.95 -13.71 66.84 Favored Glycine 0 C--N 1.312 -0.788 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.052 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -101.43 114.0 27.62 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 123.191 0.596 . . . . 0.0 109.7 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.8 p -111.06 21.81 15.98 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.035 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.25 -160.95 25.94 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.995 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.27 111.05 0.48 Allowed 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.989 3.126 . . . . 0.0 112.911 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 14.6 p -105.47 -23.99 12.71 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.631 0.729 . . . . 0.0 111.436 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.9 t -85.83 120.64 36.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.6 m -79.41 163.29 24.93 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 120.972 0.415 . . . . 0.0 111.905 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.8 163.52 25.64 Favored 'General case' 0 C--O 1.253 1.247 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -65.82 117.53 8.35 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 120.963 0.411 . . . . 0.0 110.178 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.8 -19.48 25.67 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.86 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.642 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 19.8 p -103.14 147.6 26.81 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 122.445 -0.444 . . . . 0.0 109.909 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.4 p -127.47 135.26 50.16 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 122.475 0.31 . . . . 0.0 111.311 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.3 t -73.87 111.3 8.9 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.423 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 76.5 mt-30 -109.15 121.74 45.8 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-O 121.517 0.675 . . . . 0.0 109.613 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.9 t -80.14 104.31 8.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.368 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.8 mt -80.7 -44.34 18.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.863 0.84 . . . . 0.0 108.908 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -136.15 164.4 43.26 Favored Pre-proline 0 C--N 1.298 -1.655 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.473 ' O ' HG13 ' A' ' 11' ' ' ILE . 4.3 Cg_exo -64.4 -30.59 62.68 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 CA-C-N 120.554 1.234 . . . . 0.0 111.664 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.582 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 78.6 m-85 -97.77 -27.86 14.13 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 118.919 -1.113 . . . . 0.0 111.314 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.418 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 61.6 t80 -105.9 114.31 28.38 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.469 -0.892 . . . . 0.0 112.316 175.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.577 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 36.6 m -121.49 131.36 54.1 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 175.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.418 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 36.1 tt0 -120.66 138.52 53.89 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -174.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.642 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 12.0 t -85.84 123.21 30.95 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 120.364 -0.535 . . . . 0.0 110.544 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.477 ' HA ' ' CD2' ' A' ' 4' ' ' HIS . 95.6 mt . . . . . 0 C--N 1.286 -2.169 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.435 ' H3 ' ' HA3' ' A' ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.3 p . . . . . 0 C--O 1.237 0.419 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.84 153.96 42.61 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.006 0.431 . . . . 0.0 110.509 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.1 p -99.66 152.82 19.63 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.718 -172.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -71.77 122.73 21.18 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.422 ' HA ' ' CG ' ' A' ' 34' ' ' GLN . 55.7 m-85 77.8 2.19 2.92 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.546 1.138 . . . . 0.0 111.546 -175.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.445 ' HA3' ' H2 ' ' A' ' 101' ' ' MAN . . . -97.28 174.16 29.51 Favored Glycine 0 N--CA 1.418 -2.522 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.59 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.2 tt0 -79.3 130.81 35.83 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 17' ' ' THR . 10.7 p -114.86 -31.8 5.99 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 113.107 0.781 . . . . 0.0 113.107 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.0 62.75 0.22 Allowed Glycine 0 CA--C 1.48 -2.117 0 C-N-CA 118.459 -1.829 . . . . 0.0 112.729 -175.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.82 162.67 14.06 Favored Glycine 0 C--N 1.29 -1.974 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.506 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 61.7 mt -65.36 119.37 9.81 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.34 -7.61 32.48 Favored Glycine 0 C--N 1.306 -1.101 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.599 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -94.86 115.59 27.66 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.1 p -104.2 6.74 35.81 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.037 0.446 . . . . 0.0 111.037 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.02 -173.29 43.6 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.199 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.48 114.47 1.96 Allowed 'Trans proline' 0 C--N 1.328 -0.535 0 C-N-CA 123.798 2.999 . . . . 0.0 111.625 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.595 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 31.7 p -87.94 -22.85 24.1 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.318 0.58 . . . . 0.0 110.945 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.5 t -72.0 117.07 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.2 m -71.72 161.35 31.11 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.7 162.88 28.93 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.072 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.5 m -62.07 113.07 2.63 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.147 0.499 . . . . 0.0 111.775 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.55 -10.18 32.85 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.107 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.54 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 23.2 p -115.07 152.13 33.05 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 122.695 -0.297 . . . . 0.0 111.102 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.4 p -128.14 139.99 52.18 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 123.118 0.261 . . . . 0.0 110.445 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.6 t -73.66 111.69 9.05 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.845 0.355 . . . . 0.0 110.177 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.488 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 69.4 mt-30 -111.28 115.62 29.64 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-O 120.948 0.404 . . . . 0.0 110.471 -178.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.4 t -71.16 110.87 4.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.2 mt -89.72 -46.6 8.5 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -131.07 168.89 15.32 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -63.91 -34.82 58.62 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 CA-C-N 120.987 1.388 . . . . 0.0 113.019 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.511 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 12.4 m-85 -102.72 -24.76 13.71 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 119.306 -0.958 . . . . 0.0 110.892 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -103.54 114.86 29.45 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.946 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.59 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 13.7 m -120.89 127.63 52.05 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 36.3 tt0 -111.94 135.88 51.99 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 123.509 0.506 . . . . 0.0 109.721 -173.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.54 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 12.3 t -85.95 115.78 23.77 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.253 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.488 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 89.3 mt . . . . . 0 N--CA 1.414 -2.237 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.445 ' H2 ' ' HA3' ' A' ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.44 -0.959 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.14 144.41 27.51 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 p -106.32 155.75 19.2 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.311 -0.859 . . . . 0.0 113.139 -172.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -59.44 124.51 20.27 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.75 1.22 . . . . 0.0 109.836 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 71.75 10.25 6.31 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.726 1.21 . . . . 0.0 112.702 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -104.8 165.88 14.69 Favored Glycine 0 N--CA 1.42 -2.401 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 174.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.6 tt0 -70.57 128.81 37.39 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.661 ' O ' ' HA ' ' A' ' 17' ' ' THR . 16.7 p -109.72 -36.64 5.87 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.6 63.81 0.18 Allowed Glycine 0 CA--C 1.483 -1.953 0 C-N-CA 118.359 -1.877 . . . . 0.0 113.015 -174.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.77 159.92 15.09 Favored Glycine 0 C--N 1.291 -1.97 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 175.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.418 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 58.3 mt -61.4 116.23 2.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 117.774 0.787 . . . . 0.0 109.696 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.61 -11.76 21.14 Favored Glycine 0 N--CA 1.436 -1.337 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.111 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -90.99 109.19 20.42 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.7 p -92.64 5.25 51.68 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.492 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.26 -179.09 50.75 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.287 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -55.02 122.81 12.37 Favored 'Trans proline' 0 N--CA 1.479 0.647 0 C-N-CA 124.594 3.529 . . . . 0.0 112.501 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.661 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.5 p -90.98 -20.22 22.38 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.4 t -83.95 126.46 40.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.8 m -76.35 171.13 15.08 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.57 176.17 9.6 Favored 'General case' 0 C--O 1.252 1.225 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.115 177.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -62.64 119.39 9.16 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.483 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.87 6.3 58.15 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.998 -0.62 . . . . 0.0 113.471 176.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.713 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 3.0 p -131.23 150.95 51.93 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 117.196 0.498 . . . . 0.0 111.245 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.9 p -129.95 144.14 51.17 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.636 0.236 . . . . 0.0 111.636 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.8 t -79.43 107.9 12.54 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -107.91 116.31 31.72 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-O 121.522 0.677 . . . . 0.0 110.353 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.4 t -74.92 108.77 6.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.115 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.2 mt -85.22 -50.49 7.33 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -129.87 166.58 25.21 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.16 -33.69 71.46 Favored 'Trans proline' 0 C--N 1.348 0.53 0 CA-C-N 120.669 1.274 . . . . 0.0 112.804 -177.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.498 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 53.0 m-85 -98.39 -26.49 14.46 Favored 'General case' 0 N--CA 1.434 -1.268 0 C-N-CA 118.914 -1.115 . . . . 0.0 110.827 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 57.4 t80 -105.11 114.25 28.34 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 119.188 -1.005 . . . . 0.0 112.978 175.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.8 m -122.72 131.4 53.77 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 174.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.431 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 35.5 tt0 -117.82 138.83 51.82 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 123.407 0.442 . . . . 0.0 110.094 -173.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.713 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 14.4 t -84.35 115.67 22.62 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.035 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.9 mt . . . . . 0 C--N 1.286 -2.193 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.601 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.442 -0.874 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.77 143.35 47.98 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-O 120.864 0.364 . . . . 0.0 110.228 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.3 p -92.77 162.86 13.96 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.66 -177.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -67.77 126.74 30.37 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 81.16 6.47 1.29 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.485 1.114 . . . . 0.0 112.699 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.78 159.7 21.61 Favored Glycine 0 N--CA 1.436 -1.309 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -70.86 126.38 29.43 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 17' ' ' THR . 6.2 p -104.23 -42.67 5.44 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -176.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.4 64.83 0.29 Allowed Glycine 0 CA--C 1.476 -2.353 0 C-N-CA 118.31 -1.9 . . . . 0.0 112.852 -172.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.34 156.2 16.77 Favored Glycine 0 N--CA 1.42 -2.415 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 177.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.571 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 62.4 mt -61.62 121.25 9.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.18 -11.79 40.36 Favored Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -100.92 116.5 32.93 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.9 p -114.49 17.07 17.56 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.08 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.56 -162.38 31.4 Favored Glycine 0 C--O 1.24 0.494 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.76 109.05 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.406 2.738 . . . . 0.0 111.579 175.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 11.1 p -95.25 -22.24 17.92 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.782 -177.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.52 119.57 35.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.7 m -73.21 170.09 15.7 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.79 162.97 25.74 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.375 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.1 m -65.03 113.17 3.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.05 0.452 . . . . 0.0 110.11 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.16 7.65 26.5 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.977 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.679 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 19.2 p -131.9 146.72 52.27 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.4 p -127.25 138.87 53.19 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 121.208 -0.197 . . . . 0.0 110.881 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.7 t -75.97 109.95 10.03 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -105.2 133.15 50.44 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-O 121.445 0.641 . . . . 0.0 111.351 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.4 t -81.48 99.59 4.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.9 mt -82.18 -40.63 21.49 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -145.01 168.46 12.05 Favored Pre-proline 0 N--CA 1.431 -1.399 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -65.16 -38.95 25.35 Favored 'Trans proline' 0 C--O 1.25 1.084 0 CA-C-N 120.403 1.18 . . . . 0.0 112.659 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.571 ' CD1' ' HB ' ' A' ' 11' ' ' ILE . 53.0 m-85 -96.1 -27.01 15.28 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.643 -176.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -104.2 114.08 28.07 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.589 -0.845 . . . . 0.0 111.418 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.5 m -125.68 130.04 50.76 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 174.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -118.56 144.63 45.95 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -172.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.679 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 10.2 t -87.54 114.46 24.17 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.086 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.5 mt . . . . . 0 N--CA 1.418 -2.058 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -177.72 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.572 ' H61' ' O3 ' ' A' ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.436 -1.158 0 CA-C-O 120.875 0.369 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.75 131.57 37.7 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.5 p -93.92 166.1 12.34 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.361 0.601 . . . . 0.0 111.8 -175.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -61.89 124.07 19.77 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.067 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 80.14 6.31 1.71 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.288 1.435 . . . . 0.0 112.866 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.31 159.17 20.56 Favored Glycine 0 N--CA 1.435 -1.393 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.524 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.5 tt0 -70.66 128.94 37.8 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.2 p -120.27 8.14 10.83 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 153.38 76.21 0.02 OUTLIER Glycine 0 CA--C 1.483 -1.93 0 C-N-CA 117.292 -2.385 . . . . 0.0 114.511 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.54 166.63 14.38 Favored Glycine 0 N--CA 1.419 -2.459 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 176.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.3 mt -64.93 118.54 7.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.54 -13.92 66.3 Favored Glycine 0 C--N 1.315 -0.637 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.362 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -79.49 108.4 12.99 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.22 0.533 . . . . 0.0 110.548 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.2 p -92.24 6.94 44.88 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.222 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.44 -171.23 41.08 Favored Glycine 0 C--N 1.316 -0.569 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.647 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -49.22 131.47 26.67 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 124.556 3.504 . . . . 0.0 112.299 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.4 p -125.52 -22.32 4.31 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 51.7 t -91.1 119.53 38.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.7 m -76.45 166.01 24.01 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.397 0.618 . . . . 0.0 112.479 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.91 167.82 20.03 Favored 'General case' 0 C--O 1.255 1.374 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.004 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.2 m -70.15 119.83 14.93 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 120.964 0.412 . . . . 0.0 110.268 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.46 -16.74 29.04 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.658 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 27.1 p -109.18 146.5 34.05 Favored 'General case' 0 C--O 1.251 1.163 0 O-C-N 122.426 -0.455 . . . . 0.0 111.329 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.0 p -124.9 133.73 52.95 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.799 -177.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.0 t -76.08 111.99 12.06 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -113.71 119.01 35.93 Favored 'General case' 0 N--CA 1.406 -2.648 0 CA-C-O 121.206 0.526 . . . . 0.0 110.866 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 82.4 t -70.78 108.48 2.59 Favored 'Isoleucine or valine' 0 C--O 1.253 1.248 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.816 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.418 HD11 ' CE2' ' A' ' 32' ' ' TYR . 71.2 mt -85.61 -46.41 10.81 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -133.49 166.76 26.9 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.63 -31.17 79.51 Favored 'Trans proline' 0 C--N 1.35 0.62 0 CA-C-N 120.906 1.359 . . . . 0.0 112.347 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.539 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 92.5 m-85 -99.89 -26.28 14.06 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.757 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.418 ' CE2' HD11 ' A' ' 28' ' ' LEU . 54.2 t80 -104.85 114.12 28.14 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 119.463 -0.895 . . . . 0.0 111.819 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 26.8 m -122.32 128.94 51.66 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 176.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -121.99 138.72 54.32 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -175.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.658 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 8.6 t -82.04 118.71 23.22 Favored 'General case' 0 N--CA 1.422 -1.854 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.937 -178.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.0 mt . . . . . 0 C--N 1.286 -2.194 0 C-N-CA 123.78 0.832 . . . . 0.0 109.364 -176.517 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 110.644 -0.132 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.25 159.97 30.18 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.47 0.652 . . . . 0.0 111.227 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.5 p -104.86 158.38 16.57 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.767 -175.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -71.87 128.75 36.74 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 77.56 -0.78 2.76 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.084 1.354 . . . . 0.0 111.551 -176.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.14 165.83 36.3 Favored Glycine 0 N--CA 1.416 -2.638 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.597 ' HA ' ' O ' ' A' ' 33' ' ' SER . 60.7 tt0 -74.65 123.39 24.79 Favored 'General case' 0 C--O 1.199 -1.599 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 23.9 p -108.88 -5.62 16.11 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 163.41 57.53 0.02 OUTLIER Glycine 0 CA--C 1.474 -2.477 0 C-N-CA 117.717 -2.182 . . . . 0.0 112.858 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -106.3 164.13 13.62 Favored Glycine 0 N--CA 1.421 -2.358 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 176.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.0 116.87 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 117.401 0.6 . . . . 0.0 109.728 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.68 -25.5 8.5 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.422 -178.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -83.78 121.9 27.94 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.0 p -116.58 13.73 15.34 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.253 0.549 . . . . 0.0 111.194 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.04 -170.29 47.01 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.075 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -57.23 117.13 3.77 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 123.933 3.089 . . . . 0.0 110.9 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 39.5 p -93.75 -4.9 49.53 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.1 t -93.15 134.48 30.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 175.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.5 m -81.29 169.45 17.28 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -177.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.93 165.71 23.77 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.901 177.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 p -60.07 116.9 4.51 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.4 -17.26 37.15 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.031 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.63 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 41.4 p -108.87 148.94 29.86 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.61 -177.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.7 p -127.47 141.68 51.6 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 122.492 -0.13 . . . . 0.0 110.725 -178.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.1 t -79.05 113.04 16.85 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -116.58 113.41 22.69 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-O 121.305 0.574 . . . . 0.0 110.188 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.4 t -70.91 106.01 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.779 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.8 mt -87.04 -39.29 15.76 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.596 0.712 . . . . 0.0 109.397 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -141.24 167.75 16.25 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.19 -33.81 29.85 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 CA-C-N 120.917 1.363 . . . . 0.0 112.559 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.536 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 48.0 m-85 -97.32 -27.47 14.48 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 118.351 -1.34 . . . . 0.0 109.829 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.552 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 57.9 t80 -104.57 113.68 27.41 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 118.703 -1.199 . . . . 0.0 112.548 177.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.9 m -118.13 130.72 56.28 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 173.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.552 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 36.3 tt0 -116.94 140.55 49.33 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 118.057 0.39 . . . . 0.0 110.311 -173.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.63 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 18.5 t -89.09 121.91 31.89 Favored 'General case' 0 N--CA 1.416 -2.137 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.715 177.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 N--CA 1.421 -1.92 0 C-N-CA 123.975 0.91 . . . . 0.0 108.941 -179.565 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.3 p . . . . . 0 N--CA 1.445 -0.721 0 N-CA-C 110.592 -0.151 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.34 148.78 51.36 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.321 0.582 . . . . 0.0 110.925 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 13.9 p -99.83 153.26 19.29 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.919 -171.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -70.51 116.96 11.45 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.862 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 77.63 19.47 1.18 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.287 1.035 . . . . 0.0 110.864 -176.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.45 159.28 13.78 Favored Glycine 0 N--CA 1.416 -2.64 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 172.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.5 tt0 -68.44 136.15 52.8 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 177.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 17' ' ' THR . 9.5 p -122.36 -37.39 2.81 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -175.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.85 58.38 0.31 Allowed Glycine 0 CA--C 1.484 -1.88 0 C-N-CA 118.815 -1.66 . . . . 0.0 112.37 -173.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.48 155.01 17.06 Favored Glycine 0 N--CA 1.421 -2.343 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 59.6 mt -65.0 115.67 3.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.34 -12.02 14.18 Favored Glycine 0 C--N 1.297 -1.599 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.75 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.668 ' OH ' ' H4 ' ' A' ' 101' ' ' MAN . 62.2 t80 -93.9 122.79 36.75 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.143 0.497 . . . . 0.0 110.076 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 p -109.28 15.38 23.19 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.551 -177.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.49 -168.93 32.78 Favored Glycine 0 C--N 1.315 -0.6 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.892 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -53.64 117.3 3.69 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.955 3.103 . . . . 0.0 112.655 177.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 19.8 p -90.04 -25.75 20.65 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 123.295 0.638 . . . . 0.0 111.648 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -83.07 118.89 31.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.6 m -72.05 170.69 13.34 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.48 169.31 17.86 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.622 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.7 m -64.96 114.46 4.57 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.745 0.307 . . . . 0.0 110.867 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.3 6.17 45.2 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.268 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.668 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 27.4 p -128.26 147.17 50.58 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.8 p -129.38 137.71 51.09 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.728 0.299 . . . . 0.0 110.778 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.4 t -75.58 107.5 7.77 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.445 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 78.5 mt-30 -107.38 126.01 51.93 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-O 121.391 0.615 . . . . 0.0 110.949 -176.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.5 t -77.45 110.64 13.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.934 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.1 mt -89.3 -48.51 7.31 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -132.81 168.32 18.45 Favored Pre-proline 0 C--N 1.299 -1.597 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -63.39 -40.89 29.08 Favored 'Trans proline' 0 C--O 1.253 1.258 0 CA-C-N 120.994 1.391 . . . . 0.0 113.074 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.499 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 24.3 m-85 -94.72 -26.17 16.4 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.866 -177.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -104.63 113.49 27.1 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.982 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.0 m -127.03 133.88 50.42 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -124.1 143.03 50.7 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -172.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.668 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.2 t -85.84 121.74 28.91 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.28 0.562 . . . . 0.0 110.724 -177.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.445 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 94.5 mt . . . . . 0 C--N 1.289 -2.032 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.668 ' H4 ' ' OH ' ' A' ' 13' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 19.7 p . . . . . 0 N--CA 1.445 -0.684 0 CA-C-O 120.827 0.346 . . . . 0.0 110.615 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.26 149.66 27.72 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p -88.02 143.51 27.05 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.606 -173.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -64.79 126.44 27.95 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 76.41 6.51 3.51 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.833 1.253 . . . . 0.0 111.375 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.413 ' HA3' ' H3 ' ' A' ' 101' ' ' MAN . . . -101.09 164.39 18.31 Favored Glycine 0 N--CA 1.423 -2.194 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 177.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.8 tt0 -69.35 128.98 38.49 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 17' ' ' THR . 24.7 p -122.96 -8.98 8.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -173.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.34 64.47 0.04 OUTLIER Glycine 0 CA--C 1.482 -1.986 0 C-N-CA 116.855 -2.593 . . . . 0.0 114.072 -177.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.68 171.0 17.76 Favored Glycine 0 C--N 1.293 -1.841 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 175.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.8 mt -69.03 124.23 24.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.63 -1.68 60.14 Favored Glycine 0 C--N 1.305 -1.165 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.341 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.704 ' OH ' ' H62' ' A' ' 101' ' ' MAN . 82.6 t80 -101.01 106.67 17.99 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.5 p -101.59 1.9 38.33 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.844 -176.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.77 -168.36 12.16 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.468 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -52.58 113.45 1.24 Allowed 'Trans proline' 0 N--CA 1.484 0.915 0 C-N-CA 124.183 3.255 . . . . 0.0 112.145 177.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.4 p -101.52 -30.28 11.49 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.889 0.376 . . . . 0.0 111.981 -178.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 1' ' ' THR . 57.7 t -73.79 112.29 10.22 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.249 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 54.1 m -66.93 165.2 15.96 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.17 175.62 9.49 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.006 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -66.7 115.36 6.43 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.792 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.35 9.14 58.17 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 121.251 -0.499 . . . . 0.0 112.733 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.593 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 41.2 p -122.88 148.03 45.89 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.839 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.5 p -128.66 135.12 48.85 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 123.125 0.266 . . . . 0.0 111.615 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.4 t -79.33 116.62 19.68 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.851 0.358 . . . . 0.0 110.05 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.44 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 60.0 mt-30 -114.89 114.8 25.97 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 120.778 0.323 . . . . 0.0 110.418 -177.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.4 t -70.99 118.21 15.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.43 HD12 ' CE2' ' A' ' 32' ' ' TYR . 93.7 mt -98.08 -49.28 4.8 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.282 0.563 . . . . 0.0 109.775 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.435 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 80.9 m-20 -124.25 169.11 11.25 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 178.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 29' ' ' ASN . 6.0 Cg_endo -64.14 -31.87 64.24 Favored 'Trans proline' 0 C--N 1.353 0.768 0 CA-C-N 121.404 1.537 . . . . 0.0 112.563 -177.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.485 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 51.8 m-85 -103.34 -24.51 13.5 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.159 0.504 . . . . 0.0 110.61 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.43 ' CE2' HD12 ' A' ' 28' ' ' LEU . 71.7 t80 -103.39 115.16 30.02 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 121.885 -0.509 . . . . 0.0 112.119 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.566 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.6 m -127.82 131.95 49.48 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 176.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -117.51 139.16 51.3 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -173.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.593 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.9 t -86.14 112.57 21.43 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.511 0.672 . . . . 0.0 110.566 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.44 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 43.0 mt . . . . . 0 N--CA 1.408 -2.531 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.704 ' H62' ' OH ' ' A' ' 13' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.442 -0.831 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.28 127.86 33.74 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.461 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 31.4 p -89.04 172.1 9.36 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.509 -175.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.62 ' O ' ' H2 ' ' A' ' 101' ' ' MAN . 18.3 t-160 -71.6 124.28 24.36 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 174.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 78.36 16.82 1.2 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.807 0.843 . . . . 0.0 111.664 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.48 153.86 17.17 Favored Glycine 0 N--CA 1.426 -1.989 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 174.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.582 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.5 tt0 -68.47 124.11 22.65 Favored 'General case' 0 C--O 1.21 -1.021 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.3 p -115.72 2.41 13.68 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.05 62.0 0.01 OUTLIER Glycine 0 CA--C 1.49 -1.53 0 C-N-CA 117.645 -2.217 . . . . 0.0 113.868 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.69 163.47 14.0 Favored Glycine 0 C--N 1.291 -1.922 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 59.8 mt -58.82 118.94 2.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 117.48 0.64 . . . . 0.0 110.492 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.4 -17.13 47.75 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.119 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -81.57 112.0 18.38 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 p -107.66 22.62 15.7 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.897 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.11 -169.22 39.37 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.367 177.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.74 122.99 12.77 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.95 3.1 . . . . 0.0 112.29 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 p -99.49 -10.06 22.59 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.437 0.637 . . . . 0.0 111.968 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.3 t -87.46 130.78 36.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.9 m -90.34 165.71 13.72 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.463 0.649 . . . . 0.0 112.106 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.71 163.99 26.72 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.459 176.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.6 m -74.34 124.29 26.2 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.62 -2.64 29.14 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -174.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.598 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 32.9 p -132.84 150.07 52.2 Favored 'General case' 0 C--O 1.248 1.017 0 O-C-N 122.763 -0.257 . . . . 0.0 111.018 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.3 p -128.64 139.51 52.22 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.6 t -77.44 116.56 18.12 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -117.74 122.63 43.97 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-O 121.259 0.552 . . . . 0.0 110.947 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.4 t -74.12 109.69 7.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.2 mt -87.3 -41.07 13.93 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -141.91 166.49 21.28 Favored Pre-proline 0 C--N 1.301 -1.535 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -62.6 -37.01 60.94 Favored 'Trans proline' 0 C--N 1.351 0.68 0 CA-C-N 121.206 1.467 . . . . 0.0 113.081 -177.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.514 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 84.6 m-85 -94.63 -27.25 15.98 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 118.501 -1.279 . . . . 0.0 110.813 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.485 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 48.1 t80 -105.52 113.93 27.79 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.416 -0.914 . . . . 0.0 112.782 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.582 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.0 m -120.24 129.13 53.92 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 174.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.485 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.9 tt0 -120.07 138.37 53.58 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -174.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.598 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.1 t -83.4 122.35 28.37 Favored 'General case' 0 N--CA 1.426 -1.661 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.839 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 N--CA 1.421 -1.881 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.024 -177.457 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.62 ' H2 ' ' O ' ' A' ' 4' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.8 p . . . . . 0 CA--C 1.535 0.398 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.31 140.06 37.65 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 120.934 0.397 . . . . 0.0 109.938 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.9 p -83.94 153.64 23.81 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 114.844 -1.071 . . . . 0.0 113.069 -173.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -73.56 127.63 33.27 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 76.22 2.84 3.6 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.243 1.017 . . . . 0.0 111.471 -176.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.99 169.68 29.78 Favored Glycine 0 N--CA 1.415 -2.726 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 176.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.2 tt0 -77.36 127.34 32.4 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 18.7 p -116.09 4.47 13.67 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -174.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.51 62.85 0.01 OUTLIER Glycine 0 CA--C 1.481 -2.093 0 C-N-CA 118.085 -2.007 . . . . 0.0 113.417 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.38 161.25 14.75 Favored Glycine 0 N--CA 1.425 -2.059 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 177.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.49 119.79 5.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 117.724 0.762 . . . . 0.0 109.256 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.26 -22.13 25.46 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -81.05 117.15 21.39 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.038 0.447 . . . . 0.0 110.288 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.0 p -101.67 -0.23 34.98 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.751 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.33 -173.61 44.65 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.591 -177.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -53.33 124.34 15.45 Favored 'Trans proline' 0 N--CA 1.477 0.509 0 C-N-CA 124.435 3.423 . . . . 0.0 112.362 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.4 p -104.03 -18.97 14.36 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.17 0.509 . . . . 0.0 111.589 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.8 t -78.75 112.71 17.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 52.4 m -65.41 162.96 16.66 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.98 172.59 12.04 Favored 'General case' 0 C--O 1.254 1.334 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.086 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.5 m -67.13 119.95 12.91 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.714 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.85 19.93 35.44 Favored Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.905 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.582 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 44.4 p -138.09 148.49 45.06 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 117.038 0.419 . . . . 0.0 110.061 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.4 p -126.17 133.33 51.6 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 122.103 0.161 . . . . 0.0 110.943 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.1 t -74.25 119.82 18.99 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -119.0 120.17 36.46 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-O 121.558 0.694 . . . . 0.0 110.818 -178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.2 t -75.24 101.21 2.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.982 177.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.426 HD12 ' CE1' ' A' ' 32' ' ' TYR . 77.3 mt -79.51 -46.23 17.79 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.42 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 93.5 m-20 -140.31 170.5 9.52 Favored Pre-proline 0 C--N 1.31 -1.138 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 29' ' ' ASN . 4.3 Cg_exo -62.88 -43.15 21.23 Favored 'Trans proline' 0 C--N 1.358 1.056 0 CA-C-N 120.763 1.308 . . . . 0.0 112.979 -178.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.527 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 89.8 m-85 -89.77 -27.18 20.19 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 118.299 -1.36 . . . . 0.0 110.021 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.555 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 40.0 t80 -104.05 113.91 27.78 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 118.789 -1.164 . . . . 0.0 112.503 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.3 m -127.31 123.78 37.16 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 174.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.555 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 31.8 tt0 -116.64 140.59 49.23 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 123.504 0.502 . . . . 0.0 110.391 -173.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.582 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.4 t -88.81 123.25 33.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.5 mt . . . . . 0 C--N 1.296 -1.738 0 C-N-CA 123.794 0.838 . . . . 0.0 109.362 -176.556 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 19' ' ' CYS . . . . . . . . 0 N--CA 1.43 -1.46 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 4.0 p -104.69 153.12 21.66 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.22 -173.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -69.67 123.19 20.72 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 78.06 6.96 2.61 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.589 1.156 . . . . 0.0 112.002 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -103.3 167.29 16.69 Favored Glycine 0 N--CA 1.423 -2.213 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 175.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.6 tt0 -70.39 127.63 33.4 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 17' ' ' THR . 20.1 p -103.52 -39.1 6.87 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.18 76.13 0.11 Allowed Glycine 0 CA--C 1.484 -1.844 0 C-N-CA 118.392 -1.861 . . . . 0.0 113.608 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.34 169.78 16.77 Favored Glycine 0 C--N 1.291 -1.926 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 176.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.0 mt -66.95 119.49 12.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.71 -17.17 42.9 Favored Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -85.1 106.25 16.43 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.0 p -94.37 4.9 53.26 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.298 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.26 -169.8 32.65 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 115.553 -0.748 . . . . 0.0 112.692 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -59.55 114.49 2.07 Favored 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 123.592 2.861 . . . . 0.0 111.797 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.7 p -93.98 -17.12 23.27 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.539 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.8 t -88.68 120.59 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 2' ' ' ALA . 66.7 m -72.89 167.61 20.64 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.42 165.0 24.96 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.419 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.1 m -64.85 124.11 21.13 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 120.643 0.259 . . . . 0.0 110.367 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.92 -0.01 48.41 Favored Glycine 0 N--CA 1.432 -1.593 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.331 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.554 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 42.1 p -128.43 151.03 49.85 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.6 p -130.15 137.72 50.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.759 0.314 . . . . 0.0 111.679 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.1 t -74.16 114.78 12.89 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -121.76 117.7 27.24 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-O 121.379 0.609 . . . . 0.0 111.109 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.5 t -71.02 116.89 13.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.437 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.9 mt -97.44 -39.76 9.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.889 0.852 . . . . 0.0 108.95 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -137.7 164.32 42.07 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -62.61 -32.73 79.27 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 CA-C-N 120.865 1.344 . . . . 0.0 112.002 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.502 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 31.1 m-85 -97.77 -26.58 14.67 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 119.094 -1.042 . . . . 0.0 111.597 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.41 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 68.4 t80 -105.3 114.32 28.43 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 119.779 -0.769 . . . . 0.0 112.664 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.0 m -121.05 130.8 53.93 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 174.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.41 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 53.9 tt0 -115.06 140.78 48.78 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -173.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.554 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 13.3 t -87.12 112.96 22.44 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.593 178.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.3 mt . . . . . 0 C--N 1.278 -2.532 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -179.58 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.495 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.8 p -98.09 153.51 18.38 Favored 'General case' 0 C--N 1.272 -2.78 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.146 -172.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -65.35 122.51 17.31 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 79.34 12.26 1.26 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.815 1.246 . . . . 0.0 111.416 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -107.56 168.05 13.86 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.5 tt0 -77.31 122.4 25.05 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.59 ' O ' ' HA ' ' A' ' 17' ' ' THR . 7.2 p -104.97 -37.01 7.13 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.32 68.13 0.12 Allowed Glycine 0 CA--C 1.474 -2.53 0 C-N-CA 118.052 -2.023 . . . . 0.0 113.127 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.84 165.75 13.99 Favored Glycine 0 C--N 1.284 -2.316 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.0 mt -62.21 126.71 20.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.92 -11.52 57.49 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.88 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -100.9 126.6 47.53 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.8 p -119.26 14.48 12.99 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.491 0.663 . . . . 0.0 111.661 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.88 -155.86 16.12 Favored Glycine 0 C--O 1.258 1.644 0 CA-C-N 115.954 -0.566 . . . . 0.0 113.086 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -56.27 104.94 0.15 Allowed 'Trans proline' 0 C--O 1.222 -0.277 0 C-N-CA 123.854 3.036 . . . . 0.0 113.372 174.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.0 p -87.79 -15.76 36.0 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.55 0.691 . . . . 0.0 110.776 177.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.8 t -88.09 122.94 40.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.069 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.415 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 56.6 m -79.22 175.3 10.71 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.344 0.592 . . . . 0.0 112.274 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.74 163.4 24.52 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.2 m -64.64 122.95 18.04 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.77 5.76 54.97 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.433 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.568 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 40.0 p -128.28 149.21 50.59 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.3 p -130.61 138.7 50.24 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 117.793 0.269 . . . . 0.0 111.275 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.7 t -72.98 111.42 8.07 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -109.6 133.09 53.52 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-O 121.292 0.568 . . . . 0.0 110.515 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.6 t -83.83 105.93 13.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.646 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.1 mt -87.41 -38.36 16.22 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.981 0.896 . . . . 0.0 108.691 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -144.51 167.77 14.09 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -64.45 -41.71 19.39 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 CA-C-N 120.807 1.324 . . . . 0.0 112.101 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.507 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 17.7 m-85 -91.97 -26.44 18.4 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.628 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -104.76 113.24 26.7 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.875 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.4 m -121.89 130.01 53.01 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 174.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -119.94 139.01 53.1 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -173.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.568 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 9.7 t -81.03 117.08 21.32 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-O 121.502 0.668 . . . . 0.0 110.093 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 N--CA 1.405 -2.678 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.693 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 19' ' ' CYS . . . . . . . . 0 N--CA 1.438 -1.036 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 99.8 p -86.71 166.79 15.02 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.705 -175.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -70.89 123.87 23.02 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 78.53 11.69 1.66 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.059 0.944 . . . . 0.0 112.493 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.37 160.83 19.06 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 174.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.3 tt0 -73.79 121.63 21.15 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 17' ' ' THR . 6.8 p -103.53 -44.15 5.2 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -174.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.35 68.15 0.24 Allowed Glycine 0 CA--C 1.476 -2.377 0 C-N-CA 118.183 -1.96 . . . . 0.0 113.559 -171.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.593 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -104.73 160.15 15.61 Favored Glycine 0 C--N 1.279 -2.626 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.3 mt -62.51 122.83 14.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.33 -14.85 50.97 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.045 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -92.01 116.45 28.93 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 p -111.63 21.25 16.31 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.41 0.624 . . . . 0.0 111.675 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.413 ' HA3' ' HD2' ' A' ' 16' ' ' PRO . . . -84.76 -153.87 20.02 Favored Glycine 0 C--O 1.252 1.241 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.975 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.413 ' HD2' ' HA3' ' A' ' 15' ' ' GLY . 30.2 Cg_endo -61.77 110.56 0.99 Allowed 'Trans proline' 0 C--N 1.328 -0.523 0 C-N-CA 123.889 3.059 . . . . 0.0 111.871 174.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.587 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 62.7 p -96.31 -20.94 18.13 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.745 0.783 . . . . 0.0 110.524 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.7 t -82.04 118.46 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.092 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.42 ' HA ' ' HB3' ' A' ' 2' ' ' ALA . 59.3 m -77.21 164.09 25.93 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 120.991 0.424 . . . . 0.0 111.72 177.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.46 153.85 37.36 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.7 m -60.88 121.03 11.34 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.41 0.624 . . . . 0.0 111.22 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.22 -20.84 23.07 Favored Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.554 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.536 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 35.3 p -105.65 146.55 29.56 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 122.278 -0.542 . . . . 0.0 110.101 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.1 p -124.85 134.16 52.83 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 122.352 0.261 . . . . 0.0 110.784 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.5 t -73.11 112.91 9.58 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -116.82 132.65 56.64 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-O 121.246 0.546 . . . . 0.0 111.116 -177.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.3 t -75.22 117.01 18.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.783 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 32.8 mt -93.87 -48.47 6.27 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.468 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 81.1 m-20 -131.18 167.67 20.66 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 29' ' ' ASN . 1.6 Cg_endo -60.9 -33.34 92.69 Favored 'Trans proline' 0 C--N 1.359 1.13 0 CA-C-N 121.335 1.513 . . . . 0.0 113.167 -176.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.593 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 82.4 m-85 -99.95 -25.21 14.4 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.239 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -103.57 113.83 27.63 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.583 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.7 m -120.93 132.04 54.71 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 175.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -119.98 139.76 51.98 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -174.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.536 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 9.9 t -84.87 121.38 27.65 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.201 -177.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 N--CA 1.422 -1.833 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 -176.923 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.572 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.6 p -85.37 163.73 18.37 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.996 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -65.95 124.41 22.46 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 81.26 9.62 0.96 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.146 1.378 . . . . 0.0 112.114 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.07 164.65 20.53 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 33' ' ' SER . 61.5 tt0 -75.6 125.25 28.66 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 17' ' ' THR . 24.5 p -112.75 1.72 15.75 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -172.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.18 73.98 0.01 OUTLIER Glycine 0 CA--C 1.487 -1.68 0 C-N-CA 116.695 -2.669 . . . . 0.0 114.895 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -94.96 165.04 25.28 Favored Glycine 0 N--CA 1.423 -2.218 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 176.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.5 mt -62.05 115.91 2.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 121.206 0.527 . . . . 0.0 110.805 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.96 1.19 70.51 Favored Glycine 0 C--N 1.312 -0.796 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.039 -178.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -100.11 106.84 18.61 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.9 p -101.99 18.8 19.75 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.954 -176.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.97 -161.14 16.06 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.95 114.02 1.43 Allowed 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 123.526 2.817 . . . . 0.0 111.783 175.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 12.9 p -110.69 -30.3 7.65 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.501 0.667 . . . . 0.0 111.499 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.5 t -79.7 128.51 38.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.8 m -88.65 174.02 8.28 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.22 0.533 . . . . 0.0 112.348 -177.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.66 169.66 12.49 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.781 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.4 m -63.64 113.09 3.13 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.78 9.57 32.44 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.164 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.631 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 21.4 p -132.13 149.12 52.48 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-N 117.451 0.626 . . . . 0.0 110.595 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.8 p -128.34 139.04 52.61 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.466 0.175 . . . . 0.0 111.393 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.3 t -76.57 117.86 18.64 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -118.65 128.29 54.39 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-O 121.368 0.604 . . . . 0.0 110.936 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -79.23 114.25 19.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.272 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.6 mt -95.87 -44.49 7.37 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -136.71 167.61 20.54 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -63.91 -42.46 19.37 Favored 'Trans proline' 0 C--O 1.241 0.639 0 CA-C-N 120.99 1.389 . . . . 0.0 112.577 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.62 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 76.8 m-85 -92.06 -24.81 19.05 Favored 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.412 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -104.66 113.83 27.66 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.568 -0.853 . . . . 0.0 112.273 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 35.1 m -122.55 134.83 54.53 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 174.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -122.09 140.97 51.88 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -174.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.631 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 10.4 t -84.82 114.57 22.18 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.0 mt . . . . . 0 C--N 1.283 -2.298 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -176.528 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.381 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.9 p -83.87 153.93 23.73 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.558 -173.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -61.94 119.34 8.65 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 85.1 3.45 0.65 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.29 1.436 . . . . 0.0 112.743 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.81 165.16 22.02 Favored Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -73.35 128.76 36.39 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 17' ' ' THR . 14.5 p -107.2 -45.76 4.04 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -175.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.09 74.75 0.14 Allowed Glycine 0 CA--C 1.488 -1.62 0 C-N-CA 118.265 -1.921 . . . . 0.0 114.427 -173.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.76 164.57 13.89 Favored Glycine 0 C--N 1.295 -1.739 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 175.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.41 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 53.3 mt -61.74 120.37 7.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 117.29 0.545 . . . . 0.0 110.252 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.47 -7.85 51.26 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.5 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -100.79 106.65 18.07 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.3 p -104.33 28.27 7.03 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.583 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.44 -163.67 39.26 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -59.16 111.71 1.0 Allowed 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.399 2.733 . . . . 0.0 111.476 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 36.3 p -99.39 -11.0 21.55 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.172 0.51 . . . . 0.0 111.791 -178.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.6 t -85.23 120.52 35.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 57.0 m -84.52 158.65 20.91 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.35 0.595 . . . . 0.0 112.382 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.39 172.62 11.58 Favored 'General case' 0 C--O 1.251 1.136 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.884 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.5 m -64.86 112.55 3.32 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 123.196 0.598 . . . . 0.0 110.95 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.19 -4.14 38.14 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.44 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.649 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 37.5 p -117.65 147.39 42.94 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.041 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.0 p -129.77 140.62 51.02 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 123.1 0.25 . . . . 0.0 110.795 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -75.14 102.86 5.09 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 121.054 0.454 . . . . 0.0 110.34 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -101.02 124.01 46.09 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-O 121.96 0.886 . . . . 0.0 112.388 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.3 t -77.91 112.93 16.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 114.176 -1.375 . . . . 0.0 108.688 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.45 HD12 ' CE1' ' A' ' 32' ' ' TYR . 89.0 mt -94.14 -39.62 10.48 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -141.08 169.15 12.1 Favored Pre-proline 0 C--N 1.297 -1.701 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.9 -36.31 39.86 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 CA-C-N 121.24 1.479 . . . . 0.0 113.144 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.584 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 31.0 m-85 -98.94 -25.6 14.54 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.059 -176.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.45 ' CE1' HD12 ' A' ' 28' ' ' LEU . 67.7 t80 -104.04 114.12 28.15 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.116 0.484 . . . . 0.0 111.639 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 m -126.35 132.31 51.62 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 175.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -119.89 139.34 52.55 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.649 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.0 t -82.7 115.67 21.73 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.837 -178.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.4 mt . . . . . 0 N--CA 1.418 -2.075 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 -179.546 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -1.777 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.1 p -101.99 155.26 18.28 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.557 -171.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -66.92 125.19 25.17 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 81.07 -0.4 1.75 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.909 1.283 . . . . 0.0 111.612 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -96.17 172.14 28.99 Favored Glycine 0 N--CA 1.428 -1.853 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.586 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.1 tt0 -78.57 130.61 36.14 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 17' ' ' THR . 21.4 p -113.6 -25.83 8.54 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -175.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.2 65.96 0.09 OUTLIER Glycine 0 CA--C 1.489 -1.575 0 C-N-CA 118.273 -1.918 . . . . 0.0 113.431 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.79 165.33 13.92 Favored Glycine 0 C--N 1.298 -1.574 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 176.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.8 mt -60.17 117.77 2.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 117.341 0.57 . . . . 0.0 109.896 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.6 -2.96 57.47 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.349 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -92.52 108.42 19.96 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 p -104.81 26.43 9.18 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.426 -177.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.98 -169.44 33.59 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.327 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -58.14 126.39 21.41 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.901 3.067 . . . . 0.0 111.311 176.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 4.9 p -102.61 -21.14 14.2 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.064 -176.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.7 t -81.71 121.33 34.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.4 m -75.64 174.48 9.7 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.14 165.05 17.76 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.481 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.2 m -58.1 115.29 2.81 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 123.17 0.588 . . . . 0.0 111.271 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.84 -14.25 37.95 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.613 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.596 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 34.3 p -111.97 148.4 33.86 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 122.477 -0.425 . . . . 0.0 111.433 -177.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.4 p -126.63 139.35 53.24 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.1 t -74.08 110.62 8.51 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.449 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 76.3 mt-30 -111.07 119.42 38.96 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-O 121.468 0.652 . . . . 0.0 110.189 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.7 t -78.42 109.69 13.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.162 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.485 HD12 ' CE2' ' A' ' 32' ' ' TYR . 76.0 mt -88.79 -51.36 5.69 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -125.55 167.15 17.38 Favored Pre-proline 0 C--N 1.291 -1.964 0 N-CA-C 105.026 -2.212 . . . . 0.0 105.026 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -65.4 -33.59 46.84 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 CA-C-N 120.799 1.321 . . . . 0.0 111.188 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.475 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 6.7 m-85 -94.6 -27.45 15.9 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.27 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.485 ' CE2' HD12 ' A' ' 28' ' ' LEU . 52.9 t80 -105.27 114.01 27.94 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.264 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.586 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.5 m -126.39 127.69 45.86 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 175.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 31.8 tt0 -116.94 137.95 51.87 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 123.416 0.447 . . . . 0.0 110.209 -174.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.596 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 14.9 t -84.22 121.91 28.14 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 119.819 -0.753 . . . . 0.0 109.493 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.449 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 97.2 mt . . . . . 0 C--N 1.294 -1.818 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -1.746 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.3 p -78.34 164.02 25.19 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.118 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -65.21 123.19 18.9 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 82.78 5.65 0.92 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.866 1.266 . . . . 0.0 111.629 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.53 160.03 20.43 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 175.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.584 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.4 tt0 -70.92 137.76 49.52 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 23.5 p -126.54 -4.0 6.63 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -173.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.73 70.74 0.02 OUTLIER Glycine 0 CA--C 1.487 -1.686 0 C-N-CA 117.295 -2.383 . . . . 0.0 114.071 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.53 167.43 14.74 Favored Glycine 0 C--N 1.294 -1.773 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 176.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.2 mt -63.63 119.61 8.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 117.746 0.773 . . . . 0.0 110.282 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.62 14.52 59.68 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.105 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -101.21 113.38 26.37 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.114 0.483 . . . . 0.0 110.142 177.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.5 p -101.15 8.44 42.71 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.171 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.26 -165.98 41.13 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.544 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.27 118.53 5.41 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.879 3.053 . . . . 0.0 112.192 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.1 p -106.87 -5.46 18.3 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.85 0.833 . . . . 0.0 111.126 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.2 t -98.02 117.46 42.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.325 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.0 m -78.2 179.18 7.05 Favored 'General case' 0 C--O 1.254 1.321 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.07 -179.14 4.43 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.646 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.1 m -72.41 121.91 20.34 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.29 19.35 36.02 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.005 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.678 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 23.6 p -140.29 142.63 35.67 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.1 p -131.63 139.87 49.24 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 123.319 0.387 . . . . 0.0 111.477 -177.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.3 t -73.05 114.14 10.88 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 120.835 0.35 . . . . 0.0 110.41 -178.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.519 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 67.4 mt-30 -111.33 123.31 49.95 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 120.876 0.37 . . . . 0.0 110.163 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.2 t -81.43 108.75 14.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.3 mt -86.27 -42.49 13.71 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -140.79 165.49 29.29 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.64 -31.17 59.86 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 120.932 1.369 . . . . 0.0 112.9 -175.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.548 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 68.9 m-85 -100.35 -26.84 13.75 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 119.051 -1.059 . . . . 0.0 110.302 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -105.7 114.01 27.92 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.961 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.584 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.2 m -123.03 134.71 54.28 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -122.32 138.28 54.57 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -172.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.678 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 9.8 t -83.02 114.48 21.3 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.419 0.628 . . . . 0.0 110.293 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.519 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 52.9 mt . . . . . 0 N--CA 1.412 -2.349 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.172 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.3 p -96.86 159.96 14.63 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.369 0.604 . . . . 0.0 112.195 -173.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -68.51 123.07 19.82 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 81.67 5.86 1.21 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.793 1.237 . . . . 0.0 112.483 -175.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.75 164.39 18.69 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 175.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.2 tt0 -71.66 137.11 47.61 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 17' ' ' THR . 10.4 p -125.9 -16.92 5.51 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -174.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.16 64.62 0.07 OUTLIER Glycine 0 CA--C 1.489 -1.568 0 C-N-CA 117.687 -2.197 . . . . 0.0 113.759 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -106.01 162.29 14.08 Favored Glycine 0 C--N 1.295 -1.731 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.215 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.4 mt -64.14 119.09 7.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.058 0.456 . . . . 0.0 109.894 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.74 -22.79 23.25 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.224 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -87.66 132.14 34.2 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 123.666 0.786 . . . . 0.0 109.109 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.9 p -131.66 17.73 4.76 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.127 0.489 . . . . 0.0 111.012 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.403 ' HA3' ' HD2' ' A' ' 16' ' ' PRO . . . -83.55 -156.97 23.7 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.435 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.403 ' HD2' ' HA3' ' A' ' 15' ' ' GLY . 9.3 Cg_endo -52.19 114.79 1.8 Allowed 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 124.11 3.206 . . . . 0.0 112.254 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.1 p -103.77 -25.61 13.04 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.663 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.0 t -81.91 111.24 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 47.2 m -68.59 156.76 37.47 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.28 158.91 19.04 Favored 'General case' 0 C--O 1.253 1.239 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.625 176.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -65.35 112.99 3.76 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.014 0.435 . . . . 0.0 110.825 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.7 -2.38 29.01 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.257 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.527 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 26.4 p -120.24 150.07 41.26 Favored 'General case' 0 C--N 1.319 -0.749 0 O-C-N 122.329 -0.512 . . . . 0.0 110.908 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.1 p -126.6 138.42 53.45 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 122.446 0.299 . . . . 0.0 111.714 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 34.4 t -75.37 117.87 17.64 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -120.12 124.6 46.19 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.72 0.771 . . . . 0.0 111.207 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.7 t -76.78 117.67 22.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.483 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.475 HD12 ' CE2' ' A' ' 32' ' ' TYR . 88.0 mt -100.05 -44.66 5.93 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -130.87 167.4 21.59 Favored Pre-proline 0 C--N 1.31 -1.132 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -64.32 -35.18 52.24 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 CA-C-N 120.998 1.392 . . . . 0.0 111.048 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.596 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 27.8 m-85 -94.05 -27.49 16.26 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 119.879 -0.728 . . . . 0.0 109.927 -178.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.475 ' CE2' HD12 ' A' ' 28' ' ' LEU . 54.5 t80 -103.99 113.95 27.84 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.654 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.1 m -129.18 123.67 32.66 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -113.69 141.59 47.05 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 123.647 0.592 . . . . 0.0 109.974 -173.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.527 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 9.0 t -85.02 121.68 28.15 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.428 -1.555 0 C-N-CA 123.829 0.852 . . . . 0.0 109.522 -176.856 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.573 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.5 p -75.15 165.24 25.52 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.531 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -69.38 127.96 34.87 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 76.37 6.91 3.51 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.276 1.431 . . . . 0.0 112.171 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.82 165.06 28.04 Favored Glycine 0 C--O 1.256 1.494 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 176.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.2 tt0 -72.94 120.27 18.33 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.591 ' O ' ' HA ' ' A' ' 17' ' ' THR . 22.1 p -100.93 -39.12 7.91 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -174.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.59 75.34 0.09 OUTLIER Glycine 0 CA--C 1.484 -1.906 0 C-N-CA 117.873 -2.108 . . . . 0.0 113.881 -173.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.52 169.08 15.84 Favored Glycine 0 C--N 1.285 -2.278 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 176.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.4 mt -61.22 127.59 21.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 117.655 0.727 . . . . 0.0 109.901 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.89 -21.65 42.53 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.11 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -79.41 116.71 19.8 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 121.05 0.453 . . . . 0.0 109.813 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 p -107.11 17.55 22.84 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.202 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.36 -176.49 51.35 Favored Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.389 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -54.04 111.3 0.66 Allowed 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 124.076 3.184 . . . . 0.0 112.627 177.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.2 p -89.09 -23.34 22.53 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.074 0.464 . . . . 0.0 111.914 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -79.81 118.69 27.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.409 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 59.8 m -73.73 171.39 13.4 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.05 -179.34 6.62 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.779 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.0 m -70.65 119.97 15.58 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.08 20.19 33.95 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 119.863 -1.16 . . . . 0.0 112.897 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.762 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 21.9 p -136.72 148.37 47.27 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.8 p -127.17 134.83 50.1 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 122.838 0.455 . . . . 0.0 111.081 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.6 t -75.25 112.57 11.67 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -118.78 127.27 53.37 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-O 121.042 0.449 . . . . 0.0 110.575 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.3 t -74.23 121.92 26.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.526 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.6 mt -101.75 -37.52 8.28 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.595 0.712 . . . . 0.0 109.466 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.444 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 52.2 m-80 -142.15 167.44 16.59 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 29' ' ' ASN . 1.8 Cg_endo -61.83 -32.47 85.6 Favored 'Trans proline' 0 C--N 1.353 0.793 0 CA-C-N 121.187 1.459 . . . . 0.0 112.762 -176.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.62 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 63.8 m-85 -100.43 -25.97 14.03 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.797 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -103.69 114.11 28.13 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.814 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.8 m -123.42 133.73 54.04 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -120.01 142.65 48.61 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -173.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.762 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 13.4 t -86.88 118.78 26.49 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.159 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 C--N 1.295 -1.783 0 C-N-CA 123.687 0.795 . . . . 0.0 108.928 -179.644 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.008 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 p -83.99 159.19 21.28 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -64.52 126.31 27.46 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.89 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 78.48 1.29 2.61 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.94 1.296 . . . . 0.0 113.408 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.49 164.83 24.54 Favored Glycine 0 C--O 1.254 1.352 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.608 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.0 tt0 -68.24 120.18 13.99 Favored 'General case' 0 C--O 1.207 -1.154 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 15.0 p -102.51 -29.28 11.68 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -175.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.19 65.88 0.1 Allowed Glycine 0 CA--C 1.483 -1.918 0 C-N-CA 118.415 -1.85 . . . . 0.0 112.652 -175.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.76 162.68 14.09 Favored Glycine 0 N--CA 1.429 -1.818 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 178.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.2 mt -59.47 123.34 11.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.29 -13.29 58.56 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.323 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -87.79 113.96 23.95 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.1 p -101.27 9.36 41.84 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.677 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.6 -171.68 48.34 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.411 -177.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.94 122.34 11.56 Favored 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 124.211 3.274 . . . . 0.0 111.753 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 29.1 p -101.07 -18.58 16.18 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.103 0.478 . . . . 0.0 111.558 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.0 t -79.16 113.89 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.9 m -71.91 169.48 15.76 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.7 169.39 18.32 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.409 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.4 m -58.01 121.46 10.66 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.301 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.86 -18.45 54.86 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.692 176.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.606 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 43.8 p -103.37 146.84 27.88 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 122.5 -0.412 . . . . 0.0 111.045 -176.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.2 p -127.41 144.56 51.04 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 122.144 0.177 . . . . 0.0 110.831 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -80.62 113.36 18.76 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.076 0.465 . . . . 0.0 109.855 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.429 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 78.7 mt-30 -113.54 112.89 24.32 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-O 121.198 0.523 . . . . 0.0 109.825 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -75.4 104.02 3.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.1 mt -80.3 -48.19 13.38 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.464 0.649 . . . . 0.0 109.429 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.404 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 2.3 m-20 -127.57 165.21 31.29 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 29' ' ' ASN . 3.1 Cg_exo -61.46 -37.29 72.23 Favored 'Trans proline' 0 C--O 1.246 0.894 0 CA-C-N 121.469 1.56 . . . . 0.0 112.56 -176.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.515 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 46.6 m-85 -93.06 -26.27 17.56 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.927 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -104.0 113.5 27.08 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 118.966 -1.093 . . . . 0.0 112.376 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.608 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.5 m -121.84 132.5 54.61 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 175.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -120.98 136.53 54.96 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 123.154 0.284 . . . . 0.0 110.296 -174.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.606 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 14.4 t -83.56 122.04 28.03 Favored 'General case' 0 N--CA 1.429 -1.522 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.728 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.429 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 89.8 mt . . . . . 0 C--N 1.291 -1.942 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.019 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.3 p -100.8 165.47 11.35 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.286 -175.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -69.02 123.8 22.02 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 82.48 9.69 0.71 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.221 1.409 . . . . 0.0 112.61 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.52 158.19 19.33 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.602 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.3 tt0 -68.88 127.06 31.76 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 17' ' ' THR . 13.3 p -116.58 5.76 13.34 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -173.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.93 75.42 0.01 OUTLIER Glycine 0 CA--C 1.482 -2.012 0 C-N-CA 116.934 -2.555 . . . . 0.0 114.791 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.593 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.87 165.39 13.89 Favored Glycine 0 C--N 1.289 -2.075 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 175.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 30' ' ' PRO . 60.1 mt -61.62 127.03 20.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.95 -13.71 66.84 Favored Glycine 0 C--N 1.312 -0.788 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.052 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -101.43 114.0 27.62 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 123.191 0.596 . . . . 0.0 109.7 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.8 p -111.06 21.81 15.98 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.035 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.25 -160.95 25.94 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.995 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.27 111.05 0.48 Allowed 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.989 3.126 . . . . 0.0 112.911 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 14.6 p -105.47 -23.99 12.71 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.631 0.729 . . . . 0.0 111.436 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.9 t -85.83 120.64 36.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.6 m -79.41 163.29 24.93 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 120.972 0.415 . . . . 0.0 111.905 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.8 163.52 25.64 Favored 'General case' 0 C--O 1.253 1.247 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -65.82 117.53 8.35 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 120.963 0.411 . . . . 0.0 110.178 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.8 -19.48 25.67 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.86 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.643 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 19.8 p -103.14 147.6 26.81 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 122.445 -0.444 . . . . 0.0 109.909 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.4 p -127.47 135.26 50.16 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 122.475 0.31 . . . . 0.0 111.311 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.3 t -73.87 111.3 8.9 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.433 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 76.5 mt-30 -109.15 121.74 45.8 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-O 121.517 0.675 . . . . 0.0 109.613 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.9 t -80.14 104.31 8.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.368 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.8 mt -80.7 -44.34 18.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.863 0.84 . . . . 0.0 108.908 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -136.15 164.4 43.26 Favored Pre-proline 0 C--N 1.298 -1.655 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.463 ' O ' HG13 ' A' ' 11' ' ' ILE . 4.3 Cg_exo -64.4 -30.59 62.68 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 CA-C-N 120.554 1.234 . . . . 0.0 111.664 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.593 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 78.6 m-85 -97.77 -27.86 14.13 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 118.919 -1.113 . . . . 0.0 111.314 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.427 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 61.6 t80 -105.9 114.31 28.38 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.469 -0.892 . . . . 0.0 112.316 175.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.602 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 36.6 m -121.49 131.36 54.1 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 175.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.427 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 36.1 tt0 -120.66 138.52 53.89 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -174.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.643 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 12.0 t -85.84 123.21 30.95 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 120.364 -0.535 . . . . 0.0 110.544 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.433 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 95.6 mt . . . . . 0 C--N 1.286 -2.169 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.439 ' HB3' ' HA ' ' A' ' 19' ' ' CYS . . . . . . . . 0 N--CA 1.442 -0.854 0 CA-C-O 121.006 0.431 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.1 p -99.66 152.82 19.63 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.718 -172.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -71.77 122.73 21.18 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 77.8 2.19 2.92 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.546 1.138 . . . . 0.0 111.546 -175.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -97.28 174.16 29.51 Favored Glycine 0 N--CA 1.418 -2.522 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.608 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.2 tt0 -79.3 130.81 35.83 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.6 ' O ' ' HA ' ' A' ' 17' ' ' THR . 10.7 p -114.86 -31.8 5.99 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 113.107 0.781 . . . . 0.0 113.107 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.0 62.75 0.22 Allowed Glycine 0 CA--C 1.48 -2.117 0 C-N-CA 118.459 -1.829 . . . . 0.0 112.729 -175.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.82 162.67 14.06 Favored Glycine 0 C--N 1.29 -1.974 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.513 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 61.7 mt -65.36 119.37 9.81 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.34 -7.61 32.48 Favored Glycine 0 C--N 1.306 -1.101 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.599 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -94.86 115.59 27.66 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.1 p -104.2 6.74 35.81 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.037 0.446 . . . . 0.0 111.037 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.02 -173.29 43.6 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.199 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.48 114.47 1.96 Allowed 'Trans proline' 0 C--N 1.328 -0.535 0 C-N-CA 123.798 2.999 . . . . 0.0 111.625 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 31.7 p -87.94 -22.85 24.1 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.318 0.58 . . . . 0.0 110.945 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.5 t -72.0 117.07 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 2' ' ' ALA . 22.2 m -71.72 161.35 31.11 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.7 162.88 28.93 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.072 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.5 m -62.07 113.07 2.63 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.147 0.499 . . . . 0.0 111.775 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.55 -10.18 32.85 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.107 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.546 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 23.2 p -115.07 152.13 33.05 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 122.695 -0.297 . . . . 0.0 111.102 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.4 p -128.14 139.99 52.18 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 123.118 0.261 . . . . 0.0 110.445 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.6 t -73.66 111.69 9.05 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.845 0.355 . . . . 0.0 110.177 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.507 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 69.4 mt-30 -111.28 115.62 29.64 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-O 120.948 0.404 . . . . 0.0 110.471 -178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.4 t -71.16 110.87 4.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.2 mt -89.72 -46.6 8.5 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -131.07 168.89 15.32 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -63.91 -34.82 58.62 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 CA-C-N 120.987 1.388 . . . . 0.0 113.019 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.521 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 12.4 m-85 -102.72 -24.76 13.71 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 119.306 -0.958 . . . . 0.0 110.892 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -103.54 114.86 29.45 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.946 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.608 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 13.7 m -120.89 127.63 52.05 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 36.3 tt0 -111.94 135.88 51.99 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 123.509 0.506 . . . . 0.0 109.721 -173.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.546 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 12.3 t -85.95 115.78 23.77 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.253 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.507 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 89.3 mt . . . . . 0 N--CA 1.414 -2.237 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.305 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 p -106.32 155.75 19.2 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.311 -0.859 . . . . 0.0 113.139 -172.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -59.44 124.51 20.27 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.75 1.22 . . . . 0.0 109.836 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 71.75 10.25 6.31 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.726 1.21 . . . . 0.0 112.702 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -104.8 165.88 14.69 Favored Glycine 0 N--CA 1.42 -2.401 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 174.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.6 tt0 -70.57 128.81 37.39 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.656 ' O ' ' HA ' ' A' ' 17' ' ' THR . 16.7 p -109.72 -36.64 5.87 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.6 63.81 0.18 Allowed Glycine 0 CA--C 1.483 -1.953 0 C-N-CA 118.359 -1.877 . . . . 0.0 113.015 -174.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.77 159.92 15.09 Favored Glycine 0 C--N 1.291 -1.97 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 175.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.419 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 58.3 mt -61.4 116.23 2.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 117.774 0.787 . . . . 0.0 109.696 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.61 -11.76 21.14 Favored Glycine 0 N--CA 1.436 -1.337 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.111 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -90.99 109.19 20.42 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.7 p -92.64 5.25 51.68 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.492 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.26 -179.09 50.75 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.287 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -55.02 122.81 12.37 Favored 'Trans proline' 0 N--CA 1.479 0.647 0 C-N-CA 124.594 3.529 . . . . 0.0 112.501 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.656 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.5 p -90.98 -20.22 22.38 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.4 t -83.95 126.46 40.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.8 m -76.35 171.13 15.08 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.57 176.17 9.6 Favored 'General case' 0 C--O 1.252 1.225 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.115 177.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -62.64 119.39 9.16 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.483 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.87 6.3 58.15 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.998 -0.62 . . . . 0.0 113.471 176.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.71 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 3.0 p -131.23 150.95 51.93 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 117.196 0.498 . . . . 0.0 111.245 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.9 p -129.95 144.14 51.17 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.636 0.236 . . . . 0.0 111.636 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.8 t -79.43 107.9 12.54 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -107.91 116.31 31.72 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-O 121.522 0.677 . . . . 0.0 110.353 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.4 t -74.92 108.77 6.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.115 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.2 mt -85.22 -50.49 7.33 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -129.87 166.58 25.21 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.16 -33.69 71.46 Favored 'Trans proline' 0 C--N 1.348 0.53 0 CA-C-N 120.669 1.274 . . . . 0.0 112.804 -177.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.499 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 53.0 m-85 -98.39 -26.49 14.46 Favored 'General case' 0 N--CA 1.434 -1.268 0 C-N-CA 118.914 -1.115 . . . . 0.0 110.827 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.44 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 57.4 t80 -105.11 114.25 28.34 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 119.188 -1.005 . . . . 0.0 112.978 175.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.8 m -122.72 131.4 53.77 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 174.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.44 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 35.5 tt0 -117.82 138.83 51.82 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 123.407 0.442 . . . . 0.0 110.094 -173.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.71 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 14.4 t -84.35 115.67 22.62 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.035 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.408 HD21 ' OE1' ' A' ' 34' ' ' GLN . 97.9 mt . . . . . 0 C--N 1.286 -2.193 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.91 0 CA-C-O 120.864 0.364 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.3 p -92.77 162.86 13.96 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.66 -177.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -67.77 126.74 30.37 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 81.16 6.47 1.29 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.485 1.114 . . . . 0.0 112.699 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.78 159.7 21.61 Favored Glycine 0 N--CA 1.436 -1.309 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -70.86 126.38 29.43 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 17' ' ' THR . 6.2 p -104.23 -42.67 5.44 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -176.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.4 64.83 0.29 Allowed Glycine 0 CA--C 1.476 -2.353 0 C-N-CA 118.31 -1.9 . . . . 0.0 112.852 -172.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.34 156.2 16.77 Favored Glycine 0 N--CA 1.42 -2.415 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 177.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.578 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 62.4 mt -61.62 121.25 9.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.18 -11.79 40.36 Favored Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -100.92 116.5 32.93 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.9 p -114.49 17.07 17.56 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.08 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.56 -162.38 31.4 Favored Glycine 0 C--O 1.24 0.494 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.76 109.05 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.406 2.738 . . . . 0.0 111.579 175.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 11.1 p -95.25 -22.24 17.92 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.782 -177.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.52 119.57 35.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.7 m -73.21 170.09 15.7 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.79 162.97 25.74 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.375 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.1 m -65.03 113.17 3.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.05 0.452 . . . . 0.0 110.11 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.16 7.65 26.5 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.977 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.678 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 19.2 p -131.9 146.72 52.27 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.4 p -127.25 138.87 53.19 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 121.208 -0.197 . . . . 0.0 110.881 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.7 t -75.97 109.95 10.03 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -105.2 133.15 50.44 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-O 121.445 0.641 . . . . 0.0 111.351 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.4 t -81.48 99.59 4.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.9 mt -82.18 -40.63 21.49 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -145.01 168.46 12.05 Favored Pre-proline 0 N--CA 1.431 -1.399 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -65.16 -38.95 25.35 Favored 'Trans proline' 0 C--O 1.25 1.084 0 CA-C-N 120.403 1.18 . . . . 0.0 112.659 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.578 ' CD1' ' HB ' ' A' ' 11' ' ' ILE . 53.0 m-85 -96.1 -27.01 15.28 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.643 -176.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -104.2 114.08 28.07 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.589 -0.845 . . . . 0.0 111.418 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.5 m -125.68 130.04 50.76 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 174.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -118.56 144.63 45.95 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -172.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.678 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 10.2 t -87.54 114.46 24.17 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.086 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.5 mt . . . . . 0 N--CA 1.418 -2.058 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -177.72 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -1.68 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.5 p -93.92 166.1 12.34 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.361 0.601 . . . . 0.0 111.8 -175.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -61.89 124.07 19.77 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.067 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 80.14 6.31 1.71 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.288 1.435 . . . . 0.0 112.866 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.31 159.17 20.56 Favored Glycine 0 N--CA 1.435 -1.393 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.559 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.5 tt0 -70.66 128.94 37.8 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.2 p -120.27 8.14 10.83 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 153.38 76.21 0.02 OUTLIER Glycine 0 CA--C 1.483 -1.93 0 C-N-CA 117.292 -2.385 . . . . 0.0 114.511 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.54 166.63 14.38 Favored Glycine 0 N--CA 1.419 -2.459 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 176.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.3 mt -64.93 118.54 7.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.54 -13.92 66.3 Favored Glycine 0 C--N 1.315 -0.637 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.362 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -79.49 108.4 12.99 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.22 0.533 . . . . 0.0 110.548 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.2 p -92.24 6.94 44.88 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.222 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.44 -171.23 41.08 Favored Glycine 0 C--N 1.316 -0.569 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.647 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -49.22 131.47 26.67 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 124.556 3.504 . . . . 0.0 112.299 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.4 p -125.52 -22.32 4.31 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 51.7 t -91.1 119.53 38.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.7 m -76.45 166.01 24.01 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.397 0.618 . . . . 0.0 112.479 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.91 167.82 20.03 Favored 'General case' 0 C--O 1.255 1.374 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.004 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.2 m -70.15 119.83 14.93 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 120.964 0.412 . . . . 0.0 110.268 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.46 -16.74 29.04 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.661 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 27.1 p -109.18 146.5 34.05 Favored 'General case' 0 C--O 1.251 1.163 0 O-C-N 122.426 -0.455 . . . . 0.0 111.329 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.0 p -124.9 133.73 52.95 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.799 -177.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.0 t -76.08 111.99 12.06 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -113.71 119.01 35.93 Favored 'General case' 0 N--CA 1.406 -2.648 0 CA-C-O 121.206 0.526 . . . . 0.0 110.866 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 82.4 t -70.78 108.48 2.59 Favored 'Isoleucine or valine' 0 C--O 1.253 1.248 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.816 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.434 HD12 ' CE2' ' A' ' 32' ' ' TYR . 71.2 mt -85.61 -46.41 10.81 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -133.49 166.76 26.9 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.63 -31.17 79.51 Favored 'Trans proline' 0 C--N 1.35 0.62 0 CA-C-N 120.906 1.359 . . . . 0.0 112.347 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.566 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 92.5 m-85 -99.89 -26.28 14.06 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.757 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.434 ' CE2' HD12 ' A' ' 28' ' ' LEU . 54.2 t80 -104.85 114.12 28.14 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 119.463 -0.895 . . . . 0.0 111.819 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 26.8 m -122.32 128.94 51.66 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 176.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -121.99 138.72 54.32 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -175.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.661 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 8.6 t -82.04 118.71 23.22 Favored 'General case' 0 N--CA 1.422 -1.854 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.937 -178.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.0 mt . . . . . 0 C--N 1.286 -2.194 0 C-N-CA 123.78 0.832 . . . . 0.0 109.364 -176.517 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.721 0 CA-C-O 121.47 0.652 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.5 p -104.86 158.38 16.57 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.767 -175.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -71.87 128.75 36.74 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 77.56 -0.78 2.76 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.084 1.354 . . . . 0.0 111.551 -176.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.14 165.83 36.3 Favored Glycine 0 N--CA 1.416 -2.638 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.62 ' HA ' ' O ' ' A' ' 33' ' ' SER . 60.7 tt0 -74.65 123.39 24.79 Favored 'General case' 0 C--O 1.199 -1.599 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 23.9 p -108.88 -5.62 16.11 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 163.41 57.53 0.02 OUTLIER Glycine 0 CA--C 1.474 -2.477 0 C-N-CA 117.717 -2.182 . . . . 0.0 112.858 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -106.3 164.13 13.62 Favored Glycine 0 N--CA 1.421 -2.358 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 176.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.0 116.87 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 117.401 0.6 . . . . 0.0 109.728 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.68 -25.5 8.5 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.422 -178.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -83.78 121.9 27.94 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.0 p -116.58 13.73 15.34 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.253 0.549 . . . . 0.0 111.194 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.04 -170.29 47.01 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.075 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -57.23 117.13 3.77 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 123.933 3.089 . . . . 0.0 110.9 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 39.5 p -93.75 -4.9 49.53 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.1 t -93.15 134.48 30.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 175.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.5 m -81.29 169.45 17.28 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -177.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.93 165.71 23.77 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.901 177.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 p -60.07 116.9 4.51 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.4 -17.26 37.15 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.031 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.637 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 41.4 p -108.87 148.94 29.86 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.61 -177.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.7 p -127.47 141.68 51.6 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 122.492 -0.13 . . . . 0.0 110.725 -178.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.1 t -79.05 113.04 16.85 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -116.58 113.41 22.69 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-O 121.305 0.574 . . . . 0.0 110.188 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.4 t -70.91 106.01 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.779 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.8 mt -87.04 -39.29 15.76 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.596 0.712 . . . . 0.0 109.397 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -141.24 167.75 16.25 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.19 -33.81 29.85 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 CA-C-N 120.917 1.363 . . . . 0.0 112.559 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.534 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 48.0 m-85 -97.32 -27.47 14.48 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 118.351 -1.34 . . . . 0.0 109.829 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.562 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 57.9 t80 -104.57 113.68 27.41 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 118.703 -1.199 . . . . 0.0 112.548 177.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.62 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.9 m -118.13 130.72 56.28 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 173.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.562 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 36.3 tt0 -116.94 140.55 49.33 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 118.057 0.39 . . . . 0.0 110.311 -173.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.637 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 18.5 t -89.09 121.91 31.89 Favored 'General case' 0 N--CA 1.416 -2.137 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.715 177.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 N--CA 1.421 -1.92 0 C-N-CA 123.975 0.91 . . . . 0.0 108.941 -179.565 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.406 ' HB3' ' HA ' ' A' ' 19' ' ' CYS . . . . . . . . 0 N--CA 1.442 -0.832 0 CA-C-O 121.321 0.582 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.438 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 13.9 p -99.83 153.26 19.29 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.919 -171.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -70.51 116.96 11.45 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.862 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 77.63 19.47 1.18 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.287 1.035 . . . . 0.0 110.864 -176.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.45 159.28 13.78 Favored Glycine 0 N--CA 1.416 -2.64 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 172.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.5 tt0 -68.44 136.15 52.8 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 177.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.608 ' O ' ' HA ' ' A' ' 17' ' ' THR . 9.5 p -122.36 -37.39 2.81 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -175.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.85 58.38 0.31 Allowed Glycine 0 CA--C 1.484 -1.88 0 C-N-CA 118.815 -1.66 . . . . 0.0 112.37 -173.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.48 155.01 17.06 Favored Glycine 0 N--CA 1.421 -2.343 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 59.6 mt -65.0 115.67 3.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.34 -12.02 14.18 Favored Glycine 0 C--N 1.297 -1.599 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.75 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -93.9 122.79 36.75 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.143 0.497 . . . . 0.0 110.076 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 p -109.28 15.38 23.19 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.551 -177.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.49 -168.93 32.78 Favored Glycine 0 C--N 1.315 -0.6 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.892 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -53.64 117.3 3.69 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.955 3.103 . . . . 0.0 112.655 177.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.608 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 19.8 p -90.04 -25.75 20.65 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 123.295 0.638 . . . . 0.0 111.648 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -83.07 118.89 31.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.406 ' HA ' ' HB3' ' A' ' 2' ' ' ALA . 60.6 m -72.05 170.69 13.34 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.48 169.31 17.86 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.622 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.7 m -64.96 114.46 4.57 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.745 0.307 . . . . 0.0 110.867 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.3 6.17 45.2 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.268 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.671 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 27.4 p -128.26 147.17 50.58 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.8 p -129.38 137.71 51.09 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.728 0.299 . . . . 0.0 110.778 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.4 t -75.58 107.5 7.77 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.453 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 78.5 mt-30 -107.38 126.01 51.93 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-O 121.391 0.615 . . . . 0.0 110.949 -176.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.5 t -77.45 110.64 13.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.934 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.1 mt -89.3 -48.51 7.31 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -132.81 168.32 18.45 Favored Pre-proline 0 C--N 1.299 -1.597 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -63.39 -40.89 29.08 Favored 'Trans proline' 0 C--O 1.253 1.258 0 CA-C-N 120.994 1.391 . . . . 0.0 113.074 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.507 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 24.3 m-85 -94.72 -26.17 16.4 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.866 -177.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -104.63 113.49 27.1 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.982 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.0 m -127.03 133.88 50.42 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -124.1 143.03 50.7 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -172.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.671 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.2 t -85.84 121.74 28.91 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.28 0.562 . . . . 0.0 110.724 -177.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.453 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 94.5 mt . . . . . 0 C--N 1.289 -2.032 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -178.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.647 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p -88.02 143.51 27.05 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.606 -173.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -64.79 126.44 27.95 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 76.41 6.51 3.51 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.833 1.253 . . . . 0.0 111.375 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.09 164.39 18.31 Favored Glycine 0 N--CA 1.423 -2.194 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 177.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.594 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.8 tt0 -69.35 128.98 38.49 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 17' ' ' THR . 24.7 p -122.96 -8.98 8.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -173.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.34 64.47 0.04 OUTLIER Glycine 0 CA--C 1.482 -1.986 0 C-N-CA 116.855 -2.593 . . . . 0.0 114.072 -177.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.68 171.0 17.76 Favored Glycine 0 C--N 1.293 -1.841 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 175.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.8 mt -69.03 124.23 24.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.63 -1.68 60.14 Favored Glycine 0 C--N 1.305 -1.165 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.341 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -101.01 106.67 17.99 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.5 p -101.59 1.9 38.33 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.844 -176.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.77 -168.36 12.16 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.468 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -52.58 113.45 1.24 Allowed 'Trans proline' 0 N--CA 1.484 0.915 0 C-N-CA 124.183 3.255 . . . . 0.0 112.145 177.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.4 p -101.52 -30.28 11.49 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.889 0.376 . . . . 0.0 111.981 -178.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -73.79 112.29 10.22 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.249 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 54.1 m -66.93 165.2 15.96 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.17 175.62 9.49 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.006 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -66.7 115.36 6.43 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.792 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.35 9.14 58.17 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 121.251 -0.499 . . . . 0.0 112.733 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.598 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 41.2 p -122.88 148.03 45.89 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.839 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.5 p -128.66 135.12 48.85 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 123.125 0.266 . . . . 0.0 111.615 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.4 t -79.33 116.62 19.68 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.851 0.358 . . . . 0.0 110.05 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.456 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 60.0 mt-30 -114.89 114.8 25.97 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 120.778 0.323 . . . . 0.0 110.418 -177.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.4 t -70.99 118.21 15.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.456 HD12 ' CE2' ' A' ' 32' ' ' TYR . 93.7 mt -98.08 -49.28 4.8 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.282 0.563 . . . . 0.0 109.775 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.468 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 80.9 m-20 -124.25 169.11 11.25 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 178.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 29' ' ' ASN . 6.0 Cg_endo -64.14 -31.87 64.24 Favored 'Trans proline' 0 C--N 1.353 0.768 0 CA-C-N 121.404 1.537 . . . . 0.0 112.563 -177.107 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.491 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 51.8 m-85 -103.34 -24.51 13.5 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.159 0.504 . . . . 0.0 110.61 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.456 ' CE2' HD12 ' A' ' 28' ' ' LEU . 71.7 t80 -103.39 115.16 30.02 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 121.885 -0.509 . . . . 0.0 112.119 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.594 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.6 m -127.82 131.95 49.48 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 176.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -117.51 139.16 51.3 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -173.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.598 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.9 t -86.14 112.57 21.43 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.511 0.672 . . . . 0.0 110.566 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.456 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 43.0 mt . . . . . 0 N--CA 1.408 -2.531 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.022 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.484 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 31.4 p -89.04 172.1 9.36 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.509 -175.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -71.6 124.28 24.36 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 174.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 78.36 16.82 1.2 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.807 0.843 . . . . 0.0 111.664 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.48 153.86 17.17 Favored Glycine 0 N--CA 1.426 -1.989 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 174.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.5 tt0 -68.47 124.11 22.65 Favored 'General case' 0 C--O 1.21 -1.021 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.3 p -115.72 2.41 13.68 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.05 62.0 0.01 OUTLIER Glycine 0 CA--C 1.49 -1.53 0 C-N-CA 117.645 -2.217 . . . . 0.0 113.868 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.69 163.47 14.0 Favored Glycine 0 C--N 1.291 -1.922 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 59.8 mt -58.82 118.94 2.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 117.48 0.64 . . . . 0.0 110.492 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.4 -17.13 47.75 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.119 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -81.57 112.0 18.38 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 p -107.66 22.62 15.7 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.897 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.11 -169.22 39.37 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.367 177.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.74 122.99 12.77 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.95 3.1 . . . . 0.0 112.29 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 p -99.49 -10.06 22.59 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.437 0.637 . . . . 0.0 111.968 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.3 t -87.46 130.78 36.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.9 m -90.34 165.71 13.72 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.463 0.649 . . . . 0.0 112.106 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.71 163.99 26.72 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.459 176.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.6 m -74.34 124.29 26.2 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.62 -2.64 29.14 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -174.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.597 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 32.9 p -132.84 150.07 52.2 Favored 'General case' 0 C--O 1.248 1.017 0 O-C-N 122.763 -0.257 . . . . 0.0 111.018 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.3 p -128.64 139.51 52.22 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.6 t -77.44 116.56 18.12 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -117.74 122.63 43.97 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-O 121.259 0.552 . . . . 0.0 110.947 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.4 t -74.12 109.69 7.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.2 mt -87.3 -41.07 13.93 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -141.91 166.49 21.28 Favored Pre-proline 0 C--N 1.301 -1.535 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -62.6 -37.01 60.94 Favored 'Trans proline' 0 C--N 1.351 0.68 0 CA-C-N 121.206 1.467 . . . . 0.0 113.081 -177.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.52 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 84.6 m-85 -94.63 -27.25 15.98 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 118.501 -1.279 . . . . 0.0 110.813 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.496 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 48.1 t80 -105.52 113.93 27.79 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.416 -0.914 . . . . 0.0 112.782 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.604 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.0 m -120.24 129.13 53.92 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 174.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.496 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.9 tt0 -120.07 138.37 53.58 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -174.079 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.597 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.1 t -83.4 122.35 28.37 Favored 'General case' 0 N--CA 1.426 -1.661 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.839 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 N--CA 1.421 -1.881 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.024 -177.457 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.453 ' HB3' ' HA ' ' A' ' 19' ' ' CYS . . . . . . . . 0 C--O 1.243 0.749 0 CA-C-O 120.934 0.397 . . . . 0.0 109.938 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.9 p -83.94 153.64 23.81 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 114.844 -1.071 . . . . 0.0 113.069 -173.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -73.56 127.63 33.27 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 76.22 2.84 3.6 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.243 1.017 . . . . 0.0 111.471 -176.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.99 169.68 29.78 Favored Glycine 0 N--CA 1.415 -2.726 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 176.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.2 tt0 -77.36 127.34 32.4 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 18.7 p -116.09 4.47 13.67 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -174.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.51 62.85 0.01 OUTLIER Glycine 0 CA--C 1.481 -2.093 0 C-N-CA 118.085 -2.007 . . . . 0.0 113.417 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.541 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.38 161.25 14.75 Favored Glycine 0 N--CA 1.425 -2.059 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 177.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.49 119.79 5.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 117.724 0.762 . . . . 0.0 109.256 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.26 -22.13 25.46 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -81.05 117.15 21.39 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.038 0.447 . . . . 0.0 110.288 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.0 p -101.67 -0.23 34.98 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.751 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.33 -173.61 44.65 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.591 -177.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -53.33 124.34 15.45 Favored 'Trans proline' 0 N--CA 1.477 0.509 0 C-N-CA 124.435 3.423 . . . . 0.0 112.362 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.4 p -104.03 -18.97 14.36 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.17 0.509 . . . . 0.0 111.589 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.8 t -78.75 112.71 17.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.453 ' HA ' ' HB3' ' A' ' 2' ' ' ALA . 52.4 m -65.41 162.96 16.66 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.98 172.59 12.04 Favored 'General case' 0 C--O 1.254 1.334 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.086 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.5 m -67.13 119.95 12.91 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.714 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.85 19.93 35.44 Favored Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.905 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.578 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 44.4 p -138.09 148.49 45.06 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 117.038 0.419 . . . . 0.0 110.061 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.4 p -126.17 133.33 51.6 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 122.103 0.161 . . . . 0.0 110.943 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.1 t -74.25 119.82 18.99 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -119.0 120.17 36.46 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-O 121.558 0.694 . . . . 0.0 110.818 -178.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.2 t -75.24 101.21 2.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.982 177.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.441 HD12 ' CE1' ' A' ' 32' ' ' TYR . 77.3 mt -79.51 -46.23 17.79 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.454 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 93.5 m-20 -140.31 170.5 9.52 Favored Pre-proline 0 C--N 1.31 -1.138 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 29' ' ' ASN . 4.3 Cg_exo -62.88 -43.15 21.23 Favored 'Trans proline' 0 C--N 1.358 1.056 0 CA-C-N 120.763 1.308 . . . . 0.0 112.979 -178.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.541 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 89.8 m-85 -89.77 -27.18 20.19 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 118.299 -1.36 . . . . 0.0 110.021 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.441 ' CE1' HD12 ' A' ' 28' ' ' LEU . 40.0 t80 -104.05 113.91 27.78 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 118.789 -1.164 . . . . 0.0 112.503 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.3 m -127.31 123.78 37.16 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 174.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -116.64 140.59 49.23 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 123.504 0.502 . . . . 0.0 110.391 -173.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.578 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.4 t -88.81 123.25 33.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.5 mt . . . . . 0 C--N 1.296 -1.738 0 C-N-CA 123.794 0.838 . . . . 0.0 109.362 -176.556 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.444 -0.734 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 19' ' ' CYS . . . -76.8 154.11 34.27 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 4.0 p -104.69 153.12 21.66 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.22 -173.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -69.67 123.19 20.72 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 78.06 6.96 2.61 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.589 1.156 . . . . 0.0 112.002 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -103.3 167.29 16.69 Favored Glycine 0 N--CA 1.423 -2.213 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 175.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.6 tt0 -70.39 127.63 33.4 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 17' ' ' THR . 20.1 p -103.52 -39.1 6.87 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.18 76.13 0.11 Allowed Glycine 0 CA--C 1.484 -1.844 0 C-N-CA 118.392 -1.861 . . . . 0.0 113.608 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.34 169.78 16.77 Favored Glycine 0 C--N 1.291 -1.926 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 176.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.0 mt -66.95 119.49 12.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.71 -17.17 42.9 Favored Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -85.1 106.25 16.43 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.0 p -94.37 4.9 53.26 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.298 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.26 -169.8 32.65 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 115.553 -0.748 . . . . 0.0 112.692 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -59.55 114.49 2.07 Favored 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 123.592 2.861 . . . . 0.0 111.797 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.7 p -93.98 -17.12 23.27 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.539 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.8 t -88.68 120.59 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 2' ' ' ALA . 66.7 m -72.89 167.61 20.64 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.42 165.0 24.96 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.419 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.1 m -64.85 124.11 21.13 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 120.643 0.259 . . . . 0.0 110.367 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.92 -0.01 48.41 Favored Glycine 0 N--CA 1.432 -1.593 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.331 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.554 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 42.1 p -128.43 151.03 49.85 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.6 p -130.15 137.72 50.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.759 0.314 . . . . 0.0 111.679 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.1 t -74.16 114.78 12.89 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -121.76 117.7 27.24 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-O 121.379 0.609 . . . . 0.0 111.109 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.5 t -71.02 116.89 13.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.437 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.9 mt -97.44 -39.76 9.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.889 0.852 . . . . 0.0 108.95 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -137.7 164.32 42.07 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -62.61 -32.73 79.27 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 CA-C-N 120.865 1.344 . . . . 0.0 112.002 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.502 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 31.1 m-85 -97.77 -26.58 14.67 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 119.094 -1.042 . . . . 0.0 111.597 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.41 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 68.4 t80 -105.3 114.32 28.43 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 119.779 -0.769 . . . . 0.0 112.664 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.0 m -121.05 130.8 53.93 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 174.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.41 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 53.9 tt0 -115.06 140.78 48.78 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -173.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.554 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 13.3 t -87.12 112.96 22.44 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.593 178.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.3 mt . . . . . 0 C--N 1.278 -2.532 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -179.58 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.8 p . . . . . 0 C--O 1.25 1.079 0 CA-C-O 120.657 0.265 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.33 143.69 44.8 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 176.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.8 p -98.09 153.51 18.38 Favored 'General case' 0 C--N 1.272 -2.78 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.146 -172.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -65.35 122.51 17.31 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 79.34 12.26 1.26 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.815 1.246 . . . . 0.0 111.416 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -107.56 168.05 13.86 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.5 tt0 -77.31 122.4 25.05 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.59 ' O ' ' HA ' ' A' ' 17' ' ' THR . 7.2 p -104.97 -37.01 7.13 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.32 68.13 0.12 Allowed Glycine 0 CA--C 1.474 -2.53 0 C-N-CA 118.052 -2.023 . . . . 0.0 113.127 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.84 165.75 13.99 Favored Glycine 0 C--N 1.284 -2.316 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.0 mt -62.21 126.71 20.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.92 -11.52 57.49 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.88 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -100.9 126.6 47.53 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.8 p -119.26 14.48 12.99 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.491 0.663 . . . . 0.0 111.661 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.88 -155.86 16.12 Favored Glycine 0 C--O 1.258 1.644 0 CA-C-N 115.954 -0.566 . . . . 0.0 113.086 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -56.27 104.94 0.15 Allowed 'Trans proline' 0 C--O 1.222 -0.277 0 C-N-CA 123.854 3.036 . . . . 0.0 113.372 174.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.0 p -87.79 -15.76 36.0 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.55 0.691 . . . . 0.0 110.776 177.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.8 t -88.09 122.94 40.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.069 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.415 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 56.6 m -79.22 175.3 10.71 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.344 0.592 . . . . 0.0 112.274 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.74 163.4 24.52 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.2 m -64.64 122.95 18.04 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.77 5.76 54.97 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.433 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.568 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 40.0 p -128.28 149.21 50.59 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.3 p -130.61 138.7 50.24 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 117.793 0.269 . . . . 0.0 111.275 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.7 t -72.98 111.42 8.07 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -109.6 133.09 53.52 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-O 121.292 0.568 . . . . 0.0 110.515 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.6 t -83.83 105.93 13.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.646 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.1 mt -87.41 -38.36 16.22 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.981 0.896 . . . . 0.0 108.691 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -144.51 167.77 14.09 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -64.45 -41.71 19.39 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 CA-C-N 120.807 1.324 . . . . 0.0 112.101 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.507 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 17.7 m-85 -91.97 -26.44 18.4 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.628 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -104.76 113.24 26.7 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.875 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.4 m -121.89 130.01 53.01 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 174.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -119.94 139.01 53.1 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -173.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.568 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 9.7 t -81.03 117.08 21.32 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-O 121.502 0.668 . . . . 0.0 110.093 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 N--CA 1.405 -2.678 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.693 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 19' ' ' CYS . . . -79.28 125.23 29.21 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 99.8 p -86.71 166.79 15.02 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.705 -175.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -70.89 123.87 23.02 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 78.53 11.69 1.66 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.059 0.944 . . . . 0.0 112.493 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.37 160.83 19.06 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 174.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.3 tt0 -73.79 121.63 21.15 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 17' ' ' THR . 6.8 p -103.53 -44.15 5.2 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -174.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.35 68.15 0.24 Allowed Glycine 0 CA--C 1.476 -2.377 0 C-N-CA 118.183 -1.96 . . . . 0.0 113.559 -171.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.593 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -104.73 160.15 15.61 Favored Glycine 0 C--N 1.279 -2.626 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.3 mt -62.51 122.83 14.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.33 -14.85 50.97 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.045 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -92.01 116.45 28.93 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 p -111.63 21.25 16.31 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.41 0.624 . . . . 0.0 111.675 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.413 ' HA3' ' HD2' ' A' ' 16' ' ' PRO . . . -84.76 -153.87 20.02 Favored Glycine 0 C--O 1.252 1.241 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.975 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.413 ' HD2' ' HA3' ' A' ' 15' ' ' GLY . 30.2 Cg_endo -61.77 110.56 0.99 Allowed 'Trans proline' 0 C--N 1.328 -0.523 0 C-N-CA 123.889 3.059 . . . . 0.0 111.871 174.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.587 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 62.7 p -96.31 -20.94 18.13 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.745 0.783 . . . . 0.0 110.524 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.7 t -82.04 118.46 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.092 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.42 ' HA ' ' HB3' ' A' ' 2' ' ' ALA . 59.3 m -77.21 164.09 25.93 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 120.991 0.424 . . . . 0.0 111.72 177.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.46 153.85 37.36 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.7 m -60.88 121.03 11.34 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.41 0.624 . . . . 0.0 111.22 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.22 -20.84 23.07 Favored Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.554 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.536 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 35.3 p -105.65 146.55 29.56 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 122.278 -0.542 . . . . 0.0 110.101 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.1 p -124.85 134.16 52.83 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 122.352 0.261 . . . . 0.0 110.784 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.5 t -73.11 112.91 9.58 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -116.82 132.65 56.64 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-O 121.246 0.546 . . . . 0.0 111.116 -177.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.3 t -75.22 117.01 18.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.783 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 32.8 mt -93.87 -48.47 6.27 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.468 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 81.1 m-20 -131.18 167.67 20.66 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 29' ' ' ASN . 1.6 Cg_endo -60.9 -33.34 92.69 Favored 'Trans proline' 0 C--N 1.359 1.13 0 CA-C-N 121.335 1.513 . . . . 0.0 113.167 -176.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.593 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 82.4 m-85 -99.95 -25.21 14.4 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.239 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -103.57 113.83 27.63 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.583 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.7 m -120.93 132.04 54.71 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 175.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -119.98 139.76 51.98 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -174.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.536 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 9.9 t -84.87 121.38 27.65 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.201 -177.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 N--CA 1.422 -1.833 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 -176.923 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.509 ' H61' ' O3 ' ' A' ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.5 p . . . . . 0 N--CA 1.443 -0.81 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.46 130.89 34.48 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.6 p -85.37 163.73 18.37 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.996 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -65.95 124.41 22.46 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 81.26 9.62 0.96 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.146 1.378 . . . . 0.0 112.114 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.07 164.65 20.53 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 33' ' ' SER . 61.5 tt0 -75.6 125.25 28.66 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 17' ' ' THR . 24.5 p -112.75 1.72 15.75 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -172.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.18 73.98 0.01 OUTLIER Glycine 0 CA--C 1.487 -1.68 0 C-N-CA 116.695 -2.669 . . . . 0.0 114.895 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -94.96 165.04 25.28 Favored Glycine 0 N--CA 1.423 -2.218 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 176.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.5 mt -62.05 115.91 2.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 121.206 0.527 . . . . 0.0 110.805 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.96 1.19 70.51 Favored Glycine 0 C--N 1.312 -0.796 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.039 -178.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -100.11 106.84 18.61 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.9 p -101.99 18.8 19.75 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.954 -176.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.97 -161.14 16.06 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.95 114.02 1.43 Allowed 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 123.526 2.817 . . . . 0.0 111.783 175.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 12.9 p -110.69 -30.3 7.65 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.501 0.667 . . . . 0.0 111.499 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.5 t -79.7 128.51 38.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.8 m -88.65 174.02 8.28 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.22 0.533 . . . . 0.0 112.348 -177.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.66 169.66 12.49 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.781 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.4 m -63.64 113.09 3.13 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.78 9.57 32.44 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.164 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.631 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 21.4 p -132.13 149.12 52.48 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-N 117.451 0.626 . . . . 0.0 110.595 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.8 p -128.34 139.04 52.61 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.466 0.175 . . . . 0.0 111.393 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.3 t -76.57 117.86 18.64 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -118.65 128.29 54.39 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-O 121.368 0.604 . . . . 0.0 110.936 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -79.23 114.25 19.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.272 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.6 mt -95.87 -44.49 7.37 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -136.71 167.61 20.54 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -63.91 -42.46 19.37 Favored 'Trans proline' 0 C--O 1.241 0.639 0 CA-C-N 120.99 1.389 . . . . 0.0 112.577 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.62 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 76.8 m-85 -92.06 -24.81 19.05 Favored 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.412 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -104.66 113.83 27.66 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.568 -0.853 . . . . 0.0 112.273 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 35.1 m -122.55 134.83 54.53 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 174.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -122.09 140.97 51.88 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -174.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.631 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 10.4 t -84.82 114.57 22.18 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.0 mt . . . . . 0 C--N 1.283 -2.298 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -176.528 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.464 ' H61' ' O3 ' ' A' ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.413 ' O ' ' H5 ' ' A' ' 101' ' ' MAN . 4.0 m . . . . . 0 N--CA 1.447 -0.616 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.46 112.46 15.52 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.9 p -83.87 153.93 23.73 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.558 -173.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -61.94 119.34 8.65 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 85.1 3.45 0.65 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.29 1.436 . . . . 0.0 112.743 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.81 165.16 22.02 Favored Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -73.35 128.76 36.39 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 17' ' ' THR . 14.5 p -107.2 -45.76 4.04 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -175.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.09 74.75 0.14 Allowed Glycine 0 CA--C 1.488 -1.62 0 C-N-CA 118.265 -1.921 . . . . 0.0 114.427 -173.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.76 164.57 13.89 Favored Glycine 0 C--N 1.295 -1.739 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 175.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.41 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 53.3 mt -61.74 120.37 7.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 117.29 0.545 . . . . 0.0 110.252 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.47 -7.85 51.26 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.5 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -100.79 106.65 18.07 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.3 p -104.33 28.27 7.03 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.583 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.44 -163.67 39.26 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -59.16 111.71 1.0 Allowed 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.399 2.733 . . . . 0.0 111.476 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 36.3 p -99.39 -11.0 21.55 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.172 0.51 . . . . 0.0 111.791 -178.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.6 t -85.23 120.52 35.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 57.0 m -84.52 158.65 20.91 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.35 0.595 . . . . 0.0 112.382 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.39 172.62 11.58 Favored 'General case' 0 C--O 1.251 1.136 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.884 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.5 m -64.86 112.55 3.32 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 123.196 0.598 . . . . 0.0 110.95 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.19 -4.14 38.14 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.44 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.649 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 37.5 p -117.65 147.39 42.94 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.041 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.0 p -129.77 140.62 51.02 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 123.1 0.25 . . . . 0.0 110.795 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -75.14 102.86 5.09 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 121.054 0.454 . . . . 0.0 110.34 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -101.02 124.01 46.09 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-O 121.96 0.886 . . . . 0.0 112.388 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.3 t -77.91 112.93 16.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 114.176 -1.375 . . . . 0.0 108.688 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.45 HD12 ' CE1' ' A' ' 32' ' ' TYR . 89.0 mt -94.14 -39.62 10.48 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -141.08 169.15 12.1 Favored Pre-proline 0 C--N 1.297 -1.701 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.9 -36.31 39.86 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 CA-C-N 121.24 1.479 . . . . 0.0 113.144 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.584 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 31.0 m-85 -98.94 -25.6 14.54 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.059 -176.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.45 ' CE1' HD12 ' A' ' 28' ' ' LEU . 67.7 t80 -104.04 114.12 28.15 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.116 0.484 . . . . 0.0 111.639 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 m -126.35 132.31 51.62 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 175.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -119.89 139.34 52.55 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.649 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.0 t -82.7 115.67 21.73 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.837 -178.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.4 mt . . . . . 0 N--CA 1.418 -2.075 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 -179.546 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.413 ' H5 ' ' O ' ' A' ' 1' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.441 -0.897 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.77 145.19 34.53 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.1 p -101.99 155.26 18.28 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.557 -171.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -66.92 125.19 25.17 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 81.07 -0.4 1.75 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.909 1.283 . . . . 0.0 111.612 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -96.17 172.14 28.99 Favored Glycine 0 N--CA 1.428 -1.853 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.586 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.1 tt0 -78.57 130.61 36.14 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 17' ' ' THR . 21.4 p -113.6 -25.83 8.54 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -175.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.2 65.96 0.09 OUTLIER Glycine 0 CA--C 1.489 -1.575 0 C-N-CA 118.273 -1.918 . . . . 0.0 113.431 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.79 165.33 13.92 Favored Glycine 0 C--N 1.298 -1.574 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 176.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.8 mt -60.17 117.77 2.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 117.341 0.57 . . . . 0.0 109.896 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.6 -2.96 57.47 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.349 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -92.52 108.42 19.96 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 p -104.81 26.43 9.18 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.426 -177.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.98 -169.44 33.59 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.327 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -58.14 126.39 21.41 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.901 3.067 . . . . 0.0 111.311 176.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 4.9 p -102.61 -21.14 14.2 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.064 -176.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.7 t -81.71 121.33 34.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.4 m -75.64 174.48 9.7 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.14 165.05 17.76 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.481 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.2 m -58.1 115.29 2.81 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 123.17 0.588 . . . . 0.0 111.271 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.84 -14.25 37.95 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.613 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.596 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 34.3 p -111.97 148.4 33.86 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 122.477 -0.425 . . . . 0.0 111.433 -177.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.4 p -126.63 139.35 53.24 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.1 t -74.08 110.62 8.51 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.449 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 76.3 mt-30 -111.07 119.42 38.96 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-O 121.468 0.652 . . . . 0.0 110.189 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.7 t -78.42 109.69 13.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.162 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.485 HD12 ' CE2' ' A' ' 32' ' ' TYR . 76.0 mt -88.79 -51.36 5.69 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -125.55 167.15 17.38 Favored Pre-proline 0 C--N 1.291 -1.964 0 N-CA-C 105.026 -2.212 . . . . 0.0 105.026 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -65.4 -33.59 46.84 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 CA-C-N 120.799 1.321 . . . . 0.0 111.188 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.475 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 6.7 m-85 -94.6 -27.45 15.9 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.27 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.485 ' CE2' HD12 ' A' ' 28' ' ' LEU . 52.9 t80 -105.27 114.01 27.94 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.264 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.586 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.5 m -126.39 127.69 45.86 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 175.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 31.8 tt0 -116.94 137.95 51.87 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 123.416 0.447 . . . . 0.0 110.209 -174.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.596 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 14.9 t -84.22 121.91 28.14 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 119.819 -0.753 . . . . 0.0 109.493 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.449 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 97.2 mt . . . . . 0 C--N 1.294 -1.818 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.3 p . . . . . 0 N--CA 1.443 -0.784 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.04 111.37 18.14 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.3 p -78.34 164.02 25.19 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.118 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -65.21 123.19 18.9 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 82.78 5.65 0.92 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.866 1.266 . . . . 0.0 111.629 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.53 160.03 20.43 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 175.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.584 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.4 tt0 -70.92 137.76 49.52 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 23.5 p -126.54 -4.0 6.63 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -173.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.73 70.74 0.02 OUTLIER Glycine 0 CA--C 1.487 -1.686 0 C-N-CA 117.295 -2.383 . . . . 0.0 114.071 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.53 167.43 14.74 Favored Glycine 0 C--N 1.294 -1.773 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 176.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.2 mt -63.63 119.61 8.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 117.746 0.773 . . . . 0.0 110.282 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.62 14.52 59.68 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.105 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -101.21 113.38 26.37 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.114 0.483 . . . . 0.0 110.142 177.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.5 p -101.15 8.44 42.71 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.171 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.26 -165.98 41.13 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.544 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.27 118.53 5.41 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.879 3.053 . . . . 0.0 112.192 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.1 p -106.87 -5.46 18.3 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.85 0.833 . . . . 0.0 111.126 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.2 t -98.02 117.46 42.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.325 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.0 m -78.2 179.18 7.05 Favored 'General case' 0 C--O 1.254 1.321 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.07 -179.14 4.43 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.646 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.1 m -72.41 121.91 20.34 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.29 19.35 36.02 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.005 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.678 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 23.6 p -140.29 142.63 35.67 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.1 p -131.63 139.87 49.24 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 123.319 0.387 . . . . 0.0 111.477 -177.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.3 t -73.05 114.14 10.88 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 120.835 0.35 . . . . 0.0 110.41 -178.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.519 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 67.4 mt-30 -111.33 123.31 49.95 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 120.876 0.37 . . . . 0.0 110.163 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.2 t -81.43 108.75 14.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.3 mt -86.27 -42.49 13.71 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -140.79 165.49 29.29 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.64 -31.17 59.86 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 120.932 1.369 . . . . 0.0 112.9 -175.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.548 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 68.9 m-85 -100.35 -26.84 13.75 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 119.051 -1.059 . . . . 0.0 110.302 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -105.7 114.01 27.92 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.961 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.584 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.2 m -123.03 134.71 54.28 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -122.32 138.28 54.57 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -172.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.678 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 9.8 t -83.02 114.48 21.3 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.419 0.628 . . . . 0.0 110.293 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.519 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 52.9 mt . . . . . 0 N--CA 1.412 -2.349 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.449 -0.48 0 CA-C-O 120.477 0.179 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.03 140.15 36.65 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.3 p -96.86 159.96 14.63 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.369 0.604 . . . . 0.0 112.195 -173.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -68.51 123.07 19.82 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 81.67 5.86 1.21 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.793 1.237 . . . . 0.0 112.483 -175.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.75 164.39 18.69 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 175.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.2 tt0 -71.66 137.11 47.61 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 17' ' ' THR . 10.4 p -125.9 -16.92 5.51 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -174.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.16 64.62 0.07 OUTLIER Glycine 0 CA--C 1.489 -1.568 0 C-N-CA 117.687 -2.197 . . . . 0.0 113.759 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -106.01 162.29 14.08 Favored Glycine 0 C--N 1.295 -1.731 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.215 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.4 mt -64.14 119.09 7.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.058 0.456 . . . . 0.0 109.894 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.74 -22.79 23.25 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.224 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -87.66 132.14 34.2 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 123.666 0.786 . . . . 0.0 109.109 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.9 p -131.66 17.73 4.76 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.127 0.489 . . . . 0.0 111.012 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.403 ' HA3' ' HD2' ' A' ' 16' ' ' PRO . . . -83.55 -156.97 23.7 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.435 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.403 ' HD2' ' HA3' ' A' ' 15' ' ' GLY . 9.3 Cg_endo -52.19 114.79 1.8 Allowed 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 124.11 3.206 . . . . 0.0 112.254 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.1 p -103.77 -25.61 13.04 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.663 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.0 t -81.91 111.24 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 47.2 m -68.59 156.76 37.47 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.28 158.91 19.04 Favored 'General case' 0 C--O 1.253 1.239 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.625 176.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -65.35 112.99 3.76 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.014 0.435 . . . . 0.0 110.825 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.7 -2.38 29.01 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.257 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.527 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 26.4 p -120.24 150.07 41.26 Favored 'General case' 0 C--N 1.319 -0.749 0 O-C-N 122.329 -0.512 . . . . 0.0 110.908 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.1 p -126.6 138.42 53.45 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 122.446 0.299 . . . . 0.0 111.714 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 34.4 t -75.37 117.87 17.64 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -120.12 124.6 46.19 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.72 0.771 . . . . 0.0 111.207 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.7 t -76.78 117.67 22.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.483 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.475 HD12 ' CE2' ' A' ' 32' ' ' TYR . 88.0 mt -100.05 -44.66 5.93 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -130.87 167.4 21.59 Favored Pre-proline 0 C--N 1.31 -1.132 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -64.32 -35.18 52.24 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 CA-C-N 120.998 1.392 . . . . 0.0 111.048 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.596 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 27.8 m-85 -94.05 -27.49 16.26 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 119.879 -0.728 . . . . 0.0 109.927 -178.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.475 ' CE2' HD12 ' A' ' 28' ' ' LEU . 54.5 t80 -103.99 113.95 27.84 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.654 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.1 m -129.18 123.67 32.66 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -113.69 141.59 47.05 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 123.647 0.592 . . . . 0.0 109.974 -173.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.527 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 9.0 t -85.02 121.68 28.15 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.428 -1.555 0 C-N-CA 123.829 0.852 . . . . 0.0 109.522 -176.856 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 26.6 p . . . . . 0 N--CA 1.441 -0.878 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.31 120.15 23.99 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.5 p -75.15 165.24 25.52 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.531 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -69.38 127.96 34.87 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 76.37 6.91 3.51 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.276 1.431 . . . . 0.0 112.171 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.82 165.06 28.04 Favored Glycine 0 C--O 1.256 1.494 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 176.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.2 tt0 -72.94 120.27 18.33 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.591 ' O ' ' HA ' ' A' ' 17' ' ' THR . 22.1 p -100.93 -39.12 7.91 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -174.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.59 75.34 0.09 OUTLIER Glycine 0 CA--C 1.484 -1.906 0 C-N-CA 117.873 -2.108 . . . . 0.0 113.881 -173.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.52 169.08 15.84 Favored Glycine 0 C--N 1.285 -2.278 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 176.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.4 mt -61.22 127.59 21.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 117.655 0.727 . . . . 0.0 109.901 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.89 -21.65 42.53 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.11 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -79.41 116.71 19.8 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 121.05 0.453 . . . . 0.0 109.813 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 p -107.11 17.55 22.84 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.202 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.36 -176.49 51.35 Favored Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.389 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -54.04 111.3 0.66 Allowed 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 124.076 3.184 . . . . 0.0 112.627 177.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.2 p -89.09 -23.34 22.53 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.074 0.464 . . . . 0.0 111.914 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -79.81 118.69 27.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.409 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 59.8 m -73.73 171.39 13.4 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.05 -179.34 6.62 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.779 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.0 m -70.65 119.97 15.58 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.08 20.19 33.95 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 119.863 -1.16 . . . . 0.0 112.897 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.762 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 21.9 p -136.72 148.37 47.27 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.8 p -127.17 134.83 50.1 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 122.838 0.455 . . . . 0.0 111.081 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.6 t -75.25 112.57 11.67 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -118.78 127.27 53.37 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-O 121.042 0.449 . . . . 0.0 110.575 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.3 t -74.23 121.92 26.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.526 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.6 mt -101.75 -37.52 8.28 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.595 0.712 . . . . 0.0 109.466 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.444 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 52.2 m-80 -142.15 167.44 16.59 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 29' ' ' ASN . 1.8 Cg_endo -61.83 -32.47 85.6 Favored 'Trans proline' 0 C--N 1.353 0.793 0 CA-C-N 121.187 1.459 . . . . 0.0 112.762 -176.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.62 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 63.8 m-85 -100.43 -25.97 14.03 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.797 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -103.69 114.11 28.13 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.814 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.8 m -123.42 133.73 54.04 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -120.01 142.65 48.61 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -173.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.762 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 13.4 t -86.88 118.78 26.49 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.159 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 C--N 1.295 -1.783 0 C-N-CA 123.687 0.795 . . . . 0.0 108.928 -179.644 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.666 ' O ' ' H5 ' ' A' ' 101' ' ' MAN . 18.3 p . . . . . 0 N--CA 1.441 -0.882 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.9 129.55 40.29 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 p -83.99 159.19 21.28 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -64.52 126.31 27.46 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.89 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 78.48 1.29 2.61 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.94 1.296 . . . . 0.0 113.408 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.49 164.83 24.54 Favored Glycine 0 C--O 1.254 1.352 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.608 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.0 tt0 -68.24 120.18 13.99 Favored 'General case' 0 C--O 1.207 -1.154 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 15.0 p -102.51 -29.28 11.68 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -175.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.19 65.88 0.1 Allowed Glycine 0 CA--C 1.483 -1.918 0 C-N-CA 118.415 -1.85 . . . . 0.0 112.652 -175.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.76 162.68 14.09 Favored Glycine 0 N--CA 1.429 -1.818 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 178.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.2 mt -59.47 123.34 11.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.29 -13.29 58.56 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.323 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -87.79 113.96 23.95 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.1 p -101.27 9.36 41.84 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.677 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.6 -171.68 48.34 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.411 -177.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.94 122.34 11.56 Favored 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 124.211 3.274 . . . . 0.0 111.753 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 29.1 p -101.07 -18.58 16.18 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.103 0.478 . . . . 0.0 111.558 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.0 t -79.16 113.89 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.9 m -71.91 169.48 15.76 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.7 169.39 18.32 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.409 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.4 m -58.01 121.46 10.66 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.301 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.86 -18.45 54.86 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.692 176.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.606 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 43.8 p -103.37 146.84 27.88 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 122.5 -0.412 . . . . 0.0 111.045 -176.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.2 p -127.41 144.56 51.04 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 122.144 0.177 . . . . 0.0 110.831 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -80.62 113.36 18.76 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.076 0.465 . . . . 0.0 109.855 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.429 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 78.7 mt-30 -113.54 112.89 24.32 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-O 121.198 0.523 . . . . 0.0 109.825 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -75.4 104.02 3.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.1 mt -80.3 -48.19 13.38 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.464 0.649 . . . . 0.0 109.429 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.404 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 2.3 m-20 -127.57 165.21 31.29 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 29' ' ' ASN . 3.1 Cg_exo -61.46 -37.29 72.23 Favored 'Trans proline' 0 C--O 1.246 0.894 0 CA-C-N 121.469 1.56 . . . . 0.0 112.56 -176.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.515 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 46.6 m-85 -93.06 -26.27 17.56 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.927 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -104.0 113.5 27.08 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 118.966 -1.093 . . . . 0.0 112.376 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.608 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.5 m -121.84 132.5 54.61 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 175.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -120.98 136.53 54.96 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 123.154 0.284 . . . . 0.0 110.296 -174.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.606 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 14.4 t -83.56 122.04 28.03 Favored 'General case' 0 N--CA 1.429 -1.522 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.728 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.429 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 89.8 mt . . . . . 0 C--N 1.291 -1.942 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.666 ' H5 ' ' O ' ' A' ' 1' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.244 0.766 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.57 139.28 32.22 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.3 p -100.8 165.47 11.35 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.286 -175.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -69.02 123.8 22.02 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 82.48 9.69 0.71 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.221 1.409 . . . . 0.0 112.61 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.491 ' HA3' ' H3 ' ' A' ' 101' ' ' MAN . . . -100.52 158.19 19.33 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 175.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.602 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.3 tt0 -68.88 127.06 31.76 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 17' ' ' THR . 13.3 p -116.58 5.76 13.34 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -173.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.93 75.42 0.01 OUTLIER Glycine 0 CA--C 1.482 -2.012 0 C-N-CA 116.934 -2.555 . . . . 0.0 114.791 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.593 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.87 165.39 13.89 Favored Glycine 0 C--N 1.289 -2.075 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 175.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 30' ' ' PRO . 60.1 mt -61.62 127.03 20.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.95 -13.71 66.84 Favored Glycine 0 C--N 1.312 -0.788 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.052 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -101.43 114.0 27.62 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 123.191 0.596 . . . . 0.0 109.7 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.8 p -111.06 21.81 15.98 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.035 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.25 -160.95 25.94 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.995 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.27 111.05 0.48 Allowed 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.989 3.126 . . . . 0.0 112.911 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 14.6 p -105.47 -23.99 12.71 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.631 0.729 . . . . 0.0 111.436 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.9 t -85.83 120.64 36.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.6 m -79.41 163.29 24.93 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 120.972 0.415 . . . . 0.0 111.905 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.8 163.52 25.64 Favored 'General case' 0 C--O 1.253 1.247 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -65.82 117.53 8.35 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 120.963 0.411 . . . . 0.0 110.178 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.8 -19.48 25.67 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.86 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.643 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 19.8 p -103.14 147.6 26.81 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 122.445 -0.444 . . . . 0.0 109.909 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.4 p -127.47 135.26 50.16 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 122.475 0.31 . . . . 0.0 111.311 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.3 t -73.87 111.3 8.9 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.433 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 76.5 mt-30 -109.15 121.74 45.8 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-O 121.517 0.675 . . . . 0.0 109.613 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.9 t -80.14 104.31 8.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.368 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.8 mt -80.7 -44.34 18.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.863 0.84 . . . . 0.0 108.908 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -136.15 164.4 43.26 Favored Pre-proline 0 C--N 1.298 -1.655 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.463 ' O ' HG13 ' A' ' 11' ' ' ILE . 4.3 Cg_exo -64.4 -30.59 62.68 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 CA-C-N 120.554 1.234 . . . . 0.0 111.664 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.593 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 78.6 m-85 -97.77 -27.86 14.13 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 118.919 -1.113 . . . . 0.0 111.314 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.427 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 61.6 t80 -105.9 114.31 28.38 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.469 -0.892 . . . . 0.0 112.316 175.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.602 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 36.6 m -121.49 131.36 54.1 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 175.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.427 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 36.1 tt0 -120.66 138.52 53.89 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -174.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.643 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 12.0 t -85.84 123.21 30.95 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 120.364 -0.535 . . . . 0.0 110.544 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.433 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 95.6 mt . . . . . 0 C--N 1.286 -2.169 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.491 ' H3 ' ' HA3' ' A' ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.3 p . . . . . 0 C--O 1.237 0.419 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.439 ' HB3' ' HA ' ' A' ' 19' ' ' CYS . . . -69.84 153.96 42.61 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.006 0.431 . . . . 0.0 110.509 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.1 p -99.66 152.82 19.63 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.718 -172.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -71.77 122.73 21.18 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 77.8 2.19 2.92 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.546 1.138 . . . . 0.0 111.546 -175.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.56 ' HA3' ' H2 ' ' A' ' 101' ' ' MAN . . . -97.28 174.16 29.51 Favored Glycine 0 N--CA 1.418 -2.522 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.608 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.2 tt0 -79.3 130.81 35.83 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.6 ' O ' ' HA ' ' A' ' 17' ' ' THR . 10.7 p -114.86 -31.8 5.99 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 113.107 0.781 . . . . 0.0 113.107 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.0 62.75 0.22 Allowed Glycine 0 CA--C 1.48 -2.117 0 C-N-CA 118.459 -1.829 . . . . 0.0 112.729 -175.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.82 162.67 14.06 Favored Glycine 0 C--N 1.29 -1.974 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.513 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 61.7 mt -65.36 119.37 9.81 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.34 -7.61 32.48 Favored Glycine 0 C--N 1.306 -1.101 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.599 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -94.86 115.59 27.66 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.1 p -104.2 6.74 35.81 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.037 0.446 . . . . 0.0 111.037 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.02 -173.29 43.6 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.199 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.48 114.47 1.96 Allowed 'Trans proline' 0 C--N 1.328 -0.535 0 C-N-CA 123.798 2.999 . . . . 0.0 111.625 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 31.7 p -87.94 -22.85 24.1 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.318 0.58 . . . . 0.0 110.945 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.5 t -72.0 117.07 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 2' ' ' ALA . 22.2 m -71.72 161.35 31.11 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.7 162.88 28.93 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.072 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.5 m -62.07 113.07 2.63 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.147 0.499 . . . . 0.0 111.775 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.55 -10.18 32.85 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.107 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.546 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 23.2 p -115.07 152.13 33.05 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 122.695 -0.297 . . . . 0.0 111.102 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.4 p -128.14 139.99 52.18 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 123.118 0.261 . . . . 0.0 110.445 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.6 t -73.66 111.69 9.05 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.845 0.355 . . . . 0.0 110.177 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.507 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 69.4 mt-30 -111.28 115.62 29.64 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-O 120.948 0.404 . . . . 0.0 110.471 -178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.4 t -71.16 110.87 4.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.2 mt -89.72 -46.6 8.5 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -131.07 168.89 15.32 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -63.91 -34.82 58.62 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 CA-C-N 120.987 1.388 . . . . 0.0 113.019 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.521 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 12.4 m-85 -102.72 -24.76 13.71 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 119.306 -0.958 . . . . 0.0 110.892 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -103.54 114.86 29.45 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.946 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.608 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 13.7 m -120.89 127.63 52.05 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 36.3 tt0 -111.94 135.88 51.99 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 123.509 0.506 . . . . 0.0 109.721 -173.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.546 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 12.3 t -85.95 115.78 23.77 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.253 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.507 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 89.3 mt . . . . . 0 N--CA 1.414 -2.237 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.56 ' H2 ' ' HA3' ' A' ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.44 -0.959 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.14 144.41 27.51 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 p -106.32 155.75 19.2 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.311 -0.859 . . . . 0.0 113.139 -172.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -59.44 124.51 20.27 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.75 1.22 . . . . 0.0 109.836 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 71.75 10.25 6.31 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.726 1.21 . . . . 0.0 112.702 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -104.8 165.88 14.69 Favored Glycine 0 N--CA 1.42 -2.401 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 174.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.6 tt0 -70.57 128.81 37.39 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.656 ' O ' ' HA ' ' A' ' 17' ' ' THR . 16.7 p -109.72 -36.64 5.87 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.6 63.81 0.18 Allowed Glycine 0 CA--C 1.483 -1.953 0 C-N-CA 118.359 -1.877 . . . . 0.0 113.015 -174.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.77 159.92 15.09 Favored Glycine 0 C--N 1.291 -1.97 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 175.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.419 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 58.3 mt -61.4 116.23 2.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 117.774 0.787 . . . . 0.0 109.696 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.61 -11.76 21.14 Favored Glycine 0 N--CA 1.436 -1.337 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.111 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -90.99 109.19 20.42 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.7 p -92.64 5.25 51.68 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.492 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.26 -179.09 50.75 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.287 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -55.02 122.81 12.37 Favored 'Trans proline' 0 N--CA 1.479 0.647 0 C-N-CA 124.594 3.529 . . . . 0.0 112.501 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.656 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.5 p -90.98 -20.22 22.38 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.4 t -83.95 126.46 40.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.8 m -76.35 171.13 15.08 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.57 176.17 9.6 Favored 'General case' 0 C--O 1.252 1.225 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.115 177.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -62.64 119.39 9.16 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.483 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.87 6.3 58.15 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.998 -0.62 . . . . 0.0 113.471 176.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.71 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 3.0 p -131.23 150.95 51.93 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 117.196 0.498 . . . . 0.0 111.245 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.9 p -129.95 144.14 51.17 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.636 0.236 . . . . 0.0 111.636 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.8 t -79.43 107.9 12.54 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -107.91 116.31 31.72 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-O 121.522 0.677 . . . . 0.0 110.353 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.4 t -74.92 108.77 6.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.115 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.2 mt -85.22 -50.49 7.33 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -129.87 166.58 25.21 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.16 -33.69 71.46 Favored 'Trans proline' 0 C--N 1.348 0.53 0 CA-C-N 120.669 1.274 . . . . 0.0 112.804 -177.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.499 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 53.0 m-85 -98.39 -26.49 14.46 Favored 'General case' 0 N--CA 1.434 -1.268 0 C-N-CA 118.914 -1.115 . . . . 0.0 110.827 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.44 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 57.4 t80 -105.11 114.25 28.34 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 119.188 -1.005 . . . . 0.0 112.978 175.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.8 m -122.72 131.4 53.77 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 174.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.44 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 35.5 tt0 -117.82 138.83 51.82 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 123.407 0.442 . . . . 0.0 110.094 -173.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.71 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 14.4 t -84.35 115.67 22.62 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.035 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.408 HD21 ' OE1' ' A' ' 34' ' ' GLN . 97.9 mt . . . . . 0 C--N 1.286 -2.193 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.442 -0.874 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.77 143.35 47.98 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-O 120.864 0.364 . . . . 0.0 110.228 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.3 p -92.77 162.86 13.96 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.66 -177.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -67.77 126.74 30.37 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 81.16 6.47 1.29 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.485 1.114 . . . . 0.0 112.699 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.78 159.7 21.61 Favored Glycine 0 N--CA 1.436 -1.309 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -70.86 126.38 29.43 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 17' ' ' THR . 6.2 p -104.23 -42.67 5.44 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -176.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.4 64.83 0.29 Allowed Glycine 0 CA--C 1.476 -2.353 0 C-N-CA 118.31 -1.9 . . . . 0.0 112.852 -172.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.34 156.2 16.77 Favored Glycine 0 N--CA 1.42 -2.415 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 177.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.578 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 62.4 mt -61.62 121.25 9.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.18 -11.79 40.36 Favored Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -100.92 116.5 32.93 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.9 p -114.49 17.07 17.56 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.08 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.56 -162.38 31.4 Favored Glycine 0 C--O 1.24 0.494 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.76 109.05 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.406 2.738 . . . . 0.0 111.579 175.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 11.1 p -95.25 -22.24 17.92 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.782 -177.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.52 119.57 35.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.7 m -73.21 170.09 15.7 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.79 162.97 25.74 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.375 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.1 m -65.03 113.17 3.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.05 0.452 . . . . 0.0 110.11 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.16 7.65 26.5 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.977 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.678 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 19.2 p -131.9 146.72 52.27 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.4 p -127.25 138.87 53.19 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 121.208 -0.197 . . . . 0.0 110.881 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.7 t -75.97 109.95 10.03 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -105.2 133.15 50.44 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-O 121.445 0.641 . . . . 0.0 111.351 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.4 t -81.48 99.59 4.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.9 mt -82.18 -40.63 21.49 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -145.01 168.46 12.05 Favored Pre-proline 0 N--CA 1.431 -1.399 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -65.16 -38.95 25.35 Favored 'Trans proline' 0 C--O 1.25 1.084 0 CA-C-N 120.403 1.18 . . . . 0.0 112.659 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.578 ' CD1' ' HB ' ' A' ' 11' ' ' ILE . 53.0 m-85 -96.1 -27.01 15.28 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.643 -176.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -104.2 114.08 28.07 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.589 -0.845 . . . . 0.0 111.418 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.5 m -125.68 130.04 50.76 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 174.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -118.56 144.63 45.95 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -172.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.678 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 10.2 t -87.54 114.46 24.17 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.086 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.5 mt . . . . . 0 N--CA 1.418 -2.058 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -177.72 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.535 ' H61' ' O3 ' ' A' ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.436 -1.158 0 CA-C-O 120.875 0.369 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.75 131.57 37.7 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.5 p -93.92 166.1 12.34 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.361 0.601 . . . . 0.0 111.8 -175.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -61.89 124.07 19.77 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.067 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 80.14 6.31 1.71 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.288 1.435 . . . . 0.0 112.866 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.31 159.17 20.56 Favored Glycine 0 N--CA 1.435 -1.393 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.559 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.5 tt0 -70.66 128.94 37.8 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.2 p -120.27 8.14 10.83 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 153.38 76.21 0.02 OUTLIER Glycine 0 CA--C 1.483 -1.93 0 C-N-CA 117.292 -2.385 . . . . 0.0 114.511 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.54 166.63 14.38 Favored Glycine 0 N--CA 1.419 -2.459 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 176.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.3 mt -64.93 118.54 7.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.54 -13.92 66.3 Favored Glycine 0 C--N 1.315 -0.637 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.362 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -79.49 108.4 12.99 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.22 0.533 . . . . 0.0 110.548 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.2 p -92.24 6.94 44.88 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.222 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.44 -171.23 41.08 Favored Glycine 0 C--N 1.316 -0.569 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.647 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -49.22 131.47 26.67 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 124.556 3.504 . . . . 0.0 112.299 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.4 p -125.52 -22.32 4.31 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 51.7 t -91.1 119.53 38.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.7 m -76.45 166.01 24.01 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.397 0.618 . . . . 0.0 112.479 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.91 167.82 20.03 Favored 'General case' 0 C--O 1.255 1.374 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.004 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.2 m -70.15 119.83 14.93 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 120.964 0.412 . . . . 0.0 110.268 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.46 -16.74 29.04 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.661 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 27.1 p -109.18 146.5 34.05 Favored 'General case' 0 C--O 1.251 1.163 0 O-C-N 122.426 -0.455 . . . . 0.0 111.329 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.0 p -124.9 133.73 52.95 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.799 -177.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.0 t -76.08 111.99 12.06 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -113.71 119.01 35.93 Favored 'General case' 0 N--CA 1.406 -2.648 0 CA-C-O 121.206 0.526 . . . . 0.0 110.866 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 82.4 t -70.78 108.48 2.59 Favored 'Isoleucine or valine' 0 C--O 1.253 1.248 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.816 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.434 HD12 ' CE2' ' A' ' 32' ' ' TYR . 71.2 mt -85.61 -46.41 10.81 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -133.49 166.76 26.9 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.63 -31.17 79.51 Favored 'Trans proline' 0 C--N 1.35 0.62 0 CA-C-N 120.906 1.359 . . . . 0.0 112.347 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.566 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 92.5 m-85 -99.89 -26.28 14.06 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.757 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.434 ' CE2' HD12 ' A' ' 28' ' ' LEU . 54.2 t80 -104.85 114.12 28.14 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 119.463 -0.895 . . . . 0.0 111.819 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 26.8 m -122.32 128.94 51.66 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 176.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -121.99 138.72 54.32 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -175.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.661 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 8.6 t -82.04 118.71 23.22 Favored 'General case' 0 N--CA 1.422 -1.854 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.937 -178.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.0 mt . . . . . 0 C--N 1.286 -2.194 0 C-N-CA 123.78 0.832 . . . . 0.0 109.364 -176.517 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 110.644 -0.132 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.25 159.97 30.18 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.47 0.652 . . . . 0.0 111.227 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.5 p -104.86 158.38 16.57 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.767 -175.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -71.87 128.75 36.74 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 77.56 -0.78 2.76 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.084 1.354 . . . . 0.0 111.551 -176.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.14 165.83 36.3 Favored Glycine 0 N--CA 1.416 -2.638 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.62 ' HA ' ' O ' ' A' ' 33' ' ' SER . 60.7 tt0 -74.65 123.39 24.79 Favored 'General case' 0 C--O 1.199 -1.599 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 23.9 p -108.88 -5.62 16.11 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 163.41 57.53 0.02 OUTLIER Glycine 0 CA--C 1.474 -2.477 0 C-N-CA 117.717 -2.182 . . . . 0.0 112.858 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -106.3 164.13 13.62 Favored Glycine 0 N--CA 1.421 -2.358 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 176.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.0 116.87 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 117.401 0.6 . . . . 0.0 109.728 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.68 -25.5 8.5 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.422 -178.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -83.78 121.9 27.94 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.0 p -116.58 13.73 15.34 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.253 0.549 . . . . 0.0 111.194 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.04 -170.29 47.01 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.075 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -57.23 117.13 3.77 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 123.933 3.089 . . . . 0.0 110.9 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 39.5 p -93.75 -4.9 49.53 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.1 t -93.15 134.48 30.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 175.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.5 m -81.29 169.45 17.28 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -177.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.93 165.71 23.77 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.901 177.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 p -60.07 116.9 4.51 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.4 -17.26 37.15 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.031 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.637 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 41.4 p -108.87 148.94 29.86 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.61 -177.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.7 p -127.47 141.68 51.6 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 122.492 -0.13 . . . . 0.0 110.725 -178.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.1 t -79.05 113.04 16.85 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -116.58 113.41 22.69 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-O 121.305 0.574 . . . . 0.0 110.188 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.4 t -70.91 106.01 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.779 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.8 mt -87.04 -39.29 15.76 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.596 0.712 . . . . 0.0 109.397 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -141.24 167.75 16.25 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.19 -33.81 29.85 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 CA-C-N 120.917 1.363 . . . . 0.0 112.559 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.534 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 48.0 m-85 -97.32 -27.47 14.48 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 118.351 -1.34 . . . . 0.0 109.829 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.562 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 57.9 t80 -104.57 113.68 27.41 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 118.703 -1.199 . . . . 0.0 112.548 177.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.62 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.9 m -118.13 130.72 56.28 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 173.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.562 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 36.3 tt0 -116.94 140.55 49.33 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 118.057 0.39 . . . . 0.0 110.311 -173.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.637 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 18.5 t -89.09 121.91 31.89 Favored 'General case' 0 N--CA 1.416 -2.137 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.715 177.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 N--CA 1.421 -1.92 0 C-N-CA 123.975 0.91 . . . . 0.0 108.941 -179.565 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.3 p . . . . . 0 N--CA 1.445 -0.721 0 N-CA-C 110.592 -0.151 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.406 ' HB3' ' HA ' ' A' ' 19' ' ' CYS . . . -66.34 148.78 51.36 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.321 0.582 . . . . 0.0 110.925 -179.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.438 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 13.9 p -99.83 153.26 19.29 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.919 -171.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -70.51 116.96 11.45 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.862 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 77.63 19.47 1.18 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.287 1.035 . . . . 0.0 110.864 -176.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.45 159.28 13.78 Favored Glycine 0 N--CA 1.416 -2.64 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 172.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.5 tt0 -68.44 136.15 52.8 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 177.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.608 ' O ' ' HA ' ' A' ' 17' ' ' THR . 9.5 p -122.36 -37.39 2.81 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -175.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.85 58.38 0.31 Allowed Glycine 0 CA--C 1.484 -1.88 0 C-N-CA 118.815 -1.66 . . . . 0.0 112.37 -173.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.48 155.01 17.06 Favored Glycine 0 N--CA 1.421 -2.343 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 59.6 mt -65.0 115.67 3.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.34 -12.02 14.18 Favored Glycine 0 C--N 1.297 -1.599 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.75 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.656 ' OH ' ' H4 ' ' A' ' 101' ' ' MAN . 62.2 t80 -93.9 122.79 36.75 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.143 0.497 . . . . 0.0 110.076 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 p -109.28 15.38 23.19 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.551 -177.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.49 -168.93 32.78 Favored Glycine 0 C--N 1.315 -0.6 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.892 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -53.64 117.3 3.69 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.955 3.103 . . . . 0.0 112.655 177.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.608 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 19.8 p -90.04 -25.75 20.65 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 123.295 0.638 . . . . 0.0 111.648 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -83.07 118.89 31.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.406 ' HA ' ' HB3' ' A' ' 2' ' ' ALA . 60.6 m -72.05 170.69 13.34 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.48 169.31 17.86 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.622 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.7 m -64.96 114.46 4.57 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.745 0.307 . . . . 0.0 110.867 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.3 6.17 45.2 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.268 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.671 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 27.4 p -128.26 147.17 50.58 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.8 p -129.38 137.71 51.09 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.728 0.299 . . . . 0.0 110.778 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.4 t -75.58 107.5 7.77 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.453 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 78.5 mt-30 -107.38 126.01 51.93 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-O 121.391 0.615 . . . . 0.0 110.949 -176.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.5 t -77.45 110.64 13.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.934 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.1 mt -89.3 -48.51 7.31 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -132.81 168.32 18.45 Favored Pre-proline 0 C--N 1.299 -1.597 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -63.39 -40.89 29.08 Favored 'Trans proline' 0 C--O 1.253 1.258 0 CA-C-N 120.994 1.391 . . . . 0.0 113.074 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.507 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 24.3 m-85 -94.72 -26.17 16.4 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.866 -177.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -104.63 113.49 27.1 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.982 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.0 m -127.03 133.88 50.42 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -124.1 143.03 50.7 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -172.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.671 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.2 t -85.84 121.74 28.91 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.28 0.562 . . . . 0.0 110.724 -177.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.453 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 94.5 mt . . . . . 0 C--N 1.289 -2.032 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.656 ' H4 ' ' OH ' ' A' ' 13' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 19.7 p . . . . . 0 N--CA 1.445 -0.684 0 CA-C-O 120.827 0.346 . . . . 0.0 110.615 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.26 149.66 27.72 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p -88.02 143.51 27.05 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.606 -173.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -64.79 126.44 27.95 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 76.41 6.51 3.51 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.833 1.253 . . . . 0.0 111.375 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.498 ' HA3' ' H3 ' ' A' ' 101' ' ' MAN . . . -101.09 164.39 18.31 Favored Glycine 0 N--CA 1.423 -2.194 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 177.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.594 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.8 tt0 -69.35 128.98 38.49 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 17' ' ' THR . 24.7 p -122.96 -8.98 8.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -173.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.34 64.47 0.04 OUTLIER Glycine 0 CA--C 1.482 -1.986 0 C-N-CA 116.855 -2.593 . . . . 0.0 114.072 -177.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.68 171.0 17.76 Favored Glycine 0 C--N 1.293 -1.841 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 175.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.8 mt -69.03 124.23 24.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.63 -1.68 60.14 Favored Glycine 0 C--N 1.305 -1.165 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.341 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.697 ' OH ' ' H62' ' A' ' 101' ' ' MAN . 82.6 t80 -101.01 106.67 17.99 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.5 p -101.59 1.9 38.33 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.844 -176.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.77 -168.36 12.16 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.468 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -52.58 113.45 1.24 Allowed 'Trans proline' 0 N--CA 1.484 0.915 0 C-N-CA 124.183 3.255 . . . . 0.0 112.145 177.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.4 p -101.52 -30.28 11.49 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.889 0.376 . . . . 0.0 111.981 -178.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 1' ' ' THR . 57.7 t -73.79 112.29 10.22 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.249 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 54.1 m -66.93 165.2 15.96 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.17 175.62 9.49 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.006 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -66.7 115.36 6.43 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.792 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.35 9.14 58.17 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 121.251 -0.499 . . . . 0.0 112.733 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.598 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 41.2 p -122.88 148.03 45.89 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.839 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.5 p -128.66 135.12 48.85 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 123.125 0.266 . . . . 0.0 111.615 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.4 t -79.33 116.62 19.68 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.851 0.358 . . . . 0.0 110.05 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.456 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 60.0 mt-30 -114.89 114.8 25.97 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 120.778 0.323 . . . . 0.0 110.418 -177.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.4 t -70.99 118.21 15.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.456 HD12 ' CE2' ' A' ' 32' ' ' TYR . 93.7 mt -98.08 -49.28 4.8 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.282 0.563 . . . . 0.0 109.775 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.468 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 80.9 m-20 -124.25 169.11 11.25 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 178.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 29' ' ' ASN . 6.0 Cg_endo -64.14 -31.87 64.24 Favored 'Trans proline' 0 C--N 1.353 0.768 0 CA-C-N 121.404 1.537 . . . . 0.0 112.563 -177.107 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.491 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 51.8 m-85 -103.34 -24.51 13.5 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.159 0.504 . . . . 0.0 110.61 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.456 ' CE2' HD12 ' A' ' 28' ' ' LEU . 71.7 t80 -103.39 115.16 30.02 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 121.885 -0.509 . . . . 0.0 112.119 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.594 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.6 m -127.82 131.95 49.48 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 176.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -117.51 139.16 51.3 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -173.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.598 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.9 t -86.14 112.57 21.43 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.511 0.672 . . . . 0.0 110.566 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.456 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 43.0 mt . . . . . 0 N--CA 1.408 -2.531 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.697 ' H62' ' OH ' ' A' ' 13' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.442 -0.831 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.28 127.86 33.74 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.484 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 31.4 p -89.04 172.1 9.36 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.509 -175.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.585 ' O ' ' H2 ' ' A' ' 101' ' ' MAN . 4.4 t60 -71.6 124.28 24.36 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 174.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 78.36 16.82 1.2 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.807 0.843 . . . . 0.0 111.664 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.48 153.86 17.17 Favored Glycine 0 N--CA 1.426 -1.989 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 174.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.5 tt0 -68.47 124.11 22.65 Favored 'General case' 0 C--O 1.21 -1.021 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.3 p -115.72 2.41 13.68 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.05 62.0 0.01 OUTLIER Glycine 0 CA--C 1.49 -1.53 0 C-N-CA 117.645 -2.217 . . . . 0.0 113.868 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.69 163.47 14.0 Favored Glycine 0 C--N 1.291 -1.922 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 59.8 mt -58.82 118.94 2.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 117.48 0.64 . . . . 0.0 110.492 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.4 -17.13 47.75 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.119 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -81.57 112.0 18.38 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 p -107.66 22.62 15.7 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.897 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.11 -169.22 39.37 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.367 177.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.74 122.99 12.77 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.95 3.1 . . . . 0.0 112.29 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 p -99.49 -10.06 22.59 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.437 0.637 . . . . 0.0 111.968 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.3 t -87.46 130.78 36.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.9 m -90.34 165.71 13.72 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.463 0.649 . . . . 0.0 112.106 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.71 163.99 26.72 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.459 176.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.6 m -74.34 124.29 26.2 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.62 -2.64 29.14 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -174.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.597 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 32.9 p -132.84 150.07 52.2 Favored 'General case' 0 C--O 1.248 1.017 0 O-C-N 122.763 -0.257 . . . . 0.0 111.018 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.3 p -128.64 139.51 52.22 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.6 t -77.44 116.56 18.12 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -117.74 122.63 43.97 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-O 121.259 0.552 . . . . 0.0 110.947 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.4 t -74.12 109.69 7.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.2 mt -87.3 -41.07 13.93 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -141.91 166.49 21.28 Favored Pre-proline 0 C--N 1.301 -1.535 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -62.6 -37.01 60.94 Favored 'Trans proline' 0 C--N 1.351 0.68 0 CA-C-N 121.206 1.467 . . . . 0.0 113.081 -177.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.52 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 84.6 m-85 -94.63 -27.25 15.98 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 118.501 -1.279 . . . . 0.0 110.813 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.496 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 48.1 t80 -105.52 113.93 27.79 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.416 -0.914 . . . . 0.0 112.782 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.604 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.0 m -120.24 129.13 53.92 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 174.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.496 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.9 tt0 -120.07 138.37 53.58 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -174.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.597 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.1 t -83.4 122.35 28.37 Favored 'General case' 0 N--CA 1.426 -1.661 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.839 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 N--CA 1.421 -1.881 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.024 -177.457 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.585 ' H2 ' ' O ' ' A' ' 4' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.8 p . . . . . 0 CA--C 1.535 0.398 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.453 ' HB3' ' HA ' ' A' ' 19' ' ' CYS . . . -79.31 140.06 37.65 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 120.934 0.397 . . . . 0.0 109.938 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.9 p -83.94 153.64 23.81 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 114.844 -1.071 . . . . 0.0 113.069 -173.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -73.56 127.63 33.27 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 76.22 2.84 3.6 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.243 1.017 . . . . 0.0 111.471 -176.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.99 169.68 29.78 Favored Glycine 0 N--CA 1.415 -2.726 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 176.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.2 tt0 -77.36 127.34 32.4 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 18.7 p -116.09 4.47 13.67 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -174.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.51 62.85 0.01 OUTLIER Glycine 0 CA--C 1.481 -2.093 0 C-N-CA 118.085 -2.007 . . . . 0.0 113.417 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.541 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.38 161.25 14.75 Favored Glycine 0 N--CA 1.425 -2.059 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 177.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.49 119.79 5.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 117.724 0.762 . . . . 0.0 109.256 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.26 -22.13 25.46 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -81.05 117.15 21.39 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.038 0.447 . . . . 0.0 110.288 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.0 p -101.67 -0.23 34.98 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.751 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.33 -173.61 44.65 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.591 -177.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -53.33 124.34 15.45 Favored 'Trans proline' 0 N--CA 1.477 0.509 0 C-N-CA 124.435 3.423 . . . . 0.0 112.362 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.4 p -104.03 -18.97 14.36 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.17 0.509 . . . . 0.0 111.589 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.8 t -78.75 112.71 17.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.453 ' HA ' ' HB3' ' A' ' 2' ' ' ALA . 52.4 m -65.41 162.96 16.66 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.98 172.59 12.04 Favored 'General case' 0 C--O 1.254 1.334 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.086 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.5 m -67.13 119.95 12.91 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.714 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.85 19.93 35.44 Favored Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.905 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.578 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 44.4 p -138.09 148.49 45.06 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 117.038 0.419 . . . . 0.0 110.061 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.4 p -126.17 133.33 51.6 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 122.103 0.161 . . . . 0.0 110.943 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.1 t -74.25 119.82 18.99 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -119.0 120.17 36.46 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-O 121.558 0.694 . . . . 0.0 110.818 -178.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.2 t -75.24 101.21 2.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.982 177.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.441 HD12 ' CE1' ' A' ' 32' ' ' TYR . 77.3 mt -79.51 -46.23 17.79 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.454 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 93.5 m-20 -140.31 170.5 9.52 Favored Pre-proline 0 C--N 1.31 -1.138 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 29' ' ' ASN . 4.3 Cg_exo -62.88 -43.15 21.23 Favored 'Trans proline' 0 C--N 1.358 1.056 0 CA-C-N 120.763 1.308 . . . . 0.0 112.979 -178.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.541 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 89.8 m-85 -89.77 -27.18 20.19 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 118.299 -1.36 . . . . 0.0 110.021 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.441 ' CE1' HD12 ' A' ' 28' ' ' LEU . 40.0 t80 -104.05 113.91 27.78 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 118.789 -1.164 . . . . 0.0 112.503 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.3 m -127.31 123.78 37.16 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 174.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -116.64 140.59 49.23 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 123.504 0.502 . . . . 0.0 110.391 -173.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.578 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.4 t -88.81 123.25 33.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.5 mt . . . . . 0 C--N 1.296 -1.738 0 C-N-CA 123.794 0.838 . . . . 0.0 109.362 -176.556 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 19' ' ' CYS . . . . . . . . 0 N--CA 1.43 -1.46 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 4.0 p -104.69 153.12 21.66 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.22 -173.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -69.67 123.19 20.72 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 78.06 6.96 2.61 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.589 1.156 . . . . 0.0 112.002 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -103.3 167.29 16.69 Favored Glycine 0 N--CA 1.423 -2.213 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 175.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.6 tt0 -70.39 127.63 33.4 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 17' ' ' THR . 20.1 p -103.52 -39.1 6.87 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.18 76.13 0.11 Allowed Glycine 0 CA--C 1.484 -1.844 0 C-N-CA 118.392 -1.861 . . . . 0.0 113.608 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.34 169.78 16.77 Favored Glycine 0 C--N 1.291 -1.926 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 176.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.0 mt -66.95 119.49 12.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.71 -17.17 42.9 Favored Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -85.1 106.25 16.43 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.0 p -94.37 4.9 53.26 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.298 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.26 -169.8 32.65 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 115.553 -0.748 . . . . 0.0 112.692 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -59.55 114.49 2.07 Favored 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 123.592 2.861 . . . . 0.0 111.797 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.7 p -93.98 -17.12 23.27 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.539 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.8 t -88.68 120.59 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 2' ' ' ALA . 66.7 m -72.89 167.61 20.64 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.42 165.0 24.96 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.419 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.1 m -64.85 124.11 21.13 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 120.643 0.259 . . . . 0.0 110.367 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.92 -0.01 48.41 Favored Glycine 0 N--CA 1.432 -1.593 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.331 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.554 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 42.1 p -128.43 151.03 49.85 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.6 p -130.15 137.72 50.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.759 0.314 . . . . 0.0 111.679 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.1 t -74.16 114.78 12.89 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.52 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 50.0 mt-30 -121.76 117.7 27.24 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-O 121.379 0.609 . . . . 0.0 111.109 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.5 t -71.02 116.89 13.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.437 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.9 mt -97.44 -39.76 9.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.889 0.852 . . . . 0.0 108.95 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -137.7 164.32 42.07 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -62.61 -32.73 79.27 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 CA-C-N 120.865 1.344 . . . . 0.0 112.002 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.502 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 31.1 m-85 -97.77 -26.58 14.67 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 119.094 -1.042 . . . . 0.0 111.597 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.41 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 68.4 t80 -105.3 114.32 28.43 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 119.779 -0.769 . . . . 0.0 112.664 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.0 m -121.05 130.8 53.93 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 174.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.41 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 53.9 tt0 -115.06 140.78 48.78 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -173.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.554 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 13.3 t -87.12 112.96 22.44 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.593 178.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.52 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 81.3 mt . . . . . 0 C--N 1.278 -2.532 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.495 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.8 p -98.09 153.51 18.38 Favored 'General case' 0 C--N 1.272 -2.78 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.146 -172.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -65.35 122.51 17.31 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 79.34 12.26 1.26 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.815 1.246 . . . . 0.0 111.416 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -107.56 168.05 13.86 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.5 tt0 -77.31 122.4 25.05 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.59 ' O ' ' HA ' ' A' ' 17' ' ' THR . 7.2 p -104.97 -37.01 7.13 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.32 68.13 0.12 Allowed Glycine 0 CA--C 1.474 -2.53 0 C-N-CA 118.052 -2.023 . . . . 0.0 113.127 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.84 165.75 13.99 Favored Glycine 0 C--N 1.284 -2.316 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.0 mt -62.21 126.71 20.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.92 -11.52 57.49 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.88 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -100.9 126.6 47.53 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.8 p -119.26 14.48 12.99 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.491 0.663 . . . . 0.0 111.661 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.88 -155.86 16.12 Favored Glycine 0 C--O 1.258 1.644 0 CA-C-N 115.954 -0.566 . . . . 0.0 113.086 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -56.27 104.94 0.15 Allowed 'Trans proline' 0 C--O 1.222 -0.277 0 C-N-CA 123.854 3.036 . . . . 0.0 113.372 174.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.0 p -87.79 -15.76 36.0 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.55 0.691 . . . . 0.0 110.776 177.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.8 t -88.09 122.94 40.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.069 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.415 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 56.6 m -79.22 175.3 10.71 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.344 0.592 . . . . 0.0 112.274 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.74 163.4 24.52 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.2 m -64.64 122.95 18.04 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.77 5.76 54.97 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.433 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.568 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 40.0 p -128.28 149.21 50.59 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.3 p -130.61 138.7 50.24 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 117.793 0.269 . . . . 0.0 111.275 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.7 t -72.98 111.42 8.07 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -109.6 133.09 53.52 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-O 121.292 0.568 . . . . 0.0 110.515 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.6 t -83.83 105.93 13.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.646 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.1 mt -87.41 -38.36 16.22 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.981 0.896 . . . . 0.0 108.691 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -144.51 167.77 14.09 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -64.45 -41.71 19.39 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 CA-C-N 120.807 1.324 . . . . 0.0 112.101 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.507 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 17.7 m-85 -91.97 -26.44 18.4 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.628 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -104.76 113.24 26.7 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.875 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.4 m -121.89 130.01 53.01 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 174.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.453 HE21 HD21 ' A' ' 36' ' ' LEU . 29.9 tt0 -119.94 139.01 53.1 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -173.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.568 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 9.7 t -81.03 117.08 21.32 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-O 121.502 0.668 . . . . 0.0 110.093 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.453 HD21 HE21 ' A' ' 34' ' ' GLN . 97.1 mt . . . . . 0 N--CA 1.405 -2.678 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 19' ' ' CYS . . . . . . . . 0 N--CA 1.438 -1.036 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 99.8 p -86.71 166.79 15.02 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.705 -175.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -70.89 123.87 23.02 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 78.53 11.69 1.66 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.059 0.944 . . . . 0.0 112.493 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.37 160.83 19.06 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 174.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.3 tt0 -73.79 121.63 21.15 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 17' ' ' THR . 6.8 p -103.53 -44.15 5.2 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -174.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.35 68.15 0.24 Allowed Glycine 0 CA--C 1.476 -2.377 0 C-N-CA 118.183 -1.96 . . . . 0.0 113.559 -171.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.593 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -104.73 160.15 15.61 Favored Glycine 0 C--N 1.279 -2.626 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.3 mt -62.51 122.83 14.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.33 -14.85 50.97 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.045 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -92.01 116.45 28.93 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 p -111.63 21.25 16.31 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.41 0.624 . . . . 0.0 111.675 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.413 ' HA3' ' HD2' ' A' ' 16' ' ' PRO . . . -84.76 -153.87 20.02 Favored Glycine 0 C--O 1.252 1.241 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.975 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.413 ' HD2' ' HA3' ' A' ' 15' ' ' GLY . 30.2 Cg_endo -61.77 110.56 0.99 Allowed 'Trans proline' 0 C--N 1.328 -0.523 0 C-N-CA 123.889 3.059 . . . . 0.0 111.871 174.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.587 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 62.7 p -96.31 -20.94 18.13 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.745 0.783 . . . . 0.0 110.524 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.7 t -82.04 118.46 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.092 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.42 ' HA ' ' HB3' ' A' ' 2' ' ' ALA . 59.3 m -77.21 164.09 25.93 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 120.991 0.424 . . . . 0.0 111.72 177.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.46 153.85 37.36 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.7 m -60.88 121.03 11.34 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.41 0.624 . . . . 0.0 111.22 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.22 -20.84 23.07 Favored Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.554 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.536 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 35.3 p -105.65 146.55 29.56 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 122.278 -0.542 . . . . 0.0 110.101 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.1 p -124.85 134.16 52.83 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 122.352 0.261 . . . . 0.0 110.784 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.5 t -73.11 112.91 9.58 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -116.82 132.65 56.64 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-O 121.246 0.546 . . . . 0.0 111.116 -177.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.3 t -75.22 117.01 18.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.783 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 32.8 mt -93.87 -48.47 6.27 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.468 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 81.1 m-20 -131.18 167.67 20.66 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 29' ' ' ASN . 1.6 Cg_endo -60.9 -33.34 92.69 Favored 'Trans proline' 0 C--N 1.359 1.13 0 CA-C-N 121.335 1.513 . . . . 0.0 113.167 -176.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.593 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 82.4 m-85 -99.95 -25.21 14.4 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.239 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -103.57 113.83 27.63 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.583 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.7 m -120.93 132.04 54.71 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 175.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -119.98 139.76 51.98 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -174.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.536 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 9.9 t -84.87 121.38 27.65 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.201 -177.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 N--CA 1.422 -1.833 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 -176.923 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.572 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.6 p -85.37 163.73 18.37 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.996 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -65.95 124.41 22.46 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 81.26 9.62 0.96 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.146 1.378 . . . . 0.0 112.114 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.07 164.65 20.53 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 33' ' ' SER . 61.5 tt0 -75.6 125.25 28.66 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 17' ' ' THR . 24.5 p -112.75 1.72 15.75 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -172.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.18 73.98 0.01 OUTLIER Glycine 0 CA--C 1.487 -1.68 0 C-N-CA 116.695 -2.669 . . . . 0.0 114.895 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -94.96 165.04 25.28 Favored Glycine 0 N--CA 1.423 -2.218 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 176.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.5 mt -62.05 115.91 2.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 121.206 0.527 . . . . 0.0 110.805 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.96 1.19 70.51 Favored Glycine 0 C--N 1.312 -0.796 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.039 -178.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -100.11 106.84 18.61 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.9 p -101.99 18.8 19.75 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.954 -176.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.97 -161.14 16.06 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.95 114.02 1.43 Allowed 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 123.526 2.817 . . . . 0.0 111.783 175.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 12.9 p -110.69 -30.3 7.65 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.501 0.667 . . . . 0.0 111.499 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.5 t -79.7 128.51 38.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.8 m -88.65 174.02 8.28 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.22 0.533 . . . . 0.0 112.348 -177.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.66 169.66 12.49 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.781 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.4 m -63.64 113.09 3.13 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.78 9.57 32.44 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.164 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.631 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 21.4 p -132.13 149.12 52.48 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-N 117.451 0.626 . . . . 0.0 110.595 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.8 p -128.34 139.04 52.61 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.466 0.175 . . . . 0.0 111.393 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.3 t -76.57 117.86 18.64 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -118.65 128.29 54.39 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-O 121.368 0.604 . . . . 0.0 110.936 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -79.23 114.25 19.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.272 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.6 mt -95.87 -44.49 7.37 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -136.71 167.61 20.54 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -63.91 -42.46 19.37 Favored 'Trans proline' 0 C--O 1.241 0.639 0 CA-C-N 120.99 1.389 . . . . 0.0 112.577 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.62 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 76.8 m-85 -92.06 -24.81 19.05 Favored 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.412 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -104.66 113.83 27.66 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.568 -0.853 . . . . 0.0 112.273 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 35.1 m -122.55 134.83 54.53 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 174.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -122.09 140.97 51.88 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -174.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.631 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 10.4 t -84.82 114.57 22.18 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.0 mt . . . . . 0 C--N 1.283 -2.298 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -176.528 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.381 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.9 p -83.87 153.93 23.73 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.558 -173.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -61.94 119.34 8.65 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 85.1 3.45 0.65 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.29 1.436 . . . . 0.0 112.743 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.81 165.16 22.02 Favored Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -73.35 128.76 36.39 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 17' ' ' THR . 14.5 p -107.2 -45.76 4.04 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -175.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.09 74.75 0.14 Allowed Glycine 0 CA--C 1.488 -1.62 0 C-N-CA 118.265 -1.921 . . . . 0.0 114.427 -173.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.76 164.57 13.89 Favored Glycine 0 C--N 1.295 -1.739 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 175.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.41 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 53.3 mt -61.74 120.37 7.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 117.29 0.545 . . . . 0.0 110.252 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.47 -7.85 51.26 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.5 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -100.79 106.65 18.07 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.3 p -104.33 28.27 7.03 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.583 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.44 -163.67 39.26 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -59.16 111.71 1.0 Allowed 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.399 2.733 . . . . 0.0 111.476 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 36.3 p -99.39 -11.0 21.55 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.172 0.51 . . . . 0.0 111.791 -178.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.6 t -85.23 120.52 35.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 57.0 m -84.52 158.65 20.91 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.35 0.595 . . . . 0.0 112.382 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.39 172.62 11.58 Favored 'General case' 0 C--O 1.251 1.136 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.884 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.5 m -64.86 112.55 3.32 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 123.196 0.598 . . . . 0.0 110.95 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.19 -4.14 38.14 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.44 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.649 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 37.5 p -117.65 147.39 42.94 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.041 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.0 p -129.77 140.62 51.02 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 123.1 0.25 . . . . 0.0 110.795 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -75.14 102.86 5.09 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 121.054 0.454 . . . . 0.0 110.34 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.43 HE21 ' HB2' ' A' ' 36' ' ' LEU . 44.3 mt-30 -101.02 124.01 46.09 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-O 121.96 0.886 . . . . 0.0 112.388 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.3 t -77.91 112.93 16.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 114.176 -1.375 . . . . 0.0 108.688 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.45 HD12 ' CE1' ' A' ' 32' ' ' TYR . 89.0 mt -94.14 -39.62 10.48 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -141.08 169.15 12.1 Favored Pre-proline 0 C--N 1.297 -1.701 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.9 -36.31 39.86 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 CA-C-N 121.24 1.479 . . . . 0.0 113.144 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.584 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 31.0 m-85 -98.94 -25.6 14.54 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.059 -176.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.45 ' CE1' HD12 ' A' ' 28' ' ' LEU . 67.7 t80 -104.04 114.12 28.15 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.116 0.484 . . . . 0.0 111.639 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 m -126.35 132.31 51.62 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 175.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -119.89 139.34 52.55 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.649 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.0 t -82.7 115.67 21.73 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.837 -178.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.43 ' HB2' HE21 ' A' ' 26' ' ' GLN . 77.4 mt . . . . . 0 N--CA 1.418 -2.075 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -1.777 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.1 p -101.99 155.26 18.28 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.557 -171.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -66.92 125.19 25.17 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 81.07 -0.4 1.75 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.909 1.283 . . . . 0.0 111.612 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -96.17 172.14 28.99 Favored Glycine 0 N--CA 1.428 -1.853 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.586 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.1 tt0 -78.57 130.61 36.14 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 17' ' ' THR . 21.4 p -113.6 -25.83 8.54 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -175.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.2 65.96 0.09 OUTLIER Glycine 0 CA--C 1.489 -1.575 0 C-N-CA 118.273 -1.918 . . . . 0.0 113.431 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.79 165.33 13.92 Favored Glycine 0 C--N 1.298 -1.574 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 176.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.8 mt -60.17 117.77 2.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 117.341 0.57 . . . . 0.0 109.896 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.6 -2.96 57.47 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.349 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -92.52 108.42 19.96 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 p -104.81 26.43 9.18 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.426 -177.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.98 -169.44 33.59 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.327 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -58.14 126.39 21.41 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.901 3.067 . . . . 0.0 111.311 176.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 4.9 p -102.61 -21.14 14.2 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.064 -176.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.7 t -81.71 121.33 34.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.4 m -75.64 174.48 9.7 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.14 165.05 17.76 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.481 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.2 m -58.1 115.29 2.81 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 123.17 0.588 . . . . 0.0 111.271 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.84 -14.25 37.95 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.613 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.596 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 34.3 p -111.97 148.4 33.86 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 122.477 -0.425 . . . . 0.0 111.433 -177.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.4 p -126.63 139.35 53.24 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.1 t -74.08 110.62 8.51 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.449 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 76.3 mt-30 -111.07 119.42 38.96 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-O 121.468 0.652 . . . . 0.0 110.189 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.7 t -78.42 109.69 13.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.162 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.485 HD12 ' CE2' ' A' ' 32' ' ' TYR . 76.0 mt -88.79 -51.36 5.69 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -125.55 167.15 17.38 Favored Pre-proline 0 C--N 1.291 -1.964 0 N-CA-C 105.026 -2.212 . . . . 0.0 105.026 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -65.4 -33.59 46.84 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 CA-C-N 120.799 1.321 . . . . 0.0 111.188 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.475 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 6.7 m-85 -94.6 -27.45 15.9 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.27 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.485 ' CE2' HD12 ' A' ' 28' ' ' LEU . 52.9 t80 -105.27 114.01 27.94 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.264 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.586 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.5 m -126.39 127.69 45.86 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 175.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 31.8 tt0 -116.94 137.95 51.87 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 123.416 0.447 . . . . 0.0 110.209 -174.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.596 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 14.9 t -84.22 121.91 28.14 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 119.819 -0.753 . . . . 0.0 109.493 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.449 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 97.2 mt . . . . . 0 C--N 1.294 -1.818 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -1.746 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.3 p -78.34 164.02 25.19 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.118 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -65.21 123.19 18.9 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 82.78 5.65 0.92 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.866 1.266 . . . . 0.0 111.629 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.53 160.03 20.43 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 175.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.584 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.4 tt0 -70.92 137.76 49.52 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 23.5 p -126.54 -4.0 6.63 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -173.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.73 70.74 0.02 OUTLIER Glycine 0 CA--C 1.487 -1.686 0 C-N-CA 117.295 -2.383 . . . . 0.0 114.071 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.53 167.43 14.74 Favored Glycine 0 C--N 1.294 -1.773 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 176.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.2 mt -63.63 119.61 8.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 117.746 0.773 . . . . 0.0 110.282 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.62 14.52 59.68 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.105 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -101.21 113.38 26.37 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.114 0.483 . . . . 0.0 110.142 177.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.5 p -101.15 8.44 42.71 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.171 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.26 -165.98 41.13 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.544 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.27 118.53 5.41 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.879 3.053 . . . . 0.0 112.192 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.1 p -106.87 -5.46 18.3 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.85 0.833 . . . . 0.0 111.126 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.2 t -98.02 117.46 42.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.325 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.0 m -78.2 179.18 7.05 Favored 'General case' 0 C--O 1.254 1.321 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.07 -179.14 4.43 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.646 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.1 m -72.41 121.91 20.34 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.29 19.35 36.02 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.005 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.678 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 23.6 p -140.29 142.63 35.67 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.1 p -131.63 139.87 49.24 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 123.319 0.387 . . . . 0.0 111.477 -177.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.3 t -73.05 114.14 10.88 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 120.835 0.35 . . . . 0.0 110.41 -178.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.519 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 67.4 mt-30 -111.33 123.31 49.95 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 120.876 0.37 . . . . 0.0 110.163 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.2 t -81.43 108.75 14.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.3 mt -86.27 -42.49 13.71 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -140.79 165.49 29.29 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.64 -31.17 59.86 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 120.932 1.369 . . . . 0.0 112.9 -175.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.548 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 68.9 m-85 -100.35 -26.84 13.75 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 119.051 -1.059 . . . . 0.0 110.302 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -105.7 114.01 27.92 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.961 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.584 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.2 m -123.03 134.71 54.28 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -122.32 138.28 54.57 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -172.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.678 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 9.8 t -83.02 114.48 21.3 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.419 0.628 . . . . 0.0 110.293 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.519 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 52.9 mt . . . . . 0 N--CA 1.412 -2.349 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.172 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.3 p -96.86 159.96 14.63 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.369 0.604 . . . . 0.0 112.195 -173.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -68.51 123.07 19.82 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 81.67 5.86 1.21 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.793 1.237 . . . . 0.0 112.483 -175.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.75 164.39 18.69 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 175.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.2 tt0 -71.66 137.11 47.61 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 17' ' ' THR . 10.4 p -125.9 -16.92 5.51 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -174.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.16 64.62 0.07 OUTLIER Glycine 0 CA--C 1.489 -1.568 0 C-N-CA 117.687 -2.197 . . . . 0.0 113.759 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -106.01 162.29 14.08 Favored Glycine 0 C--N 1.295 -1.731 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.215 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.4 mt -64.14 119.09 7.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.058 0.456 . . . . 0.0 109.894 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.74 -22.79 23.25 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.224 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -87.66 132.14 34.2 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 123.666 0.786 . . . . 0.0 109.109 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.9 p -131.66 17.73 4.76 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.127 0.489 . . . . 0.0 111.012 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.403 ' HA3' ' HD2' ' A' ' 16' ' ' PRO . . . -83.55 -156.97 23.7 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.435 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.403 ' HD2' ' HA3' ' A' ' 15' ' ' GLY . 9.3 Cg_endo -52.19 114.79 1.8 Allowed 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 124.11 3.206 . . . . 0.0 112.254 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.1 p -103.77 -25.61 13.04 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.663 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.0 t -81.91 111.24 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 47.2 m -68.59 156.76 37.47 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.28 158.91 19.04 Favored 'General case' 0 C--O 1.253 1.239 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.625 176.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -65.35 112.99 3.76 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.014 0.435 . . . . 0.0 110.825 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.7 -2.38 29.01 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.257 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.527 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 26.4 p -120.24 150.07 41.26 Favored 'General case' 0 C--N 1.319 -0.749 0 O-C-N 122.329 -0.512 . . . . 0.0 110.908 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.1 p -126.6 138.42 53.45 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 122.446 0.299 . . . . 0.0 111.714 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 34.4 t -75.37 117.87 17.64 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -120.12 124.6 46.19 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.72 0.771 . . . . 0.0 111.207 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.7 t -76.78 117.67 22.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.483 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.475 HD12 ' CE2' ' A' ' 32' ' ' TYR . 88.0 mt -100.05 -44.66 5.93 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -130.87 167.4 21.59 Favored Pre-proline 0 C--N 1.31 -1.132 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -64.32 -35.18 52.24 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 CA-C-N 120.998 1.392 . . . . 0.0 111.048 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.596 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 27.8 m-85 -94.05 -27.49 16.26 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 119.879 -0.728 . . . . 0.0 109.927 -178.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.475 ' CE2' HD12 ' A' ' 28' ' ' LEU . 54.5 t80 -103.99 113.95 27.84 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.654 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.1 m -129.18 123.67 32.66 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -113.69 141.59 47.05 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 123.647 0.592 . . . . 0.0 109.974 -173.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.527 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 9.0 t -85.02 121.68 28.15 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.428 -1.555 0 C-N-CA 123.829 0.852 . . . . 0.0 109.522 -176.856 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.573 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.5 p -75.15 165.24 25.52 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.531 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -69.38 127.96 34.87 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 76.37 6.91 3.51 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.276 1.431 . . . . 0.0 112.171 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.82 165.06 28.04 Favored Glycine 0 C--O 1.256 1.494 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 176.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.2 tt0 -72.94 120.27 18.33 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.591 ' O ' ' HA ' ' A' ' 17' ' ' THR . 22.1 p -100.93 -39.12 7.91 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -174.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.59 75.34 0.09 OUTLIER Glycine 0 CA--C 1.484 -1.906 0 C-N-CA 117.873 -2.108 . . . . 0.0 113.881 -173.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.52 169.08 15.84 Favored Glycine 0 C--N 1.285 -2.278 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 176.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.4 mt -61.22 127.59 21.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 117.655 0.727 . . . . 0.0 109.901 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.89 -21.65 42.53 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.11 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -79.41 116.71 19.8 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 121.05 0.453 . . . . 0.0 109.813 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 p -107.11 17.55 22.84 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.202 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.36 -176.49 51.35 Favored Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.389 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -54.04 111.3 0.66 Allowed 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 124.076 3.184 . . . . 0.0 112.627 177.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.2 p -89.09 -23.34 22.53 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.074 0.464 . . . . 0.0 111.914 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -79.81 118.69 27.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.409 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 59.8 m -73.73 171.39 13.4 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.05 -179.34 6.62 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.779 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.0 m -70.65 119.97 15.58 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.08 20.19 33.95 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 119.863 -1.16 . . . . 0.0 112.897 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.762 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 21.9 p -136.72 148.37 47.27 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.8 p -127.17 134.83 50.1 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 122.838 0.455 . . . . 0.0 111.081 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.6 t -75.25 112.57 11.67 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -118.78 127.27 53.37 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-O 121.042 0.449 . . . . 0.0 110.575 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.3 t -74.23 121.92 26.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.526 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.6 mt -101.75 -37.52 8.28 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.595 0.712 . . . . 0.0 109.466 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.444 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 52.2 m-80 -142.15 167.44 16.59 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 29' ' ' ASN . 1.8 Cg_endo -61.83 -32.47 85.6 Favored 'Trans proline' 0 C--N 1.353 0.793 0 CA-C-N 121.187 1.459 . . . . 0.0 112.762 -176.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.62 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 63.8 m-85 -100.43 -25.97 14.03 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.797 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -103.69 114.11 28.13 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.814 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.8 m -123.42 133.73 54.04 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.426 HE21 HD21 ' A' ' 36' ' ' LEU . 29.4 tt0 -120.01 142.65 48.61 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -173.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.762 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 13.4 t -86.88 118.78 26.49 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.159 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.426 HD21 HE21 ' A' ' 34' ' ' GLN . 95.5 mt . . . . . 0 C--N 1.295 -1.783 0 C-N-CA 123.687 0.795 . . . . 0.0 108.928 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.008 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 p -83.99 159.19 21.28 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -64.52 126.31 27.46 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.89 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 78.48 1.29 2.61 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.94 1.296 . . . . 0.0 113.408 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.49 164.83 24.54 Favored Glycine 0 C--O 1.254 1.352 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.608 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.0 tt0 -68.24 120.18 13.99 Favored 'General case' 0 C--O 1.207 -1.154 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 15.0 p -102.51 -29.28 11.68 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -175.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.19 65.88 0.1 Allowed Glycine 0 CA--C 1.483 -1.918 0 C-N-CA 118.415 -1.85 . . . . 0.0 112.652 -175.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.76 162.68 14.09 Favored Glycine 0 N--CA 1.429 -1.818 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 178.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.2 mt -59.47 123.34 11.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.29 -13.29 58.56 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.323 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -87.79 113.96 23.95 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.1 p -101.27 9.36 41.84 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.677 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.6 -171.68 48.34 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.411 -177.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.94 122.34 11.56 Favored 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 124.211 3.274 . . . . 0.0 111.753 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 29.1 p -101.07 -18.58 16.18 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.103 0.478 . . . . 0.0 111.558 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.0 t -79.16 113.89 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.9 m -71.91 169.48 15.76 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.7 169.39 18.32 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.409 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.4 m -58.01 121.46 10.66 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.301 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.86 -18.45 54.86 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.692 176.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.606 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 43.8 p -103.37 146.84 27.88 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 122.5 -0.412 . . . . 0.0 111.045 -176.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.2 p -127.41 144.56 51.04 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 122.144 0.177 . . . . 0.0 110.831 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -80.62 113.36 18.76 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.076 0.465 . . . . 0.0 109.855 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.429 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 78.7 mt-30 -113.54 112.89 24.32 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-O 121.198 0.523 . . . . 0.0 109.825 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -75.4 104.02 3.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' HD22 ' A' ' 29' ' ' ASN . 72.1 mt -80.3 -48.19 13.38 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.464 0.649 . . . . 0.0 109.429 -177.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.404 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -127.57 165.21 31.29 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 178.686 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 29' ' ' ASN . 3.1 Cg_exo -61.46 -37.29 72.23 Favored 'Trans proline' 0 C--O 1.246 0.894 0 CA-C-N 121.469 1.56 . . . . 0.0 112.56 -176.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.515 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 46.6 m-85 -93.06 -26.27 17.56 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.927 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -104.0 113.5 27.08 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 118.966 -1.093 . . . . 0.0 112.376 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.608 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.5 m -121.84 132.5 54.61 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 175.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -120.98 136.53 54.96 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 123.154 0.284 . . . . 0.0 110.296 -174.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.606 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 14.4 t -83.56 122.04 28.03 Favored 'General case' 0 N--CA 1.429 -1.522 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.728 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.429 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 89.8 mt . . . . . 0 C--N 1.291 -1.942 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.019 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.3 p -100.8 165.47 11.35 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.286 -175.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.472 ' CD2' ' HA ' ' A' ' 36' ' ' LEU . 14.3 t-160 -69.02 123.8 22.02 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 82.48 9.69 0.71 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.221 1.409 . . . . 0.0 112.61 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.52 158.19 19.33 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.602 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.3 tt0 -68.88 127.06 31.76 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 17' ' ' THR . 13.3 p -116.58 5.76 13.34 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -173.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.93 75.42 0.01 OUTLIER Glycine 0 CA--C 1.482 -2.012 0 C-N-CA 116.934 -2.555 . . . . 0.0 114.791 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.593 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.87 165.39 13.89 Favored Glycine 0 C--N 1.289 -2.075 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 175.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 30' ' ' PRO . 60.1 mt -61.62 127.03 20.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.95 -13.71 66.84 Favored Glycine 0 C--N 1.312 -0.788 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.052 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -101.43 114.0 27.62 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 123.191 0.596 . . . . 0.0 109.7 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.8 p -111.06 21.81 15.98 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.035 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.25 -160.95 25.94 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.995 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.27 111.05 0.48 Allowed 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.989 3.126 . . . . 0.0 112.911 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 14.6 p -105.47 -23.99 12.71 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.631 0.729 . . . . 0.0 111.436 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.9 t -85.83 120.64 36.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.6 m -79.41 163.29 24.93 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 120.972 0.415 . . . . 0.0 111.905 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.8 163.52 25.64 Favored 'General case' 0 C--O 1.253 1.247 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -65.82 117.53 8.35 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 120.963 0.411 . . . . 0.0 110.178 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.8 -19.48 25.67 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.86 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.643 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 19.8 p -103.14 147.6 26.81 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 122.445 -0.444 . . . . 0.0 109.909 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.4 p -127.47 135.26 50.16 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 122.475 0.31 . . . . 0.0 111.311 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.3 t -73.87 111.3 8.9 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.433 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 76.5 mt-30 -109.15 121.74 45.8 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-O 121.517 0.675 . . . . 0.0 109.613 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.9 t -80.14 104.31 8.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.368 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.8 mt -80.7 -44.34 18.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.863 0.84 . . . . 0.0 108.908 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -136.15 164.4 43.26 Favored Pre-proline 0 C--N 1.298 -1.655 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.463 ' O ' HG13 ' A' ' 11' ' ' ILE . 4.3 Cg_exo -64.4 -30.59 62.68 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 CA-C-N 120.554 1.234 . . . . 0.0 111.664 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.593 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 78.6 m-85 -97.77 -27.86 14.13 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 118.919 -1.113 . . . . 0.0 111.314 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.427 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 61.6 t80 -105.9 114.31 28.38 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.469 -0.892 . . . . 0.0 112.316 175.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.602 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 36.6 m -121.49 131.36 54.1 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 175.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.427 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 36.1 tt0 -120.66 138.52 53.89 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -174.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.643 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 12.0 t -85.84 123.21 30.95 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 120.364 -0.535 . . . . 0.0 110.544 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.472 ' HA ' ' CD2' ' A' ' 4' ' ' HIS . 95.6 mt . . . . . 0 C--N 1.286 -2.169 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.439 ' HB3' ' HA ' ' A' ' 19' ' ' CYS . . . . . . . . 0 N--CA 1.442 -0.854 0 CA-C-O 121.006 0.431 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.1 p -99.66 152.82 19.63 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.718 -172.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -71.77 122.73 21.18 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 77.8 2.19 2.92 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.546 1.138 . . . . 0.0 111.546 -175.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -97.28 174.16 29.51 Favored Glycine 0 N--CA 1.418 -2.522 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.608 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.2 tt0 -79.3 130.81 35.83 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.6 ' O ' ' HA ' ' A' ' 17' ' ' THR . 10.7 p -114.86 -31.8 5.99 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 113.107 0.781 . . . . 0.0 113.107 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.0 62.75 0.22 Allowed Glycine 0 CA--C 1.48 -2.117 0 C-N-CA 118.459 -1.829 . . . . 0.0 112.729 -175.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.82 162.67 14.06 Favored Glycine 0 C--N 1.29 -1.974 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.513 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 61.7 mt -65.36 119.37 9.81 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.34 -7.61 32.48 Favored Glycine 0 C--N 1.306 -1.101 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.599 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -94.86 115.59 27.66 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.1 p -104.2 6.74 35.81 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.037 0.446 . . . . 0.0 111.037 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.02 -173.29 43.6 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.199 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.48 114.47 1.96 Allowed 'Trans proline' 0 C--N 1.328 -0.535 0 C-N-CA 123.798 2.999 . . . . 0.0 111.625 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 31.7 p -87.94 -22.85 24.1 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.318 0.58 . . . . 0.0 110.945 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.5 t -72.0 117.07 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 2' ' ' ALA . 22.2 m -71.72 161.35 31.11 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.7 162.88 28.93 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.072 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.5 m -62.07 113.07 2.63 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.147 0.499 . . . . 0.0 111.775 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.55 -10.18 32.85 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.107 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.546 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 23.2 p -115.07 152.13 33.05 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 122.695 -0.297 . . . . 0.0 111.102 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.4 p -128.14 139.99 52.18 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 123.118 0.261 . . . . 0.0 110.445 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.6 t -73.66 111.69 9.05 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.845 0.355 . . . . 0.0 110.177 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.507 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 69.4 mt-30 -111.28 115.62 29.64 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-O 120.948 0.404 . . . . 0.0 110.471 -178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.4 t -71.16 110.87 4.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.2 mt -89.72 -46.6 8.5 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -131.07 168.89 15.32 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -63.91 -34.82 58.62 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 CA-C-N 120.987 1.388 . . . . 0.0 113.019 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.521 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 12.4 m-85 -102.72 -24.76 13.71 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 119.306 -0.958 . . . . 0.0 110.892 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -103.54 114.86 29.45 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.946 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.608 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 13.7 m -120.89 127.63 52.05 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 36.3 tt0 -111.94 135.88 51.99 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 123.509 0.506 . . . . 0.0 109.721 -173.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.546 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 12.3 t -85.95 115.78 23.77 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.253 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.507 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 89.3 mt . . . . . 0 N--CA 1.414 -2.237 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.305 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 p -106.32 155.75 19.2 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.311 -0.859 . . . . 0.0 113.139 -172.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -59.44 124.51 20.27 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.75 1.22 . . . . 0.0 109.836 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 71.75 10.25 6.31 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.726 1.21 . . . . 0.0 112.702 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -104.8 165.88 14.69 Favored Glycine 0 N--CA 1.42 -2.401 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 174.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.6 tt0 -70.57 128.81 37.39 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.656 ' O ' ' HA ' ' A' ' 17' ' ' THR . 16.7 p -109.72 -36.64 5.87 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.6 63.81 0.18 Allowed Glycine 0 CA--C 1.483 -1.953 0 C-N-CA 118.359 -1.877 . . . . 0.0 113.015 -174.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.77 159.92 15.09 Favored Glycine 0 C--N 1.291 -1.97 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 175.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.419 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 58.3 mt -61.4 116.23 2.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 117.774 0.787 . . . . 0.0 109.696 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.61 -11.76 21.14 Favored Glycine 0 N--CA 1.436 -1.337 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.111 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -90.99 109.19 20.42 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.7 p -92.64 5.25 51.68 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.492 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.26 -179.09 50.75 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.287 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -55.02 122.81 12.37 Favored 'Trans proline' 0 N--CA 1.479 0.647 0 C-N-CA 124.594 3.529 . . . . 0.0 112.501 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.656 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.5 p -90.98 -20.22 22.38 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.4 t -83.95 126.46 40.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.8 m -76.35 171.13 15.08 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.57 176.17 9.6 Favored 'General case' 0 C--O 1.252 1.225 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.115 177.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -62.64 119.39 9.16 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.483 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.87 6.3 58.15 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.998 -0.62 . . . . 0.0 113.471 176.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.71 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 3.0 p -131.23 150.95 51.93 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 117.196 0.498 . . . . 0.0 111.245 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.9 p -129.95 144.14 51.17 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.636 0.236 . . . . 0.0 111.636 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.8 t -79.43 107.9 12.54 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -107.91 116.31 31.72 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-O 121.522 0.677 . . . . 0.0 110.353 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.4 t -74.92 108.77 6.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.115 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.2 mt -85.22 -50.49 7.33 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -129.87 166.58 25.21 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.16 -33.69 71.46 Favored 'Trans proline' 0 C--N 1.348 0.53 0 CA-C-N 120.669 1.274 . . . . 0.0 112.804 -177.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.499 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 53.0 m-85 -98.39 -26.49 14.46 Favored 'General case' 0 N--CA 1.434 -1.268 0 C-N-CA 118.914 -1.115 . . . . 0.0 110.827 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.44 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 57.4 t80 -105.11 114.25 28.34 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 119.188 -1.005 . . . . 0.0 112.978 175.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.8 m -122.72 131.4 53.77 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 174.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.44 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 35.5 tt0 -117.82 138.83 51.82 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 123.407 0.442 . . . . 0.0 110.094 -173.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.71 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 14.4 t -84.35 115.67 22.62 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.035 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.408 HD21 ' OE1' ' A' ' 34' ' ' GLN . 97.9 mt . . . . . 0 C--N 1.286 -2.193 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.91 0 CA-C-O 120.864 0.364 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.3 p -92.77 162.86 13.96 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.66 -177.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -67.77 126.74 30.37 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 81.16 6.47 1.29 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.485 1.114 . . . . 0.0 112.699 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.78 159.7 21.61 Favored Glycine 0 N--CA 1.436 -1.309 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -70.86 126.38 29.43 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 17' ' ' THR . 6.2 p -104.23 -42.67 5.44 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -176.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.4 64.83 0.29 Allowed Glycine 0 CA--C 1.476 -2.353 0 C-N-CA 118.31 -1.9 . . . . 0.0 112.852 -172.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.34 156.2 16.77 Favored Glycine 0 N--CA 1.42 -2.415 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 177.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.578 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 62.4 mt -61.62 121.25 9.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.18 -11.79 40.36 Favored Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -100.92 116.5 32.93 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.9 p -114.49 17.07 17.56 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.08 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.56 -162.38 31.4 Favored Glycine 0 C--O 1.24 0.494 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.76 109.05 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.406 2.738 . . . . 0.0 111.579 175.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 11.1 p -95.25 -22.24 17.92 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.782 -177.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.52 119.57 35.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.7 m -73.21 170.09 15.7 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.79 162.97 25.74 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.375 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.1 m -65.03 113.17 3.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.05 0.452 . . . . 0.0 110.11 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.16 7.65 26.5 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.977 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.678 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 19.2 p -131.9 146.72 52.27 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.4 p -127.25 138.87 53.19 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 121.208 -0.197 . . . . 0.0 110.881 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.7 t -75.97 109.95 10.03 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -105.2 133.15 50.44 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-O 121.445 0.641 . . . . 0.0 111.351 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.4 t -81.48 99.59 4.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.9 mt -82.18 -40.63 21.49 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -145.01 168.46 12.05 Favored Pre-proline 0 N--CA 1.431 -1.399 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -65.16 -38.95 25.35 Favored 'Trans proline' 0 C--O 1.25 1.084 0 CA-C-N 120.403 1.18 . . . . 0.0 112.659 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.578 ' CD1' ' HB ' ' A' ' 11' ' ' ILE . 53.0 m-85 -96.1 -27.01 15.28 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.643 -176.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -104.2 114.08 28.07 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.589 -0.845 . . . . 0.0 111.418 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.5 m -125.68 130.04 50.76 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 174.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -118.56 144.63 45.95 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -172.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.678 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 10.2 t -87.54 114.46 24.17 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.086 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.5 mt . . . . . 0 N--CA 1.418 -2.058 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -177.72 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -1.68 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.5 p -93.92 166.1 12.34 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.361 0.601 . . . . 0.0 111.8 -175.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -61.89 124.07 19.77 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.067 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 80.14 6.31 1.71 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.288 1.435 . . . . 0.0 112.866 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.31 159.17 20.56 Favored Glycine 0 N--CA 1.435 -1.393 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.559 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.5 tt0 -70.66 128.94 37.8 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.2 p -120.27 8.14 10.83 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 153.38 76.21 0.02 OUTLIER Glycine 0 CA--C 1.483 -1.93 0 C-N-CA 117.292 -2.385 . . . . 0.0 114.511 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.54 166.63 14.38 Favored Glycine 0 N--CA 1.419 -2.459 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 176.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.3 mt -64.93 118.54 7.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.54 -13.92 66.3 Favored Glycine 0 C--N 1.315 -0.637 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.362 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -79.49 108.4 12.99 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.22 0.533 . . . . 0.0 110.548 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.2 p -92.24 6.94 44.88 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.222 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.44 -171.23 41.08 Favored Glycine 0 C--N 1.316 -0.569 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.647 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -49.22 131.47 26.67 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 124.556 3.504 . . . . 0.0 112.299 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.4 p -125.52 -22.32 4.31 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 51.7 t -91.1 119.53 38.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.7 m -76.45 166.01 24.01 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.397 0.618 . . . . 0.0 112.479 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.91 167.82 20.03 Favored 'General case' 0 C--O 1.255 1.374 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.004 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.2 m -70.15 119.83 14.93 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 120.964 0.412 . . . . 0.0 110.268 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.46 -16.74 29.04 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.661 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 27.1 p -109.18 146.5 34.05 Favored 'General case' 0 C--O 1.251 1.163 0 O-C-N 122.426 -0.455 . . . . 0.0 111.329 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.0 p -124.9 133.73 52.95 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.799 -177.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.0 t -76.08 111.99 12.06 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -113.71 119.01 35.93 Favored 'General case' 0 N--CA 1.406 -2.648 0 CA-C-O 121.206 0.526 . . . . 0.0 110.866 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 82.4 t -70.78 108.48 2.59 Favored 'Isoleucine or valine' 0 C--O 1.253 1.248 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.816 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.434 HD12 ' CE2' ' A' ' 32' ' ' TYR . 71.2 mt -85.61 -46.41 10.81 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -133.49 166.76 26.9 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.63 -31.17 79.51 Favored 'Trans proline' 0 C--N 1.35 0.62 0 CA-C-N 120.906 1.359 . . . . 0.0 112.347 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.566 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 92.5 m-85 -99.89 -26.28 14.06 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.757 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.434 ' CE2' HD12 ' A' ' 28' ' ' LEU . 54.2 t80 -104.85 114.12 28.14 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 119.463 -0.895 . . . . 0.0 111.819 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 26.8 m -122.32 128.94 51.66 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 176.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.552 HE21 HD21 ' A' ' 36' ' ' LEU . 29.3 tt0 -121.99 138.72 54.32 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -175.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.661 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 8.6 t -82.04 118.71 23.22 Favored 'General case' 0 N--CA 1.422 -1.854 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.937 -178.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.552 HD21 HE21 ' A' ' 34' ' ' GLN . 98.0 mt . . . . . 0 C--N 1.286 -2.194 0 C-N-CA 123.78 0.832 . . . . 0.0 109.364 -176.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.721 0 CA-C-O 121.47 0.652 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.5 p -104.86 158.38 16.57 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.767 -175.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -71.87 128.75 36.74 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 77.56 -0.78 2.76 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.084 1.354 . . . . 0.0 111.551 -176.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.14 165.83 36.3 Favored Glycine 0 N--CA 1.416 -2.638 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.62 ' HA ' ' O ' ' A' ' 33' ' ' SER . 60.7 tt0 -74.65 123.39 24.79 Favored 'General case' 0 C--O 1.199 -1.599 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 23.9 p -108.88 -5.62 16.11 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 163.41 57.53 0.02 OUTLIER Glycine 0 CA--C 1.474 -2.477 0 C-N-CA 117.717 -2.182 . . . . 0.0 112.858 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -106.3 164.13 13.62 Favored Glycine 0 N--CA 1.421 -2.358 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 176.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.0 116.87 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 117.401 0.6 . . . . 0.0 109.728 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.68 -25.5 8.5 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.422 -178.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -83.78 121.9 27.94 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.0 p -116.58 13.73 15.34 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.253 0.549 . . . . 0.0 111.194 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.04 -170.29 47.01 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.075 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -57.23 117.13 3.77 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 123.933 3.089 . . . . 0.0 110.9 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 39.5 p -93.75 -4.9 49.53 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.1 t -93.15 134.48 30.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 175.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.5 m -81.29 169.45 17.28 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -177.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.93 165.71 23.77 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.901 177.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 p -60.07 116.9 4.51 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.4 -17.26 37.15 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.031 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.637 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 41.4 p -108.87 148.94 29.86 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.61 -177.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.7 p -127.47 141.68 51.6 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 122.492 -0.13 . . . . 0.0 110.725 -178.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.1 t -79.05 113.04 16.85 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -116.58 113.41 22.69 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-O 121.305 0.574 . . . . 0.0 110.188 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.4 t -70.91 106.01 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.779 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.8 mt -87.04 -39.29 15.76 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.596 0.712 . . . . 0.0 109.397 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -141.24 167.75 16.25 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.19 -33.81 29.85 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 CA-C-N 120.917 1.363 . . . . 0.0 112.559 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.534 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 48.0 m-85 -97.32 -27.47 14.48 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 118.351 -1.34 . . . . 0.0 109.829 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.562 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 57.9 t80 -104.57 113.68 27.41 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 118.703 -1.199 . . . . 0.0 112.548 177.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.62 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.9 m -118.13 130.72 56.28 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 173.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.562 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 36.3 tt0 -116.94 140.55 49.33 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 118.057 0.39 . . . . 0.0 110.311 -173.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.637 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 18.5 t -89.09 121.91 31.89 Favored 'General case' 0 N--CA 1.416 -2.137 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.715 177.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 N--CA 1.421 -1.92 0 C-N-CA 123.975 0.91 . . . . 0.0 108.941 -179.565 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.406 ' HB3' ' HA ' ' A' ' 19' ' ' CYS . . . . . . . . 0 N--CA 1.442 -0.832 0 CA-C-O 121.321 0.582 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.438 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 13.9 p -99.83 153.26 19.29 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.919 -171.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -70.51 116.96 11.45 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.862 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 77.63 19.47 1.18 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.287 1.035 . . . . 0.0 110.864 -176.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.45 159.28 13.78 Favored Glycine 0 N--CA 1.416 -2.64 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 172.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.5 tt0 -68.44 136.15 52.8 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 177.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.608 ' O ' ' HA ' ' A' ' 17' ' ' THR . 9.5 p -122.36 -37.39 2.81 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -175.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.85 58.38 0.31 Allowed Glycine 0 CA--C 1.484 -1.88 0 C-N-CA 118.815 -1.66 . . . . 0.0 112.37 -173.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.48 155.01 17.06 Favored Glycine 0 N--CA 1.421 -2.343 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 59.6 mt -65.0 115.67 3.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.34 -12.02 14.18 Favored Glycine 0 C--N 1.297 -1.599 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.75 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -93.9 122.79 36.75 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.143 0.497 . . . . 0.0 110.076 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 p -109.28 15.38 23.19 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.551 -177.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.49 -168.93 32.78 Favored Glycine 0 C--N 1.315 -0.6 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.892 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -53.64 117.3 3.69 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.955 3.103 . . . . 0.0 112.655 177.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.608 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 19.8 p -90.04 -25.75 20.65 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 123.295 0.638 . . . . 0.0 111.648 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -83.07 118.89 31.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.406 ' HA ' ' HB3' ' A' ' 2' ' ' ALA . 60.6 m -72.05 170.69 13.34 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.48 169.31 17.86 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.622 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.7 m -64.96 114.46 4.57 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.745 0.307 . . . . 0.0 110.867 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.3 6.17 45.2 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.268 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.671 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 27.4 p -128.26 147.17 50.58 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.8 p -129.38 137.71 51.09 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.728 0.299 . . . . 0.0 110.778 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.4 t -75.58 107.5 7.77 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.453 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 78.5 mt-30 -107.38 126.01 51.93 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-O 121.391 0.615 . . . . 0.0 110.949 -176.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.5 t -77.45 110.64 13.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.934 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.1 mt -89.3 -48.51 7.31 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -132.81 168.32 18.45 Favored Pre-proline 0 C--N 1.299 -1.597 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -63.39 -40.89 29.08 Favored 'Trans proline' 0 C--O 1.253 1.258 0 CA-C-N 120.994 1.391 . . . . 0.0 113.074 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.507 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 24.3 m-85 -94.72 -26.17 16.4 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.866 -177.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -104.63 113.49 27.1 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.982 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.0 m -127.03 133.88 50.42 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.47 HE21 HD21 ' A' ' 36' ' ' LEU . 29.2 tt0 -124.1 143.03 50.7 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -172.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.671 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.2 t -85.84 121.74 28.91 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.28 0.562 . . . . 0.0 110.724 -177.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.47 HD21 HE21 ' A' ' 34' ' ' GLN . 94.5 mt . . . . . 0 C--N 1.289 -2.032 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -178.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.647 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p -88.02 143.51 27.05 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.606 -173.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -64.79 126.44 27.95 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 76.41 6.51 3.51 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.833 1.253 . . . . 0.0 111.375 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.09 164.39 18.31 Favored Glycine 0 N--CA 1.423 -2.194 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 177.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.594 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.8 tt0 -69.35 128.98 38.49 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 17' ' ' THR . 24.7 p -122.96 -8.98 8.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -173.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.34 64.47 0.04 OUTLIER Glycine 0 CA--C 1.482 -1.986 0 C-N-CA 116.855 -2.593 . . . . 0.0 114.072 -177.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.68 171.0 17.76 Favored Glycine 0 C--N 1.293 -1.841 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 175.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.8 mt -69.03 124.23 24.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.63 -1.68 60.14 Favored Glycine 0 C--N 1.305 -1.165 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.341 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -101.01 106.67 17.99 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.5 p -101.59 1.9 38.33 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.844 -176.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.77 -168.36 12.16 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.468 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -52.58 113.45 1.24 Allowed 'Trans proline' 0 N--CA 1.484 0.915 0 C-N-CA 124.183 3.255 . . . . 0.0 112.145 177.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.4 p -101.52 -30.28 11.49 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.889 0.376 . . . . 0.0 111.981 -178.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -73.79 112.29 10.22 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.249 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 54.1 m -66.93 165.2 15.96 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.17 175.62 9.49 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.006 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -66.7 115.36 6.43 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.792 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.35 9.14 58.17 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 121.251 -0.499 . . . . 0.0 112.733 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.598 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 41.2 p -122.88 148.03 45.89 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.839 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.5 p -128.66 135.12 48.85 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 123.125 0.266 . . . . 0.0 111.615 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.4 t -79.33 116.62 19.68 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.851 0.358 . . . . 0.0 110.05 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.456 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 60.0 mt-30 -114.89 114.8 25.97 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 120.778 0.323 . . . . 0.0 110.418 -177.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.4 t -70.99 118.21 15.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.456 HD12 ' CE2' ' A' ' 32' ' ' TYR . 93.7 mt -98.08 -49.28 4.8 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.282 0.563 . . . . 0.0 109.775 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.468 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 80.9 m-20 -124.25 169.11 11.25 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 178.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 29' ' ' ASN . 6.0 Cg_endo -64.14 -31.87 64.24 Favored 'Trans proline' 0 C--N 1.353 0.768 0 CA-C-N 121.404 1.537 . . . . 0.0 112.563 -177.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.491 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 51.8 m-85 -103.34 -24.51 13.5 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.159 0.504 . . . . 0.0 110.61 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.456 ' CE2' HD12 ' A' ' 28' ' ' LEU . 71.7 t80 -103.39 115.16 30.02 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 121.885 -0.509 . . . . 0.0 112.119 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.594 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.6 m -127.82 131.95 49.48 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 176.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -117.51 139.16 51.3 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -173.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.598 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.9 t -86.14 112.57 21.43 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.511 0.672 . . . . 0.0 110.566 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.456 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 43.0 mt . . . . . 0 N--CA 1.408 -2.531 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.022 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.484 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 31.4 p -89.04 172.1 9.36 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.509 -175.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -71.6 124.28 24.36 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 174.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 78.36 16.82 1.2 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.807 0.843 . . . . 0.0 111.664 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.48 153.86 17.17 Favored Glycine 0 N--CA 1.426 -1.989 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 174.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.5 tt0 -68.47 124.11 22.65 Favored 'General case' 0 C--O 1.21 -1.021 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.3 p -115.72 2.41 13.68 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.05 62.0 0.01 OUTLIER Glycine 0 CA--C 1.49 -1.53 0 C-N-CA 117.645 -2.217 . . . . 0.0 113.868 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.69 163.47 14.0 Favored Glycine 0 C--N 1.291 -1.922 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 59.8 mt -58.82 118.94 2.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 117.48 0.64 . . . . 0.0 110.492 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.4 -17.13 47.75 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.119 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -81.57 112.0 18.38 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 p -107.66 22.62 15.7 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.897 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.11 -169.22 39.37 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.367 177.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.74 122.99 12.77 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.95 3.1 . . . . 0.0 112.29 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 p -99.49 -10.06 22.59 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.437 0.637 . . . . 0.0 111.968 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.3 t -87.46 130.78 36.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.9 m -90.34 165.71 13.72 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.463 0.649 . . . . 0.0 112.106 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.71 163.99 26.72 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.459 176.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.6 m -74.34 124.29 26.2 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.62 -2.64 29.14 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -174.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.597 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 32.9 p -132.84 150.07 52.2 Favored 'General case' 0 C--O 1.248 1.017 0 O-C-N 122.763 -0.257 . . . . 0.0 111.018 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.3 p -128.64 139.51 52.22 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.6 t -77.44 116.56 18.12 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -117.74 122.63 43.97 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-O 121.259 0.552 . . . . 0.0 110.947 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.4 t -74.12 109.69 7.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.2 mt -87.3 -41.07 13.93 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -141.91 166.49 21.28 Favored Pre-proline 0 C--N 1.301 -1.535 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -62.6 -37.01 60.94 Favored 'Trans proline' 0 C--N 1.351 0.68 0 CA-C-N 121.206 1.467 . . . . 0.0 113.081 -177.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.52 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 84.6 m-85 -94.63 -27.25 15.98 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 118.501 -1.279 . . . . 0.0 110.813 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.496 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 48.1 t80 -105.52 113.93 27.79 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.416 -0.914 . . . . 0.0 112.782 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.604 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.0 m -120.24 129.13 53.92 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 174.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.496 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.9 tt0 -120.07 138.37 53.58 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -174.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.597 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.1 t -83.4 122.35 28.37 Favored 'General case' 0 N--CA 1.426 -1.661 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.839 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 N--CA 1.421 -1.881 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.024 -177.457 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.453 ' HB3' ' HA ' ' A' ' 19' ' ' CYS . . . . . . . . 0 C--O 1.243 0.749 0 CA-C-O 120.934 0.397 . . . . 0.0 109.938 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.9 p -83.94 153.64 23.81 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 114.844 -1.071 . . . . 0.0 113.069 -173.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -73.56 127.63 33.27 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 76.22 2.84 3.6 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.243 1.017 . . . . 0.0 111.471 -176.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.99 169.68 29.78 Favored Glycine 0 N--CA 1.415 -2.726 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 176.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.2 tt0 -77.36 127.34 32.4 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 18.7 p -116.09 4.47 13.67 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -174.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.51 62.85 0.01 OUTLIER Glycine 0 CA--C 1.481 -2.093 0 C-N-CA 118.085 -2.007 . . . . 0.0 113.417 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.541 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.38 161.25 14.75 Favored Glycine 0 N--CA 1.425 -2.059 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 177.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.49 119.79 5.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 117.724 0.762 . . . . 0.0 109.256 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.26 -22.13 25.46 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -81.05 117.15 21.39 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.038 0.447 . . . . 0.0 110.288 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.0 p -101.67 -0.23 34.98 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.751 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.33 -173.61 44.65 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.591 -177.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -53.33 124.34 15.45 Favored 'Trans proline' 0 N--CA 1.477 0.509 0 C-N-CA 124.435 3.423 . . . . 0.0 112.362 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.4 p -104.03 -18.97 14.36 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.17 0.509 . . . . 0.0 111.589 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.8 t -78.75 112.71 17.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.453 ' HA ' ' HB3' ' A' ' 2' ' ' ALA . 52.4 m -65.41 162.96 16.66 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.98 172.59 12.04 Favored 'General case' 0 C--O 1.254 1.334 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.086 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.5 m -67.13 119.95 12.91 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.714 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.85 19.93 35.44 Favored Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.905 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.578 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 44.4 p -138.09 148.49 45.06 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 117.038 0.419 . . . . 0.0 110.061 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.4 p -126.17 133.33 51.6 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 122.103 0.161 . . . . 0.0 110.943 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.1 t -74.25 119.82 18.99 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -119.0 120.17 36.46 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-O 121.558 0.694 . . . . 0.0 110.818 -178.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.2 t -75.24 101.21 2.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.982 177.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.441 HD12 ' CE1' ' A' ' 32' ' ' TYR . 77.3 mt -79.51 -46.23 17.79 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.454 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 93.5 m-20 -140.31 170.5 9.52 Favored Pre-proline 0 C--N 1.31 -1.138 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 29' ' ' ASN . 4.3 Cg_exo -62.88 -43.15 21.23 Favored 'Trans proline' 0 C--N 1.358 1.056 0 CA-C-N 120.763 1.308 . . . . 0.0 112.979 -178.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.541 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 89.8 m-85 -89.77 -27.18 20.19 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 118.299 -1.36 . . . . 0.0 110.021 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.441 ' CE1' HD12 ' A' ' 28' ' ' LEU . 40.0 t80 -104.05 113.91 27.78 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 118.789 -1.164 . . . . 0.0 112.503 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.3 m -127.31 123.78 37.16 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 174.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -116.64 140.59 49.23 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 123.504 0.502 . . . . 0.0 110.391 -173.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.578 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.4 t -88.81 123.25 33.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.5 mt . . . . . 0 C--N 1.296 -1.738 0 C-N-CA 123.794 0.838 . . . . 0.0 109.362 -176.556 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.444 -0.734 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 19' ' ' CYS . . . -76.8 154.11 34.27 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 4.0 p -104.69 153.12 21.66 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.22 -173.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -69.67 123.19 20.72 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 78.06 6.96 2.61 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.589 1.156 . . . . 0.0 112.002 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -103.3 167.29 16.69 Favored Glycine 0 N--CA 1.423 -2.213 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 175.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.6 tt0 -70.39 127.63 33.4 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 17' ' ' THR . 20.1 p -103.52 -39.1 6.87 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.18 76.13 0.11 Allowed Glycine 0 CA--C 1.484 -1.844 0 C-N-CA 118.392 -1.861 . . . . 0.0 113.608 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.34 169.78 16.77 Favored Glycine 0 C--N 1.291 -1.926 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 176.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.0 mt -66.95 119.49 12.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.71 -17.17 42.9 Favored Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -85.1 106.25 16.43 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.0 p -94.37 4.9 53.26 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.298 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.26 -169.8 32.65 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 115.553 -0.748 . . . . 0.0 112.692 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -59.55 114.49 2.07 Favored 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 123.592 2.861 . . . . 0.0 111.797 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.7 p -93.98 -17.12 23.27 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.539 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.8 t -88.68 120.59 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 2' ' ' ALA . 66.7 m -72.89 167.61 20.64 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.42 165.0 24.96 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.419 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.1 m -64.85 124.11 21.13 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 120.643 0.259 . . . . 0.0 110.367 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.92 -0.01 48.41 Favored Glycine 0 N--CA 1.432 -1.593 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.331 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.554 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 42.1 p -128.43 151.03 49.85 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.6 p -130.15 137.72 50.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.759 0.314 . . . . 0.0 111.679 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.1 t -74.16 114.78 12.89 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.52 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 50.0 mt-30 -121.76 117.7 27.24 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-O 121.379 0.609 . . . . 0.0 111.109 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.5 t -71.02 116.89 13.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.437 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.9 mt -97.44 -39.76 9.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.889 0.852 . . . . 0.0 108.95 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -137.7 164.32 42.07 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -62.61 -32.73 79.27 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 CA-C-N 120.865 1.344 . . . . 0.0 112.002 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.502 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 31.1 m-85 -97.77 -26.58 14.67 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 119.094 -1.042 . . . . 0.0 111.597 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.41 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 68.4 t80 -105.3 114.32 28.43 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 119.779 -0.769 . . . . 0.0 112.664 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.0 m -121.05 130.8 53.93 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 174.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.41 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 53.9 tt0 -115.06 140.78 48.78 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -173.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.554 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 13.3 t -87.12 112.96 22.44 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.593 178.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.52 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 81.3 mt . . . . . 0 C--N 1.278 -2.532 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.8 p . . . . . 0 C--O 1.25 1.079 0 CA-C-O 120.657 0.265 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.33 143.69 44.8 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 176.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.8 p -98.09 153.51 18.38 Favored 'General case' 0 C--N 1.272 -2.78 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.146 -172.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -65.35 122.51 17.31 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 79.34 12.26 1.26 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.815 1.246 . . . . 0.0 111.416 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -107.56 168.05 13.86 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.5 tt0 -77.31 122.4 25.05 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.59 ' O ' ' HA ' ' A' ' 17' ' ' THR . 7.2 p -104.97 -37.01 7.13 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.32 68.13 0.12 Allowed Glycine 0 CA--C 1.474 -2.53 0 C-N-CA 118.052 -2.023 . . . . 0.0 113.127 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.84 165.75 13.99 Favored Glycine 0 C--N 1.284 -2.316 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.0 mt -62.21 126.71 20.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.92 -11.52 57.49 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.88 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -100.9 126.6 47.53 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.8 p -119.26 14.48 12.99 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.491 0.663 . . . . 0.0 111.661 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.88 -155.86 16.12 Favored Glycine 0 C--O 1.258 1.644 0 CA-C-N 115.954 -0.566 . . . . 0.0 113.086 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -56.27 104.94 0.15 Allowed 'Trans proline' 0 C--O 1.222 -0.277 0 C-N-CA 123.854 3.036 . . . . 0.0 113.372 174.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.0 p -87.79 -15.76 36.0 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.55 0.691 . . . . 0.0 110.776 177.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.8 t -88.09 122.94 40.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.069 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.415 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 56.6 m -79.22 175.3 10.71 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.344 0.592 . . . . 0.0 112.274 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.74 163.4 24.52 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.2 m -64.64 122.95 18.04 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.77 5.76 54.97 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.433 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.568 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 40.0 p -128.28 149.21 50.59 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.3 p -130.61 138.7 50.24 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 117.793 0.269 . . . . 0.0 111.275 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.7 t -72.98 111.42 8.07 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -109.6 133.09 53.52 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-O 121.292 0.568 . . . . 0.0 110.515 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.6 t -83.83 105.93 13.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.646 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.1 mt -87.41 -38.36 16.22 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.981 0.896 . . . . 0.0 108.691 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -144.51 167.77 14.09 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -64.45 -41.71 19.39 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 CA-C-N 120.807 1.324 . . . . 0.0 112.101 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.507 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 17.7 m-85 -91.97 -26.44 18.4 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.628 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -104.76 113.24 26.7 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.875 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.4 m -121.89 130.01 53.01 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 174.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.453 HE21 HD21 ' A' ' 36' ' ' LEU . 29.9 tt0 -119.94 139.01 53.1 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -173.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.568 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 9.7 t -81.03 117.08 21.32 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-O 121.502 0.668 . . . . 0.0 110.093 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.453 HD21 HE21 ' A' ' 34' ' ' GLN . 97.1 mt . . . . . 0 N--CA 1.405 -2.678 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 19' ' ' CYS . . . -79.28 125.23 29.21 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 99.8 p -86.71 166.79 15.02 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.705 -175.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -70.89 123.87 23.02 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 78.53 11.69 1.66 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.059 0.944 . . . . 0.0 112.493 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.37 160.83 19.06 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 174.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.3 tt0 -73.79 121.63 21.15 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 17' ' ' THR . 6.8 p -103.53 -44.15 5.2 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -174.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.35 68.15 0.24 Allowed Glycine 0 CA--C 1.476 -2.377 0 C-N-CA 118.183 -1.96 . . . . 0.0 113.559 -171.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.593 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -104.73 160.15 15.61 Favored Glycine 0 C--N 1.279 -2.626 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.3 mt -62.51 122.83 14.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.33 -14.85 50.97 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.045 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -92.01 116.45 28.93 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 p -111.63 21.25 16.31 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.41 0.624 . . . . 0.0 111.675 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.413 ' HA3' ' HD2' ' A' ' 16' ' ' PRO . . . -84.76 -153.87 20.02 Favored Glycine 0 C--O 1.252 1.241 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.975 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.413 ' HD2' ' HA3' ' A' ' 15' ' ' GLY . 30.2 Cg_endo -61.77 110.56 0.99 Allowed 'Trans proline' 0 C--N 1.328 -0.523 0 C-N-CA 123.889 3.059 . . . . 0.0 111.871 174.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.587 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 62.7 p -96.31 -20.94 18.13 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.745 0.783 . . . . 0.0 110.524 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.7 t -82.04 118.46 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.092 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.42 ' HA ' ' HB3' ' A' ' 2' ' ' ALA . 59.3 m -77.21 164.09 25.93 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 120.991 0.424 . . . . 0.0 111.72 177.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.46 153.85 37.36 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.7 m -60.88 121.03 11.34 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.41 0.624 . . . . 0.0 111.22 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.22 -20.84 23.07 Favored Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.554 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.536 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 35.3 p -105.65 146.55 29.56 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 122.278 -0.542 . . . . 0.0 110.101 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.1 p -124.85 134.16 52.83 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 122.352 0.261 . . . . 0.0 110.784 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.5 t -73.11 112.91 9.58 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -116.82 132.65 56.64 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-O 121.246 0.546 . . . . 0.0 111.116 -177.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.3 t -75.22 117.01 18.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.783 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 32.8 mt -93.87 -48.47 6.27 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.468 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 81.1 m-20 -131.18 167.67 20.66 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 29' ' ' ASN . 1.6 Cg_endo -60.9 -33.34 92.69 Favored 'Trans proline' 0 C--N 1.359 1.13 0 CA-C-N 121.335 1.513 . . . . 0.0 113.167 -176.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.593 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 82.4 m-85 -99.95 -25.21 14.4 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.239 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -103.57 113.83 27.63 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.583 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.7 m -120.93 132.04 54.71 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 175.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -119.98 139.76 51.98 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -174.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.536 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 9.9 t -84.87 121.38 27.65 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.201 -177.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 N--CA 1.422 -1.833 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 -176.923 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.509 ' H61' ' O3 ' ' A' ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.5 p . . . . . 0 N--CA 1.443 -0.81 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.46 130.89 34.48 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.6 p -85.37 163.73 18.37 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.996 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -65.95 124.41 22.46 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 81.26 9.62 0.96 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.146 1.378 . . . . 0.0 112.114 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.07 164.65 20.53 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 33' ' ' SER . 61.5 tt0 -75.6 125.25 28.66 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 17' ' ' THR . 24.5 p -112.75 1.72 15.75 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -172.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.18 73.98 0.01 OUTLIER Glycine 0 CA--C 1.487 -1.68 0 C-N-CA 116.695 -2.669 . . . . 0.0 114.895 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -94.96 165.04 25.28 Favored Glycine 0 N--CA 1.423 -2.218 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 176.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.5 mt -62.05 115.91 2.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 121.206 0.527 . . . . 0.0 110.805 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.96 1.19 70.51 Favored Glycine 0 C--N 1.312 -0.796 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.039 -178.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -100.11 106.84 18.61 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.9 p -101.99 18.8 19.75 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.954 -176.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.97 -161.14 16.06 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.95 114.02 1.43 Allowed 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 123.526 2.817 . . . . 0.0 111.783 175.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 12.9 p -110.69 -30.3 7.65 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.501 0.667 . . . . 0.0 111.499 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.5 t -79.7 128.51 38.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.8 m -88.65 174.02 8.28 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.22 0.533 . . . . 0.0 112.348 -177.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.66 169.66 12.49 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.781 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.4 m -63.64 113.09 3.13 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.78 9.57 32.44 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.164 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.631 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 21.4 p -132.13 149.12 52.48 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-N 117.451 0.626 . . . . 0.0 110.595 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.8 p -128.34 139.04 52.61 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.466 0.175 . . . . 0.0 111.393 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.3 t -76.57 117.86 18.64 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -118.65 128.29 54.39 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-O 121.368 0.604 . . . . 0.0 110.936 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -79.23 114.25 19.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.272 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.6 mt -95.87 -44.49 7.37 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -136.71 167.61 20.54 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -63.91 -42.46 19.37 Favored 'Trans proline' 0 C--O 1.241 0.639 0 CA-C-N 120.99 1.389 . . . . 0.0 112.577 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.62 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 76.8 m-85 -92.06 -24.81 19.05 Favored 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.412 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -104.66 113.83 27.66 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.568 -0.853 . . . . 0.0 112.273 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 35.1 m -122.55 134.83 54.53 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 174.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -122.09 140.97 51.88 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -174.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.631 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 10.4 t -84.82 114.57 22.18 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.0 mt . . . . . 0 C--N 1.283 -2.298 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -176.528 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.464 ' H61' ' O3 ' ' A' ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.413 ' O ' ' H5 ' ' A' ' 101' ' ' MAN . 4.0 m . . . . . 0 N--CA 1.447 -0.616 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.46 112.46 15.52 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.9 p -83.87 153.93 23.73 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.558 -173.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -61.94 119.34 8.65 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 85.1 3.45 0.65 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.29 1.436 . . . . 0.0 112.743 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.81 165.16 22.02 Favored Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -73.35 128.76 36.39 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 17' ' ' THR . 14.5 p -107.2 -45.76 4.04 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -175.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.09 74.75 0.14 Allowed Glycine 0 CA--C 1.488 -1.62 0 C-N-CA 118.265 -1.921 . . . . 0.0 114.427 -173.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.76 164.57 13.89 Favored Glycine 0 C--N 1.295 -1.739 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 175.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.41 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 53.3 mt -61.74 120.37 7.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 117.29 0.545 . . . . 0.0 110.252 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.47 -7.85 51.26 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.5 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -100.79 106.65 18.07 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.3 p -104.33 28.27 7.03 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.583 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.44 -163.67 39.26 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -59.16 111.71 1.0 Allowed 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.399 2.733 . . . . 0.0 111.476 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 36.3 p -99.39 -11.0 21.55 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.172 0.51 . . . . 0.0 111.791 -178.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.6 t -85.23 120.52 35.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 57.0 m -84.52 158.65 20.91 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.35 0.595 . . . . 0.0 112.382 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.39 172.62 11.58 Favored 'General case' 0 C--O 1.251 1.136 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.884 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.5 m -64.86 112.55 3.32 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 123.196 0.598 . . . . 0.0 110.95 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.19 -4.14 38.14 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.44 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.649 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 37.5 p -117.65 147.39 42.94 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.041 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.0 p -129.77 140.62 51.02 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 123.1 0.25 . . . . 0.0 110.795 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -75.14 102.86 5.09 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 121.054 0.454 . . . . 0.0 110.34 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.43 HE21 ' HB2' ' A' ' 36' ' ' LEU . 44.3 mt-30 -101.02 124.01 46.09 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-O 121.96 0.886 . . . . 0.0 112.388 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.3 t -77.91 112.93 16.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 114.176 -1.375 . . . . 0.0 108.688 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.45 HD12 ' CE1' ' A' ' 32' ' ' TYR . 89.0 mt -94.14 -39.62 10.48 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -141.08 169.15 12.1 Favored Pre-proline 0 C--N 1.297 -1.701 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.9 -36.31 39.86 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 CA-C-N 121.24 1.479 . . . . 0.0 113.144 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.584 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 31.0 m-85 -98.94 -25.6 14.54 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.059 -176.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.45 ' CE1' HD12 ' A' ' 28' ' ' LEU . 67.7 t80 -104.04 114.12 28.15 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.116 0.484 . . . . 0.0 111.639 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 m -126.35 132.31 51.62 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 175.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -119.89 139.34 52.55 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.649 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.0 t -82.7 115.67 21.73 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.837 -178.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.43 ' HB2' HE21 ' A' ' 26' ' ' GLN . 77.4 mt . . . . . 0 N--CA 1.418 -2.075 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.413 ' H5 ' ' O ' ' A' ' 1' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.441 -0.897 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.77 145.19 34.53 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.1 p -101.99 155.26 18.28 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.557 -171.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -66.92 125.19 25.17 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 81.07 -0.4 1.75 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.909 1.283 . . . . 0.0 111.612 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -96.17 172.14 28.99 Favored Glycine 0 N--CA 1.428 -1.853 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.586 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.1 tt0 -78.57 130.61 36.14 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 17' ' ' THR . 21.4 p -113.6 -25.83 8.54 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -175.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.2 65.96 0.09 OUTLIER Glycine 0 CA--C 1.489 -1.575 0 C-N-CA 118.273 -1.918 . . . . 0.0 113.431 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.79 165.33 13.92 Favored Glycine 0 C--N 1.298 -1.574 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 176.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.8 mt -60.17 117.77 2.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 117.341 0.57 . . . . 0.0 109.896 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.6 -2.96 57.47 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.349 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -92.52 108.42 19.96 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 p -104.81 26.43 9.18 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.426 -177.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.98 -169.44 33.59 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.327 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -58.14 126.39 21.41 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.901 3.067 . . . . 0.0 111.311 176.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 4.9 p -102.61 -21.14 14.2 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.064 -176.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.7 t -81.71 121.33 34.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.4 m -75.64 174.48 9.7 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.14 165.05 17.76 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.481 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.2 m -58.1 115.29 2.81 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 123.17 0.588 . . . . 0.0 111.271 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.84 -14.25 37.95 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.613 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.596 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 34.3 p -111.97 148.4 33.86 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 122.477 -0.425 . . . . 0.0 111.433 -177.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.4 p -126.63 139.35 53.24 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.1 t -74.08 110.62 8.51 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.449 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 76.3 mt-30 -111.07 119.42 38.96 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-O 121.468 0.652 . . . . 0.0 110.189 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.7 t -78.42 109.69 13.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.162 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.485 HD12 ' CE2' ' A' ' 32' ' ' TYR . 76.0 mt -88.79 -51.36 5.69 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -125.55 167.15 17.38 Favored Pre-proline 0 C--N 1.291 -1.964 0 N-CA-C 105.026 -2.212 . . . . 0.0 105.026 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -65.4 -33.59 46.84 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 CA-C-N 120.799 1.321 . . . . 0.0 111.188 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.475 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 6.7 m-85 -94.6 -27.45 15.9 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.27 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.485 ' CE2' HD12 ' A' ' 28' ' ' LEU . 52.9 t80 -105.27 114.01 27.94 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.264 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.586 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.5 m -126.39 127.69 45.86 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 175.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 31.8 tt0 -116.94 137.95 51.87 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 123.416 0.447 . . . . 0.0 110.209 -174.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.596 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 14.9 t -84.22 121.91 28.14 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 119.819 -0.753 . . . . 0.0 109.493 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.449 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 97.2 mt . . . . . 0 C--N 1.294 -1.818 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.3 p . . . . . 0 N--CA 1.443 -0.784 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.04 111.37 18.14 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.3 p -78.34 164.02 25.19 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.118 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -65.21 123.19 18.9 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 82.78 5.65 0.92 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.866 1.266 . . . . 0.0 111.629 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.53 160.03 20.43 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 175.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.584 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.4 tt0 -70.92 137.76 49.52 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 23.5 p -126.54 -4.0 6.63 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -173.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.73 70.74 0.02 OUTLIER Glycine 0 CA--C 1.487 -1.686 0 C-N-CA 117.295 -2.383 . . . . 0.0 114.071 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.53 167.43 14.74 Favored Glycine 0 C--N 1.294 -1.773 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 176.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.2 mt -63.63 119.61 8.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 117.746 0.773 . . . . 0.0 110.282 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.62 14.52 59.68 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.105 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -101.21 113.38 26.37 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.114 0.483 . . . . 0.0 110.142 177.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.5 p -101.15 8.44 42.71 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.171 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.26 -165.98 41.13 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.544 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.27 118.53 5.41 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.879 3.053 . . . . 0.0 112.192 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.1 p -106.87 -5.46 18.3 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.85 0.833 . . . . 0.0 111.126 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.2 t -98.02 117.46 42.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.325 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.0 m -78.2 179.18 7.05 Favored 'General case' 0 C--O 1.254 1.321 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.07 -179.14 4.43 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.646 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.1 m -72.41 121.91 20.34 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.29 19.35 36.02 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.005 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.678 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 23.6 p -140.29 142.63 35.67 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.1 p -131.63 139.87 49.24 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 123.319 0.387 . . . . 0.0 111.477 -177.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.3 t -73.05 114.14 10.88 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 120.835 0.35 . . . . 0.0 110.41 -178.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.519 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 67.4 mt-30 -111.33 123.31 49.95 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 120.876 0.37 . . . . 0.0 110.163 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.2 t -81.43 108.75 14.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.3 mt -86.27 -42.49 13.71 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -140.79 165.49 29.29 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.64 -31.17 59.86 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 120.932 1.369 . . . . 0.0 112.9 -175.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.548 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 68.9 m-85 -100.35 -26.84 13.75 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 119.051 -1.059 . . . . 0.0 110.302 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -105.7 114.01 27.92 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.961 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.584 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.2 m -123.03 134.71 54.28 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -122.32 138.28 54.57 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -172.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.678 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 9.8 t -83.02 114.48 21.3 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.419 0.628 . . . . 0.0 110.293 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.519 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 52.9 mt . . . . . 0 N--CA 1.412 -2.349 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.449 -0.48 0 CA-C-O 120.477 0.179 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.03 140.15 36.65 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.3 p -96.86 159.96 14.63 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.369 0.604 . . . . 0.0 112.195 -173.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -68.51 123.07 19.82 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 81.67 5.86 1.21 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.793 1.237 . . . . 0.0 112.483 -175.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.75 164.39 18.69 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 175.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.2 tt0 -71.66 137.11 47.61 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 17' ' ' THR . 10.4 p -125.9 -16.92 5.51 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -174.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.16 64.62 0.07 OUTLIER Glycine 0 CA--C 1.489 -1.568 0 C-N-CA 117.687 -2.197 . . . . 0.0 113.759 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -106.01 162.29 14.08 Favored Glycine 0 C--N 1.295 -1.731 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.215 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.4 mt -64.14 119.09 7.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.058 0.456 . . . . 0.0 109.894 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.74 -22.79 23.25 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.224 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -87.66 132.14 34.2 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 123.666 0.786 . . . . 0.0 109.109 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.9 p -131.66 17.73 4.76 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.127 0.489 . . . . 0.0 111.012 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.403 ' HA3' ' HD2' ' A' ' 16' ' ' PRO . . . -83.55 -156.97 23.7 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.435 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.403 ' HD2' ' HA3' ' A' ' 15' ' ' GLY . 9.3 Cg_endo -52.19 114.79 1.8 Allowed 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 124.11 3.206 . . . . 0.0 112.254 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.1 p -103.77 -25.61 13.04 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.663 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.0 t -81.91 111.24 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 47.2 m -68.59 156.76 37.47 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.28 158.91 19.04 Favored 'General case' 0 C--O 1.253 1.239 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.625 176.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -65.35 112.99 3.76 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.014 0.435 . . . . 0.0 110.825 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.7 -2.38 29.01 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.257 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.527 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 26.4 p -120.24 150.07 41.26 Favored 'General case' 0 C--N 1.319 -0.749 0 O-C-N 122.329 -0.512 . . . . 0.0 110.908 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.1 p -126.6 138.42 53.45 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 122.446 0.299 . . . . 0.0 111.714 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 34.4 t -75.37 117.87 17.64 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -120.12 124.6 46.19 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.72 0.771 . . . . 0.0 111.207 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.7 t -76.78 117.67 22.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.483 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.475 HD12 ' CE2' ' A' ' 32' ' ' TYR . 88.0 mt -100.05 -44.66 5.93 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -130.87 167.4 21.59 Favored Pre-proline 0 C--N 1.31 -1.132 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -64.32 -35.18 52.24 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 CA-C-N 120.998 1.392 . . . . 0.0 111.048 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.596 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 27.8 m-85 -94.05 -27.49 16.26 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 119.879 -0.728 . . . . 0.0 109.927 -178.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.475 ' CE2' HD12 ' A' ' 28' ' ' LEU . 54.5 t80 -103.99 113.95 27.84 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.654 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.1 m -129.18 123.67 32.66 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -113.69 141.59 47.05 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 123.647 0.592 . . . . 0.0 109.974 -173.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.527 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 9.0 t -85.02 121.68 28.15 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.428 -1.555 0 C-N-CA 123.829 0.852 . . . . 0.0 109.522 -176.856 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 26.6 p . . . . . 0 N--CA 1.441 -0.878 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.31 120.15 23.99 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.5 p -75.15 165.24 25.52 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.531 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -69.38 127.96 34.87 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 76.37 6.91 3.51 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.276 1.431 . . . . 0.0 112.171 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.82 165.06 28.04 Favored Glycine 0 C--O 1.256 1.494 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 176.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.2 tt0 -72.94 120.27 18.33 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.591 ' O ' ' HA ' ' A' ' 17' ' ' THR . 22.1 p -100.93 -39.12 7.91 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -174.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.59 75.34 0.09 OUTLIER Glycine 0 CA--C 1.484 -1.906 0 C-N-CA 117.873 -2.108 . . . . 0.0 113.881 -173.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.52 169.08 15.84 Favored Glycine 0 C--N 1.285 -2.278 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 176.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.4 mt -61.22 127.59 21.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 117.655 0.727 . . . . 0.0 109.901 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.89 -21.65 42.53 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.11 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -79.41 116.71 19.8 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 121.05 0.453 . . . . 0.0 109.813 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 p -107.11 17.55 22.84 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.202 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.36 -176.49 51.35 Favored Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.389 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -54.04 111.3 0.66 Allowed 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 124.076 3.184 . . . . 0.0 112.627 177.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.2 p -89.09 -23.34 22.53 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.074 0.464 . . . . 0.0 111.914 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -79.81 118.69 27.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.409 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 59.8 m -73.73 171.39 13.4 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.05 -179.34 6.62 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.779 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.0 m -70.65 119.97 15.58 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.08 20.19 33.95 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 119.863 -1.16 . . . . 0.0 112.897 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.762 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 21.9 p -136.72 148.37 47.27 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.8 p -127.17 134.83 50.1 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 122.838 0.455 . . . . 0.0 111.081 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.6 t -75.25 112.57 11.67 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -118.78 127.27 53.37 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-O 121.042 0.449 . . . . 0.0 110.575 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.3 t -74.23 121.92 26.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.526 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.6 mt -101.75 -37.52 8.28 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.595 0.712 . . . . 0.0 109.466 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.444 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 52.2 m-80 -142.15 167.44 16.59 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 29' ' ' ASN . 1.8 Cg_endo -61.83 -32.47 85.6 Favored 'Trans proline' 0 C--N 1.353 0.793 0 CA-C-N 121.187 1.459 . . . . 0.0 112.762 -176.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.62 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 63.8 m-85 -100.43 -25.97 14.03 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.797 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -103.69 114.11 28.13 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.814 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.8 m -123.42 133.73 54.04 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.426 HE21 HD21 ' A' ' 36' ' ' LEU . 29.4 tt0 -120.01 142.65 48.61 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -173.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.762 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 13.4 t -86.88 118.78 26.49 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.159 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.426 HD21 HE21 ' A' ' 34' ' ' GLN . 95.5 mt . . . . . 0 C--N 1.295 -1.783 0 C-N-CA 123.687 0.795 . . . . 0.0 108.928 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.666 ' O ' ' H5 ' ' A' ' 101' ' ' MAN . 18.3 p . . . . . 0 N--CA 1.441 -0.882 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.9 129.55 40.29 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 p -83.99 159.19 21.28 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -64.52 126.31 27.46 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.89 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 78.48 1.29 2.61 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.94 1.296 . . . . 0.0 113.408 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.49 164.83 24.54 Favored Glycine 0 C--O 1.254 1.352 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.608 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.0 tt0 -68.24 120.18 13.99 Favored 'General case' 0 C--O 1.207 -1.154 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 15.0 p -102.51 -29.28 11.68 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -175.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.19 65.88 0.1 Allowed Glycine 0 CA--C 1.483 -1.918 0 C-N-CA 118.415 -1.85 . . . . 0.0 112.652 -175.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.76 162.68 14.09 Favored Glycine 0 N--CA 1.429 -1.818 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 178.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.2 mt -59.47 123.34 11.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.29 -13.29 58.56 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.323 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -87.79 113.96 23.95 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.1 p -101.27 9.36 41.84 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.677 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.6 -171.68 48.34 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.411 -177.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.94 122.34 11.56 Favored 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 124.211 3.274 . . . . 0.0 111.753 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 29.1 p -101.07 -18.58 16.18 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.103 0.478 . . . . 0.0 111.558 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.0 t -79.16 113.89 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.9 m -71.91 169.48 15.76 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.7 169.39 18.32 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.409 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.4 m -58.01 121.46 10.66 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.301 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.86 -18.45 54.86 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.692 176.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.606 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 43.8 p -103.37 146.84 27.88 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 122.5 -0.412 . . . . 0.0 111.045 -176.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.2 p -127.41 144.56 51.04 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 122.144 0.177 . . . . 0.0 110.831 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -80.62 113.36 18.76 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.076 0.465 . . . . 0.0 109.855 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.429 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 78.7 mt-30 -113.54 112.89 24.32 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-O 121.198 0.523 . . . . 0.0 109.825 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -75.4 104.02 3.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' HD22 ' A' ' 29' ' ' ASN . 72.1 mt -80.3 -48.19 13.38 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.464 0.649 . . . . 0.0 109.429 -177.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.404 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -127.57 165.21 31.29 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 178.686 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 29' ' ' ASN . 3.1 Cg_exo -61.46 -37.29 72.23 Favored 'Trans proline' 0 C--O 1.246 0.894 0 CA-C-N 121.469 1.56 . . . . 0.0 112.56 -176.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.515 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 46.6 m-85 -93.06 -26.27 17.56 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.927 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -104.0 113.5 27.08 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 118.966 -1.093 . . . . 0.0 112.376 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.608 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.5 m -121.84 132.5 54.61 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 175.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -120.98 136.53 54.96 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 123.154 0.284 . . . . 0.0 110.296 -174.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.606 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 14.4 t -83.56 122.04 28.03 Favored 'General case' 0 N--CA 1.429 -1.522 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.728 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.429 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 89.8 mt . . . . . 0 C--N 1.291 -1.942 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.666 ' H5 ' ' O ' ' A' ' 1' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.244 0.766 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.57 139.28 32.22 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.3 p -100.8 165.47 11.35 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.286 -175.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.472 ' CD2' ' HA ' ' A' ' 36' ' ' LEU . 14.3 t-160 -69.02 123.8 22.02 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 82.48 9.69 0.71 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.221 1.409 . . . . 0.0 112.61 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.491 ' HA3' ' H3 ' ' A' ' 101' ' ' MAN . . . -100.52 158.19 19.33 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 175.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.602 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.3 tt0 -68.88 127.06 31.76 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 17' ' ' THR . 13.3 p -116.58 5.76 13.34 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -173.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.93 75.42 0.01 OUTLIER Glycine 0 CA--C 1.482 -2.012 0 C-N-CA 116.934 -2.555 . . . . 0.0 114.791 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.593 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.87 165.39 13.89 Favored Glycine 0 C--N 1.289 -2.075 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 175.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 30' ' ' PRO . 60.1 mt -61.62 127.03 20.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.95 -13.71 66.84 Favored Glycine 0 C--N 1.312 -0.788 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.052 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -101.43 114.0 27.62 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 123.191 0.596 . . . . 0.0 109.7 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.8 p -111.06 21.81 15.98 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.035 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.25 -160.95 25.94 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.995 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.27 111.05 0.48 Allowed 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.989 3.126 . . . . 0.0 112.911 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 14.6 p -105.47 -23.99 12.71 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.631 0.729 . . . . 0.0 111.436 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.9 t -85.83 120.64 36.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.6 m -79.41 163.29 24.93 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 120.972 0.415 . . . . 0.0 111.905 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.8 163.52 25.64 Favored 'General case' 0 C--O 1.253 1.247 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -65.82 117.53 8.35 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 120.963 0.411 . . . . 0.0 110.178 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.8 -19.48 25.67 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.86 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.643 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 19.8 p -103.14 147.6 26.81 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 122.445 -0.444 . . . . 0.0 109.909 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.4 p -127.47 135.26 50.16 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 122.475 0.31 . . . . 0.0 111.311 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.3 t -73.87 111.3 8.9 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.433 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 76.5 mt-30 -109.15 121.74 45.8 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-O 121.517 0.675 . . . . 0.0 109.613 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.9 t -80.14 104.31 8.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.368 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.8 mt -80.7 -44.34 18.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.863 0.84 . . . . 0.0 108.908 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -136.15 164.4 43.26 Favored Pre-proline 0 C--N 1.298 -1.655 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.463 ' O ' HG13 ' A' ' 11' ' ' ILE . 4.3 Cg_exo -64.4 -30.59 62.68 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 CA-C-N 120.554 1.234 . . . . 0.0 111.664 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.593 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 78.6 m-85 -97.77 -27.86 14.13 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 118.919 -1.113 . . . . 0.0 111.314 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.427 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 61.6 t80 -105.9 114.31 28.38 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.469 -0.892 . . . . 0.0 112.316 175.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.602 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 36.6 m -121.49 131.36 54.1 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 175.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.427 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 36.1 tt0 -120.66 138.52 53.89 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -174.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.643 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 12.0 t -85.84 123.21 30.95 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 120.364 -0.535 . . . . 0.0 110.544 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.472 ' HA ' ' CD2' ' A' ' 4' ' ' HIS . 95.6 mt . . . . . 0 C--N 1.286 -2.169 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.491 ' H3 ' ' HA3' ' A' ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.3 p . . . . . 0 C--O 1.237 0.419 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.439 ' HB3' ' HA ' ' A' ' 19' ' ' CYS . . . -69.84 153.96 42.61 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.006 0.431 . . . . 0.0 110.509 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.1 p -99.66 152.82 19.63 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.718 -172.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -71.77 122.73 21.18 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 77.8 2.19 2.92 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.546 1.138 . . . . 0.0 111.546 -175.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.56 ' HA3' ' H2 ' ' A' ' 101' ' ' MAN . . . -97.28 174.16 29.51 Favored Glycine 0 N--CA 1.418 -2.522 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.608 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.2 tt0 -79.3 130.81 35.83 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.6 ' O ' ' HA ' ' A' ' 17' ' ' THR . 10.7 p -114.86 -31.8 5.99 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 113.107 0.781 . . . . 0.0 113.107 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.0 62.75 0.22 Allowed Glycine 0 CA--C 1.48 -2.117 0 C-N-CA 118.459 -1.829 . . . . 0.0 112.729 -175.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.82 162.67 14.06 Favored Glycine 0 C--N 1.29 -1.974 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.513 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 61.7 mt -65.36 119.37 9.81 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.34 -7.61 32.48 Favored Glycine 0 C--N 1.306 -1.101 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.599 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -94.86 115.59 27.66 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.1 p -104.2 6.74 35.81 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.037 0.446 . . . . 0.0 111.037 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.02 -173.29 43.6 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.199 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.48 114.47 1.96 Allowed 'Trans proline' 0 C--N 1.328 -0.535 0 C-N-CA 123.798 2.999 . . . . 0.0 111.625 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 31.7 p -87.94 -22.85 24.1 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.318 0.58 . . . . 0.0 110.945 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.5 t -72.0 117.07 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 2' ' ' ALA . 22.2 m -71.72 161.35 31.11 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.7 162.88 28.93 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.072 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.5 m -62.07 113.07 2.63 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.147 0.499 . . . . 0.0 111.775 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.55 -10.18 32.85 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.107 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.546 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 23.2 p -115.07 152.13 33.05 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 122.695 -0.297 . . . . 0.0 111.102 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.4 p -128.14 139.99 52.18 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 123.118 0.261 . . . . 0.0 110.445 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.6 t -73.66 111.69 9.05 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.845 0.355 . . . . 0.0 110.177 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.507 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 69.4 mt-30 -111.28 115.62 29.64 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-O 120.948 0.404 . . . . 0.0 110.471 -178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.4 t -71.16 110.87 4.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.2 mt -89.72 -46.6 8.5 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -131.07 168.89 15.32 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -63.91 -34.82 58.62 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 CA-C-N 120.987 1.388 . . . . 0.0 113.019 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.521 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 12.4 m-85 -102.72 -24.76 13.71 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 119.306 -0.958 . . . . 0.0 110.892 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -103.54 114.86 29.45 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.946 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.608 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 13.7 m -120.89 127.63 52.05 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 36.3 tt0 -111.94 135.88 51.99 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 123.509 0.506 . . . . 0.0 109.721 -173.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.546 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 12.3 t -85.95 115.78 23.77 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.253 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.507 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 89.3 mt . . . . . 0 N--CA 1.414 -2.237 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.56 ' H2 ' ' HA3' ' A' ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.44 -0.959 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.14 144.41 27.51 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 p -106.32 155.75 19.2 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.311 -0.859 . . . . 0.0 113.139 -172.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -59.44 124.51 20.27 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.75 1.22 . . . . 0.0 109.836 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 71.75 10.25 6.31 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.726 1.21 . . . . 0.0 112.702 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -104.8 165.88 14.69 Favored Glycine 0 N--CA 1.42 -2.401 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 174.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.6 tt0 -70.57 128.81 37.39 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.656 ' O ' ' HA ' ' A' ' 17' ' ' THR . 16.7 p -109.72 -36.64 5.87 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.6 63.81 0.18 Allowed Glycine 0 CA--C 1.483 -1.953 0 C-N-CA 118.359 -1.877 . . . . 0.0 113.015 -174.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.77 159.92 15.09 Favored Glycine 0 C--N 1.291 -1.97 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 175.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.419 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 58.3 mt -61.4 116.23 2.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 117.774 0.787 . . . . 0.0 109.696 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.61 -11.76 21.14 Favored Glycine 0 N--CA 1.436 -1.337 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.111 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -90.99 109.19 20.42 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.7 p -92.64 5.25 51.68 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.492 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.26 -179.09 50.75 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.287 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -55.02 122.81 12.37 Favored 'Trans proline' 0 N--CA 1.479 0.647 0 C-N-CA 124.594 3.529 . . . . 0.0 112.501 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.656 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.5 p -90.98 -20.22 22.38 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.4 t -83.95 126.46 40.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.8 m -76.35 171.13 15.08 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.57 176.17 9.6 Favored 'General case' 0 C--O 1.252 1.225 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.115 177.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -62.64 119.39 9.16 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.483 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.87 6.3 58.15 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.998 -0.62 . . . . 0.0 113.471 176.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.71 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 3.0 p -131.23 150.95 51.93 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 117.196 0.498 . . . . 0.0 111.245 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.9 p -129.95 144.14 51.17 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.636 0.236 . . . . 0.0 111.636 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.8 t -79.43 107.9 12.54 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -107.91 116.31 31.72 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-O 121.522 0.677 . . . . 0.0 110.353 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.4 t -74.92 108.77 6.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.115 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.2 mt -85.22 -50.49 7.33 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -129.87 166.58 25.21 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.16 -33.69 71.46 Favored 'Trans proline' 0 C--N 1.348 0.53 0 CA-C-N 120.669 1.274 . . . . 0.0 112.804 -177.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.499 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 53.0 m-85 -98.39 -26.49 14.46 Favored 'General case' 0 N--CA 1.434 -1.268 0 C-N-CA 118.914 -1.115 . . . . 0.0 110.827 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.44 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 57.4 t80 -105.11 114.25 28.34 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 119.188 -1.005 . . . . 0.0 112.978 175.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.8 m -122.72 131.4 53.77 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 174.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.44 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 35.5 tt0 -117.82 138.83 51.82 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 123.407 0.442 . . . . 0.0 110.094 -173.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.71 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 14.4 t -84.35 115.67 22.62 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.035 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.408 HD21 ' OE1' ' A' ' 34' ' ' GLN . 97.9 mt . . . . . 0 C--N 1.286 -2.193 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.442 -0.874 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.77 143.35 47.98 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-O 120.864 0.364 . . . . 0.0 110.228 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.3 p -92.77 162.86 13.96 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.66 -177.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -67.77 126.74 30.37 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 81.16 6.47 1.29 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.485 1.114 . . . . 0.0 112.699 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.78 159.7 21.61 Favored Glycine 0 N--CA 1.436 -1.309 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -70.86 126.38 29.43 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 17' ' ' THR . 6.2 p -104.23 -42.67 5.44 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -176.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.4 64.83 0.29 Allowed Glycine 0 CA--C 1.476 -2.353 0 C-N-CA 118.31 -1.9 . . . . 0.0 112.852 -172.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.34 156.2 16.77 Favored Glycine 0 N--CA 1.42 -2.415 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 177.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.578 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 62.4 mt -61.62 121.25 9.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.18 -11.79 40.36 Favored Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -100.92 116.5 32.93 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.9 p -114.49 17.07 17.56 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.08 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.56 -162.38 31.4 Favored Glycine 0 C--O 1.24 0.494 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.76 109.05 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.406 2.738 . . . . 0.0 111.579 175.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 11.1 p -95.25 -22.24 17.92 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.782 -177.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.52 119.57 35.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.7 m -73.21 170.09 15.7 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.79 162.97 25.74 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.375 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.1 m -65.03 113.17 3.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.05 0.452 . . . . 0.0 110.11 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.16 7.65 26.5 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.977 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.678 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 19.2 p -131.9 146.72 52.27 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.4 p -127.25 138.87 53.19 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 121.208 -0.197 . . . . 0.0 110.881 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.7 t -75.97 109.95 10.03 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -105.2 133.15 50.44 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-O 121.445 0.641 . . . . 0.0 111.351 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.4 t -81.48 99.59 4.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.9 mt -82.18 -40.63 21.49 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -145.01 168.46 12.05 Favored Pre-proline 0 N--CA 1.431 -1.399 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -65.16 -38.95 25.35 Favored 'Trans proline' 0 C--O 1.25 1.084 0 CA-C-N 120.403 1.18 . . . . 0.0 112.659 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.578 ' CD1' ' HB ' ' A' ' 11' ' ' ILE . 53.0 m-85 -96.1 -27.01 15.28 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.643 -176.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -104.2 114.08 28.07 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.589 -0.845 . . . . 0.0 111.418 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.5 m -125.68 130.04 50.76 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 174.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -118.56 144.63 45.95 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -172.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.678 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 10.2 t -87.54 114.46 24.17 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.086 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.5 mt . . . . . 0 N--CA 1.418 -2.058 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -177.72 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.535 ' H61' ' O3 ' ' A' ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.436 -1.158 0 CA-C-O 120.875 0.369 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.75 131.57 37.7 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.5 p -93.92 166.1 12.34 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.361 0.601 . . . . 0.0 111.8 -175.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -61.89 124.07 19.77 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.067 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 80.14 6.31 1.71 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.288 1.435 . . . . 0.0 112.866 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.31 159.17 20.56 Favored Glycine 0 N--CA 1.435 -1.393 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.559 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.5 tt0 -70.66 128.94 37.8 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.2 p -120.27 8.14 10.83 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 153.38 76.21 0.02 OUTLIER Glycine 0 CA--C 1.483 -1.93 0 C-N-CA 117.292 -2.385 . . . . 0.0 114.511 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.54 166.63 14.38 Favored Glycine 0 N--CA 1.419 -2.459 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 176.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.3 mt -64.93 118.54 7.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.54 -13.92 66.3 Favored Glycine 0 C--N 1.315 -0.637 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.362 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -79.49 108.4 12.99 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.22 0.533 . . . . 0.0 110.548 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.2 p -92.24 6.94 44.88 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.222 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.44 -171.23 41.08 Favored Glycine 0 C--N 1.316 -0.569 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.647 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -49.22 131.47 26.67 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 124.556 3.504 . . . . 0.0 112.299 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.4 p -125.52 -22.32 4.31 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 51.7 t -91.1 119.53 38.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.7 m -76.45 166.01 24.01 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.397 0.618 . . . . 0.0 112.479 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.91 167.82 20.03 Favored 'General case' 0 C--O 1.255 1.374 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.004 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.2 m -70.15 119.83 14.93 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 120.964 0.412 . . . . 0.0 110.268 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.46 -16.74 29.04 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.661 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 27.1 p -109.18 146.5 34.05 Favored 'General case' 0 C--O 1.251 1.163 0 O-C-N 122.426 -0.455 . . . . 0.0 111.329 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.0 p -124.9 133.73 52.95 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.799 -177.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.0 t -76.08 111.99 12.06 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -113.71 119.01 35.93 Favored 'General case' 0 N--CA 1.406 -2.648 0 CA-C-O 121.206 0.526 . . . . 0.0 110.866 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 82.4 t -70.78 108.48 2.59 Favored 'Isoleucine or valine' 0 C--O 1.253 1.248 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.816 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.434 HD12 ' CE2' ' A' ' 32' ' ' TYR . 71.2 mt -85.61 -46.41 10.81 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -133.49 166.76 26.9 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.63 -31.17 79.51 Favored 'Trans proline' 0 C--N 1.35 0.62 0 CA-C-N 120.906 1.359 . . . . 0.0 112.347 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.566 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 92.5 m-85 -99.89 -26.28 14.06 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.757 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.434 ' CE2' HD12 ' A' ' 28' ' ' LEU . 54.2 t80 -104.85 114.12 28.14 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 119.463 -0.895 . . . . 0.0 111.819 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 26.8 m -122.32 128.94 51.66 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 176.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.552 HE21 HD21 ' A' ' 36' ' ' LEU . 29.3 tt0 -121.99 138.72 54.32 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -175.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.661 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 8.6 t -82.04 118.71 23.22 Favored 'General case' 0 N--CA 1.422 -1.854 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.937 -178.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.552 HD21 HE21 ' A' ' 34' ' ' GLN . 98.0 mt . . . . . 0 C--N 1.286 -2.194 0 C-N-CA 123.78 0.832 . . . . 0.0 109.364 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 110.644 -0.132 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.25 159.97 30.18 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.47 0.652 . . . . 0.0 111.227 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.5 p -104.86 158.38 16.57 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.767 -175.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -71.87 128.75 36.74 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 77.56 -0.78 2.76 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.084 1.354 . . . . 0.0 111.551 -176.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.14 165.83 36.3 Favored Glycine 0 N--CA 1.416 -2.638 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.62 ' HA ' ' O ' ' A' ' 33' ' ' SER . 60.7 tt0 -74.65 123.39 24.79 Favored 'General case' 0 C--O 1.199 -1.599 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 23.9 p -108.88 -5.62 16.11 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 163.41 57.53 0.02 OUTLIER Glycine 0 CA--C 1.474 -2.477 0 C-N-CA 117.717 -2.182 . . . . 0.0 112.858 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -106.3 164.13 13.62 Favored Glycine 0 N--CA 1.421 -2.358 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 176.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.0 116.87 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 117.401 0.6 . . . . 0.0 109.728 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.68 -25.5 8.5 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.422 -178.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -83.78 121.9 27.94 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.0 p -116.58 13.73 15.34 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.253 0.549 . . . . 0.0 111.194 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.04 -170.29 47.01 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.075 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -57.23 117.13 3.77 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 123.933 3.089 . . . . 0.0 110.9 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 39.5 p -93.75 -4.9 49.53 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.1 t -93.15 134.48 30.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 175.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.5 m -81.29 169.45 17.28 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -177.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.93 165.71 23.77 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.901 177.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 p -60.07 116.9 4.51 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.4 -17.26 37.15 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.031 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.637 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 41.4 p -108.87 148.94 29.86 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.61 -177.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.7 p -127.47 141.68 51.6 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 122.492 -0.13 . . . . 0.0 110.725 -178.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.1 t -79.05 113.04 16.85 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -116.58 113.41 22.69 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-O 121.305 0.574 . . . . 0.0 110.188 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.4 t -70.91 106.01 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.779 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.8 mt -87.04 -39.29 15.76 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.596 0.712 . . . . 0.0 109.397 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -141.24 167.75 16.25 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.19 -33.81 29.85 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 CA-C-N 120.917 1.363 . . . . 0.0 112.559 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.534 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 48.0 m-85 -97.32 -27.47 14.48 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 118.351 -1.34 . . . . 0.0 109.829 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.562 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 57.9 t80 -104.57 113.68 27.41 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 118.703 -1.199 . . . . 0.0 112.548 177.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.62 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.9 m -118.13 130.72 56.28 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 173.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.562 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 36.3 tt0 -116.94 140.55 49.33 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 118.057 0.39 . . . . 0.0 110.311 -173.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.637 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 18.5 t -89.09 121.91 31.89 Favored 'General case' 0 N--CA 1.416 -2.137 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.715 177.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 N--CA 1.421 -1.92 0 C-N-CA 123.975 0.91 . . . . 0.0 108.941 -179.565 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.3 p . . . . . 0 N--CA 1.445 -0.721 0 N-CA-C 110.592 -0.151 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.406 ' HB3' ' HA ' ' A' ' 19' ' ' CYS . . . -66.34 148.78 51.36 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.321 0.582 . . . . 0.0 110.925 -179.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.438 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 13.9 p -99.83 153.26 19.29 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.919 -171.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -70.51 116.96 11.45 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.862 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 77.63 19.47 1.18 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.287 1.035 . . . . 0.0 110.864 -176.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.45 159.28 13.78 Favored Glycine 0 N--CA 1.416 -2.64 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 172.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.5 tt0 -68.44 136.15 52.8 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 177.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.608 ' O ' ' HA ' ' A' ' 17' ' ' THR . 9.5 p -122.36 -37.39 2.81 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -175.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.85 58.38 0.31 Allowed Glycine 0 CA--C 1.484 -1.88 0 C-N-CA 118.815 -1.66 . . . . 0.0 112.37 -173.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.48 155.01 17.06 Favored Glycine 0 N--CA 1.421 -2.343 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 59.6 mt -65.0 115.67 3.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.34 -12.02 14.18 Favored Glycine 0 C--N 1.297 -1.599 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.75 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.656 ' OH ' ' H4 ' ' A' ' 101' ' ' MAN . 62.2 t80 -93.9 122.79 36.75 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.143 0.497 . . . . 0.0 110.076 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 p -109.28 15.38 23.19 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.551 -177.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.49 -168.93 32.78 Favored Glycine 0 C--N 1.315 -0.6 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.892 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -53.64 117.3 3.69 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.955 3.103 . . . . 0.0 112.655 177.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.608 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 19.8 p -90.04 -25.75 20.65 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 123.295 0.638 . . . . 0.0 111.648 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -83.07 118.89 31.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.406 ' HA ' ' HB3' ' A' ' 2' ' ' ALA . 60.6 m -72.05 170.69 13.34 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.48 169.31 17.86 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.622 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.7 m -64.96 114.46 4.57 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.745 0.307 . . . . 0.0 110.867 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.3 6.17 45.2 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.268 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.671 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 27.4 p -128.26 147.17 50.58 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.8 p -129.38 137.71 51.09 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.728 0.299 . . . . 0.0 110.778 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.4 t -75.58 107.5 7.77 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.453 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 78.5 mt-30 -107.38 126.01 51.93 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-O 121.391 0.615 . . . . 0.0 110.949 -176.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.5 t -77.45 110.64 13.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.934 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.1 mt -89.3 -48.51 7.31 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -132.81 168.32 18.45 Favored Pre-proline 0 C--N 1.299 -1.597 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -63.39 -40.89 29.08 Favored 'Trans proline' 0 C--O 1.253 1.258 0 CA-C-N 120.994 1.391 . . . . 0.0 113.074 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.507 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 24.3 m-85 -94.72 -26.17 16.4 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.866 -177.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -104.63 113.49 27.1 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.982 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.0 m -127.03 133.88 50.42 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.47 HE21 HD21 ' A' ' 36' ' ' LEU . 29.2 tt0 -124.1 143.03 50.7 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -172.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.671 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.2 t -85.84 121.74 28.91 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.28 0.562 . . . . 0.0 110.724 -177.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.47 HD21 HE21 ' A' ' 34' ' ' GLN . 94.5 mt . . . . . 0 C--N 1.289 -2.032 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.656 ' H4 ' ' OH ' ' A' ' 13' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 19.7 p . . . . . 0 N--CA 1.445 -0.684 0 CA-C-O 120.827 0.346 . . . . 0.0 110.615 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.26 149.66 27.72 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p -88.02 143.51 27.05 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.606 -173.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -64.79 126.44 27.95 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 76.41 6.51 3.51 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.833 1.253 . . . . 0.0 111.375 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.498 ' HA3' ' H3 ' ' A' ' 101' ' ' MAN . . . -101.09 164.39 18.31 Favored Glycine 0 N--CA 1.423 -2.194 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 177.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.594 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.8 tt0 -69.35 128.98 38.49 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 17' ' ' THR . 24.7 p -122.96 -8.98 8.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -173.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.34 64.47 0.04 OUTLIER Glycine 0 CA--C 1.482 -1.986 0 C-N-CA 116.855 -2.593 . . . . 0.0 114.072 -177.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.68 171.0 17.76 Favored Glycine 0 C--N 1.293 -1.841 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 175.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.8 mt -69.03 124.23 24.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.63 -1.68 60.14 Favored Glycine 0 C--N 1.305 -1.165 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.341 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.697 ' OH ' ' H62' ' A' ' 101' ' ' MAN . 82.6 t80 -101.01 106.67 17.99 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.5 p -101.59 1.9 38.33 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.844 -176.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.77 -168.36 12.16 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.468 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -52.58 113.45 1.24 Allowed 'Trans proline' 0 N--CA 1.484 0.915 0 C-N-CA 124.183 3.255 . . . . 0.0 112.145 177.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.4 p -101.52 -30.28 11.49 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.889 0.376 . . . . 0.0 111.981 -178.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 1' ' ' THR . 57.7 t -73.79 112.29 10.22 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.249 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 54.1 m -66.93 165.2 15.96 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.17 175.62 9.49 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.006 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -66.7 115.36 6.43 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.792 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.35 9.14 58.17 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 121.251 -0.499 . . . . 0.0 112.733 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.598 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 41.2 p -122.88 148.03 45.89 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.839 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.5 p -128.66 135.12 48.85 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 123.125 0.266 . . . . 0.0 111.615 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.4 t -79.33 116.62 19.68 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.851 0.358 . . . . 0.0 110.05 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.456 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 60.0 mt-30 -114.89 114.8 25.97 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 120.778 0.323 . . . . 0.0 110.418 -177.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.4 t -70.99 118.21 15.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.456 HD12 ' CE2' ' A' ' 32' ' ' TYR . 93.7 mt -98.08 -49.28 4.8 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.282 0.563 . . . . 0.0 109.775 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.468 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 80.9 m-20 -124.25 169.11 11.25 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 178.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 29' ' ' ASN . 6.0 Cg_endo -64.14 -31.87 64.24 Favored 'Trans proline' 0 C--N 1.353 0.768 0 CA-C-N 121.404 1.537 . . . . 0.0 112.563 -177.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.491 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 51.8 m-85 -103.34 -24.51 13.5 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.159 0.504 . . . . 0.0 110.61 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.456 ' CE2' HD12 ' A' ' 28' ' ' LEU . 71.7 t80 -103.39 115.16 30.02 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 121.885 -0.509 . . . . 0.0 112.119 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.594 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.6 m -127.82 131.95 49.48 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 176.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -117.51 139.16 51.3 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -173.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.598 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.9 t -86.14 112.57 21.43 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.511 0.672 . . . . 0.0 110.566 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.456 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 43.0 mt . . . . . 0 N--CA 1.408 -2.531 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.697 ' H62' ' OH ' ' A' ' 13' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.442 -0.831 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.28 127.86 33.74 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.484 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 31.4 p -89.04 172.1 9.36 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.509 -175.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.585 ' O ' ' H2 ' ' A' ' 101' ' ' MAN . 18.3 t-160 -71.6 124.28 24.36 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 174.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 78.36 16.82 1.2 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.807 0.843 . . . . 0.0 111.664 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.48 153.86 17.17 Favored Glycine 0 N--CA 1.426 -1.989 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 174.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.5 tt0 -68.47 124.11 22.65 Favored 'General case' 0 C--O 1.21 -1.021 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.3 p -115.72 2.41 13.68 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.05 62.0 0.01 OUTLIER Glycine 0 CA--C 1.49 -1.53 0 C-N-CA 117.645 -2.217 . . . . 0.0 113.868 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.69 163.47 14.0 Favored Glycine 0 C--N 1.291 -1.922 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 59.8 mt -58.82 118.94 2.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 117.48 0.64 . . . . 0.0 110.492 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.4 -17.13 47.75 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.119 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -81.57 112.0 18.38 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 p -107.66 22.62 15.7 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.897 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.11 -169.22 39.37 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.367 177.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.74 122.99 12.77 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.95 3.1 . . . . 0.0 112.29 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 p -99.49 -10.06 22.59 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.437 0.637 . . . . 0.0 111.968 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.3 t -87.46 130.78 36.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.9 m -90.34 165.71 13.72 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.463 0.649 . . . . 0.0 112.106 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.71 163.99 26.72 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.459 176.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.6 m -74.34 124.29 26.2 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.62 -2.64 29.14 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -174.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.597 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 32.9 p -132.84 150.07 52.2 Favored 'General case' 0 C--O 1.248 1.017 0 O-C-N 122.763 -0.257 . . . . 0.0 111.018 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.3 p -128.64 139.51 52.22 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.6 t -77.44 116.56 18.12 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -117.74 122.63 43.97 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-O 121.259 0.552 . . . . 0.0 110.947 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.4 t -74.12 109.69 7.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.2 mt -87.3 -41.07 13.93 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -141.91 166.49 21.28 Favored Pre-proline 0 C--N 1.301 -1.535 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -62.6 -37.01 60.94 Favored 'Trans proline' 0 C--N 1.351 0.68 0 CA-C-N 121.206 1.467 . . . . 0.0 113.081 -177.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.52 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 84.6 m-85 -94.63 -27.25 15.98 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 118.501 -1.279 . . . . 0.0 110.813 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.496 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 48.1 t80 -105.52 113.93 27.79 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.416 -0.914 . . . . 0.0 112.782 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.604 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.0 m -120.24 129.13 53.92 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 174.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.496 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.9 tt0 -120.07 138.37 53.58 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -174.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.597 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.1 t -83.4 122.35 28.37 Favored 'General case' 0 N--CA 1.426 -1.661 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.839 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 N--CA 1.421 -1.881 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.024 -177.457 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.585 ' H2 ' ' O ' ' A' ' 4' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.8 p . . . . . 0 CA--C 1.535 0.398 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.453 ' HB3' ' HA ' ' A' ' 19' ' ' CYS . . . -79.31 140.06 37.65 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 120.934 0.397 . . . . 0.0 109.938 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.9 p -83.94 153.64 23.81 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 114.844 -1.071 . . . . 0.0 113.069 -173.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -73.56 127.63 33.27 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 76.22 2.84 3.6 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.243 1.017 . . . . 0.0 111.471 -176.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.99 169.68 29.78 Favored Glycine 0 N--CA 1.415 -2.726 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 176.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.2 tt0 -77.36 127.34 32.4 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 18.7 p -116.09 4.47 13.67 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -174.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.51 62.85 0.01 OUTLIER Glycine 0 CA--C 1.481 -2.093 0 C-N-CA 118.085 -2.007 . . . . 0.0 113.417 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.541 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -105.38 161.25 14.75 Favored Glycine 0 N--CA 1.425 -2.059 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 177.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.49 119.79 5.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 117.724 0.762 . . . . 0.0 109.256 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.26 -22.13 25.46 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -81.05 117.15 21.39 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.038 0.447 . . . . 0.0 110.288 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.0 p -101.67 -0.23 34.98 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.751 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.33 -173.61 44.65 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.591 -177.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -53.33 124.34 15.45 Favored 'Trans proline' 0 N--CA 1.477 0.509 0 C-N-CA 124.435 3.423 . . . . 0.0 112.362 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.4 p -104.03 -18.97 14.36 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.17 0.509 . . . . 0.0 111.589 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.8 t -78.75 112.71 17.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.453 ' HA ' ' HB3' ' A' ' 2' ' ' ALA . 52.4 m -65.41 162.96 16.66 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.98 172.59 12.04 Favored 'General case' 0 C--O 1.254 1.334 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.086 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.5 m -67.13 119.95 12.91 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.714 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.85 19.93 35.44 Favored Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.905 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.578 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 44.4 p -138.09 148.49 45.06 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 117.038 0.419 . . . . 0.0 110.061 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.4 p -126.17 133.33 51.6 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 122.103 0.161 . . . . 0.0 110.943 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.1 t -74.25 119.82 18.99 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -119.0 120.17 36.46 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-O 121.558 0.694 . . . . 0.0 110.818 -178.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.2 t -75.24 101.21 2.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.982 177.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.441 HD12 ' CE1' ' A' ' 32' ' ' TYR . 77.3 mt -79.51 -46.23 17.79 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.454 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 93.5 m-20 -140.31 170.5 9.52 Favored Pre-proline 0 C--N 1.31 -1.138 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 29' ' ' ASN . 4.3 Cg_exo -62.88 -43.15 21.23 Favored 'Trans proline' 0 C--N 1.358 1.056 0 CA-C-N 120.763 1.308 . . . . 0.0 112.979 -178.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.541 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 89.8 m-85 -89.77 -27.18 20.19 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 118.299 -1.36 . . . . 0.0 110.021 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.441 ' CE1' HD12 ' A' ' 28' ' ' LEU . 40.0 t80 -104.05 113.91 27.78 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 118.789 -1.164 . . . . 0.0 112.503 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.3 m -127.31 123.78 37.16 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 174.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -116.64 140.59 49.23 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 123.504 0.502 . . . . 0.0 110.391 -173.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.578 ' SG ' ' HB ' ' A' ' 23' ' ' THR . 11.4 t -88.81 123.25 33.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.5 mt . . . . . 0 C--N 1.296 -1.738 0 C-N-CA 123.794 0.838 . . . . 0.0 109.362 -176.556 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_